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Abstract
Image-guided medical interventions are diagnostic and therapeutic procedures that focus
on minimizing surgical incisions for improving disease management and reducing patient
burden relative to conventional techniques. Interventional approaches, such as biopsy,
brachytherapy, and ablation procedures, have been used in the management of cancer for
many anatomical regions, including the prostate and liver. Needles and needle-like tools
are often used for achieving planned clinical outcomes, but the increased dependency on
accurate targeting, guidance, and verification can limit the widespread adoption and
clinical scope of these procedures. Image-guided interventions that incorporate 3D
information intraoperatively have been shown to improve the accuracy and feasibility of
these procedures, but clinical needs still exist for improving workflow and reducing
physician variability with widely applicable cost-conscience approaches. The objective of
this thesis was to incorporate 3D ultrasound (US) imaging and image processing methods
during image-guided cancer interventions in the prostate and liver to provide accessible,
fast, and accurate approaches for clinical improvements.
An automatic 2D-3D transrectal ultrasound (TRUS) registration algorithm was optimized
and implemented in a 3D TRUS-guided system to provide continuous prostate motion
corrections with sub-millimeter and sub-degree error in 36 ± 4 ms. An automatic and
generalizable 3D TRUS prostate segmentation method was developed on a diverse clinical
dataset of patient images from biopsy and brachytherapy procedures, resulting in errors at
gold standard accuracy with a computation time of 0.62 s. After validation of mechanical
and image reconstruction accuracy, a novel 3D US system for focal liver tumor therapy
was developed to guide therapy applicators with 4.27 ± 2.47 mm error. The verification of
applicators post-insertion motivated the development of a 3D US applicator segmentation
approach, which was demonstrated to provide clinically feasible assessments in 0.246 ±
0.007 s. Lastly, a general needle and applicator tool segmentation algorithm was developed
to provide accurate intraoperative and real-time insertion feedback for multiple anatomical
locations during a variety of clinical interventional procedures. Clinical translation of these
developed approaches has the potential to extend the overall patient quality of life and
i

outcomes by improving detection rates and reducing local cancer recurrence in patients
with prostate and liver cancer.

Keywords
Image-guided interventions, prostate cancer, liver cancer, three-dimensional ultrasound,
2D-3D image registration, 2D image segmentation, 3D image segmentation, real-time
image processing
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Summary for Lay Audience
Medical procedures that use imaging are useful for diagnosis or treatment of patients as
open surgery is often avoided, reducing the side-effects and time needed for healing.
Needle-like tools are often used for managing diseases, like prostate and liver cancer, by
taking samples for testing, bringing radiation directly into a tumor for treatment or heating
small regions in the body to kill the cancer cells. Although the small tool sizes are helpful,
higher physician skills are needed to read 2D images for understanding the 3D body while
guiding these tools, which can lead to missed cancer diagnoses and treatments that have
cancer recurrence. 3D information has been shown to reduce the occurrence of these poor
procedure outcomes, but systems that generate 3D information are often expensive and
make procedures longer. The goal of this work was to use 3D ultrasound (US) imaging
with the software during image-guided prostate and liver cancer procedures.
One software approach was created to correct for prostate motion and performed with small
errors at more than 15 times per second when installed in our 3D US system. Another
software approach was made to automatically recognize the prostate in 3D US images. This
method performed in less than one second and had the same error as humans when tested
on images from different procedures, demonstrating the multi-purpose potential of the
software. A new 3D US system was made for guiding liver cancer therapy by controlling
three motors to create new types of images and a clinical navigation procedure that guided
therapy needles to targets identified in the images. The software was made for this system
to recognize needles in 3D US images in less than one second, improving the speed that
needle placements could be checked. Lastly, the software was made to automatically
recognize needles in 2D US images from a large range of clinical procedures and areas in
the body. We believe that this research will increase the use of image-guided needle
procedures to help patients with cancer while taking advantage of the reduced side-effects
and time for healing.
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Chapter 1
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Introduction

Image-guided medical interventions is a growing field that has many clinical applications
from neurosurgery to cancer diagnosis and therapy.1 Recent advancements in hardware and
software have benefitted this field from intra-operative tools in the form of tracking,
visualization, and advanced image processing technologies, which provide easier and
enhanced image guidance. Utilities such as image segmentation and registration are
becoming necessities for physicians as they “potentially lead to shortened operation time,
reduced radiation dose, minimized contrast medium, and most importantly, increased
accuracy.”2 As the interest in minimally invasive procedures continues to rise, increasing
image guidance accuracy will lead to increased dissemination and success of current
approaches.
Diagnosis and therapy of prostate and liver cancer can be pursued with image-guided
interventional approaches, but currently suffer from undesirable limitations, such as high
false-negative rates3 and local cancer recurrence.4 Accordingly, the focus of this thesis is
to improve the accuracy and reduce user variability of image-guided interventions using
lower-cost solutions that incorporate three-dimensional (3D) ultrasound (US) and
advanced image processing techniques. This thesis is mainly focused on applications in
prostate and liver cancer diagnoses and therapies, but applications to other relevant
anatomies, such as gynecologic and kidney cancer, are provided to demonstrate the
potential widespread impact of the investigated solutions. This work has the potential to
detect clinically significant tumors earlier, result in fewer diagnostic and therapeutic
sessions, determine appropriate treatment selection, reduce the local cancer recurrence
after focal tumor ablation, and treat more complex tumor locations. The remainder of this
chapter describes the current status of prostate and liver cancer prevalence (1.1),
therapeutic options for patients with these disease sites (1.2), image-guided interventions
(1.3) with selected image processing techniques (0) as alternatives to conventional therapy,
and the unmet needs, hypothesis, and specific objectives of the thesis (1.5).
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1.1

Motivation

1.1.1

Prostate cancer

Prostate cancer is the most commonly diagnosed non-skin cancer in Canadian men with 1
in 9 males expected to be diagnosed with the disease in their lifetimes.5 This disease site
accounted for 20.3% (22,900) of all new cancer cases, with 99% of cases occurring in men
over the age of 50. Prostate cancer was projected to be the third most common cause of
cancer deaths in Canadian males in 2019, but the mortality rate has been declining by 2.8%
per year since 1994 and has the third-highest five-year net survival rate (93%) in most
recent predictions.5 Although the disease is most often highly treatable, prostate cancer has
a wide range of clinical presentation from slow-growing to fatally aggressive, which is
characterized by a standardized numerical scoring system (i.e., Gleason score).6
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Figure 1.1 Local anatomy in the male pelvis surrounding the prostate.
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The prostate is a gland of the male reproductive system located in the pelvis inferiorly to
the bladder, posterior to the pubic symphysis, and anterior to the rectum (Fig. 1).7 This
non-vital gland surrounds the urethra and contributes secretions in the formation of semen.
The presence of disease can lead to symptoms such as frequent urination, blood in the urine
and semen, as well as discomfort from an enlarged prostate.8 Although these symptoms
can be difficult and sometimes intolerable, metastatic disease that spreads through the body
is the primary concern as five-year survival rates are approximately 30% relative to almost
100% for local or regional prostate cancer.9 This variability in survival correlating with
disease aggressiveness stresses the need for earlier cancer detection before late-stage
disease development and more aggressive treatments for high-risk disease.

1.1.2

Liver cancer

Liver cancer is one of the fastest rising cancers in Canada. While it only represents less
than 2% of all new cancer cases, liver cancer incidence in Canada has been increasing in
males (3.3%) and females (2.7%), second only to thyroid cancer, based on the average
annual percent change between 1984 and 2015.5 More concerning are the annual changes
in mortality rates since 1984, which shows that liver cancer is the highest statistically
significant (p < 0.001) increasing change in males (3.1%) and females (2.2%).5 Once
diagnosed with the disease, the prognosis is poor as liver cancer has the fourth-lowest fiveyear net survival rate (19%). This rate is also an underestimate relative to other sources as
it does not consider cancers of the intrahepatic bile duct or the large number of unspecified
cases based on primary or metastatic classifications, which would increase the number of
cases by 45.9%.5
These statistics get worse on a global scale as liver cancer accounts for the fifth and ninthhighest incidence rates for cancer and the second and sixth-highest mortality rates, for men
and women respectively.10 One major cause for the high mortality rate is the asymptomatic
nature of most primary liver cancers with very few to nonexistent traditional cancer
markers, like bleeding and palpable lesions. This leads to large and late-stage tumor
diagnoses that are less treatable with curative intent. However, improvements in early
detection of liver cancer have been observed more recently, partially attributed to the
widespread use of ultrasound screening for individuals at risk for liver cancer.11
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Figure 1.2 Local anatomy in the abdomen surrounding the liver.
The liver is the largest solid organ in the body located inferiorly to the diaphragm and
normally resting against the lateral and anterior abdominal walls. It is predominantly
divided into two lobes (i.e., right and left) by the falciform ligament, but it is often more
finely divided into eight segments unequally distributed between the two lobes and in
relation to the hepatic arterial, portal, and biliary drainage.7 The primary functions of the
liver are to produce bile for digestion, process nutrients and drugs, and filter blood from
the stomach and intestines.
The most common subtype of liver cancer is hepatocellular carcinoma (HCC) and is highly
prevalent in low-income and developing countries.11 Liver cancer is predominantly due to
the incidence of hepatitis B and C viruses12,13 and is often preceded by cirrhosis (scarring),
but includes other risk factors like excessive alcohol consumption, smoking, fatty liver
disease, diabetes, obesity, and aflatoxin (produced by some fungi on crops, like corn and
peanuts14) exposure.5,12 Although increases in mortality rates have been mostly attributed
to hepatitis and alcohol consumption,12 universal vaccinations against hepatitis B have
been shown to reduce the incidence of HCC with statistical significance.15 The liver is also
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a frequent site for metastatic cancer originating from other parts of the body, such as the
lung, breast, pancreas, gastrointestinal tract and lymphatic system.12

1.2

Conventional therapeutic options

1.2.1

Prostate cancer

Over-diagnoses of prostate cancer has been a concern with the increased use of prostatespecific antigen (PSA) for screening as many prostate cancers would not affect quality or
quantity of life if left undetected.16 Recent Canadian guidelines in 2014 have mirrored the
decisions from the United States Preventive Services Task Force to decrease PSA
screening in men over 75 and asymptomatic men, which has resulted in a 9% decrease in
the annual percent change for prostate cancer incidence since 2011.17 Although surgery,
radiation, and drug-based therapies are effective in the management of prostate cancer,
recent motivation has been focused towards conservative management techniques and
focal methods of treatment.18

1.2.1.1

Active surveillance

Active surveillance refers to deferring treatment and observing patients with serial PSA
assessments, repeated biopsies, and other recurring diagnostic exams to wait until low-risk
disease shows signs of higher-risk and likely well within the window of opportunity for
cure.19 Concerns with overtreatment of low-risk prostate cancer have led to increases in the
number of patients recommended for active surveillance; for example, the percentage of
patients with low-risk disease in the United States on active surveillance increased from
15% to 42% in 2015,20 with the majority of increases in patients over age 75.9

1.2.1.2

Radical prostatectomy

Radical prostatectomy is a surgical procedure that completely removes the prostate gland
and its attachments around the base of the bladder.7 This procedure is considered an
excellent treatment option for patients with early prostate cancer;21 however, side effects
include incontinence, impotence, and altered bowel habits with approximately 35% of
patients experiencing biochemical recurrence within ten years.22 Following recent
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guidelines to reduce overtreatment of low-risk disease, prostatectomies have declined from
47% to 31% as of 2015.20

1.2.1.3

Systemic treatments

Advanced prostate cancer that has metastasized beyond the prostate is most often treated
using androgen deprivation or chemotherapy.9 Androgens like testosterone and
dihydrotestosterone are essential for the prostate and overexpression of the androgen
signaling pathways are often observed in proliferating prostate tumor cells.23 Suppressing
these hormones in the body is a foundational and mainstay treatment for advanced prostate
cancer; however, not all prostate cancers respond to this form of therapy and many can
develop into castration-resistant prostate cancer.24 The remaining treatment option is often
chemotherapy with palliative intent,25 but the utility of involving chemotherapy at different
stages of disease progression have been investigated.26

1.2.1.4

External beam radiation therapy

External beam radiation is a well-established form of therapy for low to intermediate-risk
prostate cancer, with application to high-risk in some cases, and is often treated alone or in
combination with androgen deprivation therapy.27 Radiation therapy is associated with
improved long-term sexual function and urinary continence relative to prostatectomy, but
patients have been observed to have worse bowel function and treatments are often long,
typically requiring multiple weeks of treatment sessions.28 Recent evidence suggests that
there is an increased risk of overall and prostate cancer-specific mortality compared to
surgery for clinically-localized prostate cancer,29 but new techniques incorporating
accurate imaging such as intensity-modulated and stereotactic radiation therapy have
focused on increasing the dose-per-fraction to the prostate (reducing the overall physical
dose), improving coverage of tumor volumes, and reducing adverse side effects through
the use of smaller and more conformal fields.27,30

1.2.1.5

Prostate brachytherapy

Prostate brachytherapy refers to procedures where radioactive sources are implanted or
brought within the prostate using needles, typically guided by a rigid template with
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regularly spaced holes every 5 mm in a grid-like system. Prostate brachytherapy is most
often used as a monotherapy to treat early, localized prostate cancer tumors31 and in
combination with external beam therapy for intermediate and high-risk patients. This
procedure involves either permanently implanting low-dose-rate (LDR) radioactive seeds
or temporarily holding a high-dose-rate (HDR) radioactive source at specified positions in
hollow needles based on calculated dwell time durations. Since the radioactive sources are
implanted or temporarily held within the prostate, highly conformal dose distributions can
be achieved with improved healthy tissue sparing of organs-at-risk, such as the bladder,
urethra, and rectum, compared to external beam radiation.32 For intermediate and high-risk
prostate cancer, brachytherapy can also be used to boost radiation dose to the tumor
following external beam radiation therapy for a statistically significant benefit in 5-year
biochemical-progression-free survival, but a complete understanding of long-term
toxicities is still unknown.31

1.2.2

Liver cancer

Liver cancer is typically diagnosed using a combination of health history, physical and
imaging examination, blood tests, and biopsy.33 Since the liver rests on the lateral and
anterior abdominal walls, the liver is easily accessible and can be treated using open
surgery or percutaneous (through the skin) approaches. Although it is generally understood
that early detection of cancer can lead to improved survival outcomes, early-stage HCC is
currently difficult to diagnose because it is usually a single, asymptomatic lesion measuring
less than two centimeters in diameter, with no vascular or distant metastases.34

1.2.2.1

Transplantation or resection

Resection and transplantation have conventionally been the curative surgical options of
choice for treating patients with HCC.35 This is either the removal of some of the liver
segments or the entire organ, depending on the number, location, and spread of the
disease.36 Surgical resection is usually considered for early-stage HCC with a single lesion
less than three centimeters,35 sometimes with up to three lesions,12 as sufficient remaining
liver function is necessary for survival.36 The presence of comorbidities, such as cirrhosis,
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can increase the risk of HCC recurrence after liver resection and typically motivates the
need for other treatment options, like transplantation.
Transplantation is a desirable method for curing liver cancer as it has the potential to
remove localized tumors and underlying cirrhosis, which presents as complications in other
forms for therapy. Although transplantation is the preferred treatment modality for patients
with solitary HCC, poor liver function, or multifocal HCC, patient eligibility is low,
complications can be frequent and severe, and the lack of consistent donors leads to long
waiting times.37 Both resection and transplantation are limited to approximately 10% to
20% of patients36 and even if the patient is eligible for this type of procedure, complications
rates have been observed to be approximately 26% in resection and 33% in
transplantation.38 Also, conventional techniques to treat and manage individuals with liver
cancer have been typically associated with high costs, both clinically and financially, with
the scarcity of liver donors often leading to a preferential selection of other alternatives,
such as liver ablation.12

1.2.2.2

Chemotherapy

Advanced-stage liver cancer that has spread beyond the organ to local nodes and distant
sites or has invaded the portal or hepatic veins typically have very few options for therapy.
Standard chemotherapy is not tolerated well and has not been shown to be effective in
treating advanced HCC.12 The most recognized treatment option for advanced-stage liver
cancer with well-preserved liver function is chemotherapy treatment with a molecular
target agent, sorafenib, to slow tumor proliferation and angiogenesis, but overall survival
is usually only extended by two to seven months.39,40

1.2.2.3

External beam radiation therapy

External beam radiation has been used increasingly in the treatment of liver cancer due to
advances in planning and delivery that have improved sparing of the radiosensitive healthy
tissue.12 Radiation therapy is most often ideal for early to intermediate-stage liver cancer
and is most often recommended when other techniques are not possible or as a bridge to
transplantation.41 Breathing motion and liver position changes can make it difficult for
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radiation therapy, but advances in imaging and liver motion tracking have led to more
investigation into conformal radiation delivery, dose-escalation, and fewer fractions of
therapy.42

1.2.2.4

Embolization

Intermediate stage liver cancer typically refers to a multinodular disease that has either
more than three lesions or two to three lesions with at least one greater than five
centimeters.37 Patients showing signs of this stage are often treated with embolization,43
with the most common form being transarterial chemoembolization (TACE), which
focuses on inducing tumor necrosis by acute arterial occlusion with the addition of
chemotherapeutic drugs.36 These are typically salvage or bridge therapies for patients with
preserved liver function and do not usually have curative intent as complete necrosis is not
typically achieved for larger tumors due to incomplete embolization and tumor
angiogenesis.35 Approaches that combine TACE with other procedures have been
investigated for tumors larger than three centimeters to make patients eligible for other
curative approaches,44 with the use of TACE post-resection showing benefits compared to
other anti-recurrence therapies.45 Embolization can also be performed using radiation
sources, such as Yttrium-90, with evidence suggesting potential benefits for patients with
advanced tumor stages and few treatment options.46

1.2.2.5

Ablation

Ablation techniques are considered the best treatment alternatives for HCC patients who
are not eligible for surgical techniques.36 Tumor ablation is defined as the direct application
of therapies to eradicate or substantially destroy focal tumors, either using chemicals or
energy-based (i.e., thermal or non-thermal) approaches.47 These ablation approaches can
include the use of ethanol, radiofrequency, microwave, freezing (cryo), laser, highfrequency ultrasound, and irreversible electroporation.48 Therapy is applied through the use
of applicators, such as electrodes in radiofrequency ablation (RFA), antennas in microwave
ablation, or fibres in laser ablation, to provide a focal region of therapy. These procedures
can be used in a palliative setting for pain management, but also has the potential for
curative intent on early-stage or small tumors. For example, RFA is considered a first-line
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treatment option for HCC in the liver49 and has been shown to have similar survival as a
resection for solitary lesions less than five centimeters with well-preserved liver function.50
Since these procedures have small incision sites, these minimally or less-invasive
procedures have been observed to result in procedures with a rate of complications of less
than 2%.51 In addition, these procedures are often associated with lower costs as treatment
times, hospital stays, and the need for blood transfusions are reduced.34
The most common treatment approaches for tumor ablation in the abdomen are either RFA
or microwave ablation (MWA). These thermal methods both focus on the production of
heat for tissue ablation but have different mechanisms of heat production that require
different equipment and application techniques. RFA techniques use applicators that are
needle-like and typically use a single monopolar active applicator, occasionally separating
at the tip into multiple tines for a larger ablation volume, with a 375-500 kHz alternating
current dissipating at one or more grounding pads to produce resistive heat.47,52 MWA uses
needle-like applicators without the need for grounding pads and generates microwaves with
a frequency between 915 MHz and 2.45 GHz to produce frictional heat from oscillating
water molecules.52 Both techniques allow for multiple applicators to be placed, depending
on the size and geometry of the lesion being targeted for therapy, but MWA can also allow
for simultaneous activation of applicators to exploit electromagnetic field overlap. Aside
from the current size of the MWA applicators, this method has the potential to offer
improved performance over RFA.52 Although both methods have numerous benefits, one
limitation is the proximity of lesions to large vessels as sufficient heating cannot be
achieved due to the heat sink effect, which requires other forms of therapy. The placement
accuracy of the therapeutic applicators is also critical for procedure success due to the
percutaneous nature of these procedures and the focal volume of therapy. Unfortunately,
current approaches have been observed to show a range of local cancer recurrence rates
between 6-39% of patients treated for HCC or colorectal liver metastases.4,41,50,53

1.3

3D Image-guided interventions

Medical imaging can have an impact on nearly every aspect of interventions to achieve
successful diagnostic or therapeutic outcomes. Classification for the use of medical images
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throughout a procedure is most often separated based on five separate categories: planning,
targeting, monitoring, modification, and assessment.54 With the wide use of digital images,
recent advancements have focused on merging or fusing 3D images in different
combinations from these categories, alongside image processing for clinical workflow
improvements, for improving patient side-effects and outcomes in various image-guided
interventions related to prostate and liver cancer.

1.3.1

MR-TRUS fusion biopsy
Preoperative

Intraoperative

Registration
3D MRI

Registration

3D TRUS

2D TRUS

Figure 1.3 Image-guidance pipeline for MR-TRUS fusion-guided prostate biopsy. The
prostate (yellow) and regions suspicious of cancer (red) identified in MRI can be targeted
using real-time 2D US guidance for biopsy sampling after two image registration steps.
Concerns of prostate cancer over-diagnosis with over-treatment and missed diagnoses
using conventional biopsy techniques have led to the development of a targeted magnetic
resonance (MR)-transrectal ultrasound (TRUS) fusion biopsy approach.55 The
conventional technique for definitive diagnosis of prostate cancer is a template biopsy
method that typically samples six to twelve tissue regions using biopsy cores guided by 2D
US, which are processed and examined histologically for prostate cancer. 56 In contrast,
fusion biopsy uses preoperative multi-parametric MR images, including T1-weighted, T2weighted, diffusion-weighted, and dynamic contrast-enhanced imaging,57 fused with
intraoperative US images to perform sampling of suspicious cancer regions determined
using both image modalities. This forms an imaging pipeline where the preoperative MR
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image is registered to an intraoperative 3D TRUS image, followed by a subsequent
registration between the 3D TRUS image and live 2D TRUS images.58 Although MRguided systems without TRUS have been developed,59 this combination of imaging
modalities allows for an outpatient procedure without costly interventional suites. The
combination of US with multiple MR imaging sequences enables the physician to perform
targeted biopsies based on the superior soft-tissue contrast and functional information from
MR images, while still using real-time and lower cost image guidance provided from US
imaging.
One of the main factors contributing to the success of an MR-TRUS guided procedure is
the detection of clinically significant prostate cancer. Clinically significant prostate cancer
has been defined60 as a tumor with a volume greater than 0.5 cm3, which is comparable to
a sphere with a radius of 5 mm. When using an MR-TRUS fusion approach, evidence has
been shown that clinically significant prostate cancer is sampled more frequently and with
fewer biopsy cores, leading to less detection of clinically insignificant cancer.61 Results
from the Prostate MR Imaging Study (PROMIS) showed that primary biopsy can also be
avoided in approximately 27% of patients and MR images can also be used to direct TRUS
biopsy to detect 18% more cases with clinically significant prostate cancer,62 potentially
reducing the misdiagnosis and overtreatment of prostate cancer.

1.3.2

3D US-guided brachytherapy

Brachytherapy approaches rely on the accurate guidance of needles to place radiation
sources at planned locations to achieve sufficient therapy while sparing healthy organs at
risk. Prostate cancer applications typically use 2D US as the standard of care for guiding
approximately 10-20 needles to planned locations as it is portable, inexpensive, real-time,
and does not use ionizing radiation.63 Based on an accurate volume and shape of the
prostate relative to the inserted needles, radiation plans can be computed and optimized to
produce 3D patient-specific therapies.64 Methods have been investigated to incorporate
CT65 or MR66 images for planning, but the widespread use of US has many practical
advantages as the entire procedure can be completed without moving the patient, which
saves time, resources, and clinical costs.67 However, 2D US images rely on the subjectivity
of the physician to mentally form an impression of the 3D anatomical space, which can
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introduce variability when determining needle positions relative to their intended targets
for therapy and away from organs at risk, such as the rectum and urethra.68 These images
also do not inherently allow for the required accurate 3D prostate volume and shape for
gland dose calculation, requiring interpolation and approximations based on limited fieldsof-view.
Generating 3D US images for prostate brachytherapy can provide a solution for the
limitations of conventional 2D US techniques and can be acquired using different
geometries depending on the transducers available and structures of interest. End-fire
transrectal ultrasound (TRUS) probes are often used for biopsy procedures as they can
allow for improved sampling in the sagittal and transverse sections of the prostate,69 but
are often difficult to use during brachytherapy when inserting multiple needles at a time
and correlating the US images relative to the guidance template. Side-fire TRUS probes
can take advantage of sagittal transducer elements, which generate submillimeter spatial
resolution in the needle insertion directions that can lead to <1 mm tip localization
uncertainty during prostate brachytherapy.70 Side-fire probes can also be combined with
transverse US elements to form biplane probes for accurately identifying the central crosssection of the needles for determining 3D needle trajectories and offer simple pull-back 3D
US image reconstruction with the use of commercial steppers (Civco Medical Instruments,
Iowa, United States).
Motorized 3D US systems have been developed for prostate brachytherapy applications to
provide consistent and repeatable image reconstructions while enabling approaches to
return the US probe to implants at later time points.71,72 3D US systems have also been
developed for brachytherapy applications treating breast73 and gynecologic cancers,74
which similarly requires the precise placement and identification of needles for sufficient
therapy and avoiding organs-at-risk. Regardless of the anatomical location being treated
with 3D US-guided brachytherapy or the chosen dose-rate approach, localizing needle tips
and trajectories accurately is necessary for correct computation of dose plans.
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1.3.3

Image-guided ablation

The use of CT, MR, and 2D US imaging for the five main categories of image-guided
interventions have been investigated for increasing the feasibility and scope of focal
ablation procedures in the liver. CT images provide a versatile utility for ablation
procedures as they are used preoperatively to identify the presence of cancer (typically
using intravenous contrast material),54 intraoperatively for intermittent images with partial
access during applicator insertions and verification of placement,75 and postoperatively for
follow-up.76 CT fluoroscopy can be used for near real-time intraoperative imaging, but
radiation exposure to the patient and personnel is a major consideration.77
MR images have also been used as they offer advantages such as improved soft-tissue
contrast, nonionizing radiation, and the potential for real-time treatment monitoring,78 but
intraoperative access to the patient is often limited and the need for real-time images
typically reduces the achievable image resolution and contrast,79 all with higher associated
costs. The use of 2D US for real-time image feedback is beneficial when placing
therapeutic ablation applicators intraoperatively in the treatment of liver cancer and also
does not use ionizing radiation. However, similar to issues experienced in biopsy and
brachytherapy, these images can increase the burden on the physician as they need to
mentally reconstruct the complex anatomy, which can introduce subjective image guidance
variability. These 2D US-guided insertions also require extensive training to interpret the
US images, perform image and applicator alignment for real-time tracking of the applicator
insertion, and verification of the final placement to assess expected therapeutic margins.
CT, MR, and 2D US images all have aspects that make them advantageous for imageguided ablation procedures, but variability in therapy applicator image-guidance still
remains, which leads to the insufficient placement of therapeutic applicators, contributing
to the local cancer recurrence rates as discussed in Sec. 1.2.2.5.
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1.4

Image processing in image-guided interventions

1.4.1

Image-based registration

Image registration is an image processing technique that spatially aligns two or more
images of the same scene taken from different times, viewpoints, and/or image
modalities.80 Use of the image signal intensity information to perform spatial alignment
refers to image-based registration techniques, which can be performed in multiple ways
and is dependent on the choices made on four main components: image similarity metric,
optimization approach, transformation degrees-of-freedom (DoF), and interpolator.81 In
general, the image similarity metric provides the quantitative measure for comparing
different transformations sampled using an optimization approach, with voxel interpolation
to resample the image in the new coordinate system. Transformations can be performed
simply using image translations and rotations, as in a rigid approach, up to complex
operations like pixel-wise deformations, as in a non-rigid deformable approach.82 These
choices not only influence the accuracy of an image-based registration approach but also
the computer computation time required to perform the operations, which can be an
important factor for practical implementation during procedures with intraoperative imageguidance.

1.4.2

Image-based segmentation

Image segmentation, labeling, or contouring refers to the process of classifying image
pixels or identifying boundaries corresponding to image regions that share relevant
characteristics, like an organ or an interventional tool.83 This can be done manually by
drawing regions in the image or identifying points that are later joined using defined
assumptions, which is often the gold-standard method for an image segmentation task.
However, due to the user-required effort, this is often a time-consuming process that can
be a limiting factor for clinical workflow, as is the case for some intraoperative
interventions like MR-TRUS fusion biopsy. Since this limitation can occasionally prevent
the clinical adoption of image-guided interventions, the frequent investigation into semiautomated and fully automated methods are performed to ease the burden on the user.84
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Artificial intelligence is a broad umbrella term that is defined as any device that perceives
its environment and takes actions that maximize its chance of success at some goal. 85
Recent efforts into fully automated segmentation methods have focused on data-driven
approaches, such as convolutional neural networks (CNNs), which reduce the amount of
user selection when determining relevant image features for discriminating image regions,
referred to as hand-crafted features in traditional machine learning.86 Data-driven
approaches are performed by supplying an algorithm with previously acquired data and
allowing optimization methods to determine the relevant image characteristics through
training of model parameters. This approach is often referred to as deep learning, which
can be either performed using a supervised approach, where images with previously
identified regions are provided for training, or an unsupervised approach, where only the
images are given and the algorithm tries to automatically determine inferences without
training labels. The development of graphics processing units (GPUs) has made deep
learning approaches more feasible as they allow for highly parallel and simultaneous
computational processing, unlike more traditional central processing units.87 While
supervised learning requires more effort to produce a large enough dataset with required
annotations, typically performed manually, unsupervised learning is more challenging and
often requires larger datasets to determine reliable inferences. However, providing
annotations for supervised deep learning tasks is often performed manually, which can
incorporate errors and biases into the trained deep learning network.88

1.5

Challenges in image-guided interventions

1.5.1

Previous work and unmet needs

1.5.1.1

Motion compensation during MR-TRUS fusion biopsy

Performing image-based registration during MR-TRUS guided biopsy has been
investigated previously to correct for intraoperative patient and prostate motion for
accurate needle delivery. Accurate needle sampling during fusion biopsy is typically
achieved when errors from four main sources throughout the workflow are minimal,
namely (1) the mechanical guidance system,55 (2) MR-3D TRUS multi-modal
registration,89 (3) 3D-3D TRUS preprocedural initialization and intraoperative
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correction,90 and (4) 2D-3D TRUS motion compensation.58 In the last form of correction,
real-time image guidance is performed using live 2D TRUS images, typically on a US
system with an image refresh rate of approximately 15 frames-per-second, providing the
information needed for an image-based registration.
Since the patient is awake and not constrained or intubated during the MR-TRUS fusion
biopsy, prostate motion arises due to sources including the respiratory cycle, the cardiac
cycle, and general patient motion from discomfort and response to audible feedback from
the spring-driven biopsy gun. TRUS transducer pressure caused by the physician can also
change throughout the image-guided procedure, potentially leading to prostate
deformations. These sources of motion can cause target misalignment,90 which increases
needle targeting errors and the chance of missing cancer suspicious regions based on the
registered MR image. To accurately sample a target, recent work has shown that a needle
delivery system, including hardware and image-guidance software, requires an overall
delivery error of 1.6 mm to sample a tumor of 1 cm3 with 95% probability.91
2D-3D TRUS registration has been performed with promising results using a normalized
cross-correlation (NCC) similarity metric and a Powell optimization to determine rigid
registration corrections.58 The choice to use an NCC similarity metric is beneficial for
single modality registration problems as it does not rely on the computation of derivatives,
which can be time-intensive and often unknown, while also inherently being suitable for
computational parallelization on simultaneous threads provided by GPU hardware. These
advantages allow for faster processing and lower overall computation times, with the
potential to be performed throughout the course of a fusion biopsy. However, computation
times must be less than or equal to the displayed images to provide a seamless appearance
without lag, which is often necessary for usability. In addition to physician usability, a
continuous and automatic approach has the potential to compound errors throughout the
procedure based on previous misalignments and has not been investigated.

1.5.1.2

Prostate segmentation in 3D TRUS

3D image-guided procedures in the prostate, such as MR-TRUS fusion biopsy and
brachytherapy, rely on the identification of the pixels and boundary of the prostate gland
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in 3D TRUS images for performing necessary workflow tasks like accurate needle
guidance, gland volume computation, and dose calculations. Conventional workflows
typically rely on the gold standard manual identification of the prostate in these images,
but this process is time-consuming and can be variable due to physician subjectivity, which
can increase the risk to patients during procedures that use anesthesia.92 Therefore, the
investigation into automatic approaches for prostate segmentation in 3D TRUS images
potentially provides an effective solution for providing a fast and objective method to
improve clinical workflow during 3D US-guided prostate procedures.
3D TRUS prostate segmentation that is partial or fully automatic has been previously
investigated and has been shown to be feasible in numerous publications.93–96
Unfortunately, 3D TRUS prostate segmentation still remains a clinically unmet need as
investigated methods have lacked clinical translation due to computation complexity and
time. Most recently, the data-driven approach of CNNs have been investigated to address
these issues,97,98 but minimal evidence of robustness to variable clinical datasets has been
shown as these methods have been applied to specific and limited dataset sizes. 3D TRUS
images previously investigated are typically from a single US machine and one acquisition
geometry with matched voxel dimensions and sizes, which can limit understanding of
performance, especially when pursuing cross-validation approaches. Additionally,
comparison between previous publications can be challenging when not assessed on the
same dataset and when reported evaluation metrics are not consistent.

1.5.1.3

Image-guidance during focal liver tumor therapies

Focal liver tumor therapies rely on the accurate guidance of ablation applicators to provide
sufficient cancer therapy. Procedures that incorporate 3D information, such as CT
imaging,99 MR imaging,78 and electromagnetic tool tracking,100 have been shown to
improve targeting accuracy that leads to higher clinical success rates on first ablation
attempts and fewer sessions overall when compared to conventional techniques.101,102
However, these methods can be limited in widespread adoption as factors like increased
procedure times, patient radiation dose, sophisticated and costly interventional suites, and
environmental limitations can make these approaches less feasible. Therefore, a clinical
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need exists for a cost-effective intraoperative approach that can help physicians improve
the image guidance to lesions for sufficient cancer therapy without local recurrence.
3D US is an alternative method for image guidance that can provide real-time
intraoperative imaging that is portable and able to provide multiplanar images for
visualizing complex anatomy and focal therapy ablation applicators.103,104 Similar to a
prostate fusion biopsy or brachytherapy workflow, a mechanical 3D US system has been
previously developed that has the potential to provide a lower-cost guidance system for
accurately targeting lesions based on targets derived in 3D US or other image modalities if
registered.105 While this system provided sufficient proof-of-concept information on
clinical feasibility and validation of needle positions within 3D US images, clinical
usability was limited due to factors like manual locking components, scanner bulkiness,
and a lack of tracking information for guidance, and was never investigated for performing
active navigation to prospective targets.

1.5.1.4

Segmentation of therapy applicators in 3D US liver images

3D US imaging and systems like the one described in Sec. 1.5.1.3 have the potential to
improve focal liver tumor therapies by increasing visualization of anatomy, reducing the
mental burden and complexity for physicians, and enabling accurate localization of therapy
needle-like applicators. Although 3D US has the potential to provide benefits to these
procedures, increasing the visual information presented to the physician could add time to
the procedure and visibility of the needle applicators can change depending on factors such
as insertion angle, depth, applicator diameter, and choice of US transducer.106 Providing
automation to applicator identification based on image information may provide a low-cost
solution to reduce the time required for verifying applicator positions, especially during
multi-applicator insertions, increasing the feasibility of incorporating 3D US into focal
liver tumor ablation therapies.
Existing methods for image-based 3D US applicator segmentation have primarily focused
on other needle applications for the prostate,107 breast,108 heart,109 and anesthetic
administration,110 where factors affecting needle visibility are drastically different. Deep
applicator insertions up to 30 cm and steep insertion angles relative to the US transducer
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result in challenging images for determining tip and trajectory information necessary for
assessing the expected therapeutic volumes in focal liver ablation therapies. A clinical
dataset on liver patients has also not been investigated and could present unexpected issues
relative to current work on other applications and benchtop experiments.

1.5.1.5

Segmentation of tools during 2D US interventions

Identifying and localizing needle-like tools intraoperatively is a common need in imageguided interventions that conventionally use 2D US imaging, such as biopsy,
brachytherapy, and ablation, for guiding these tools to perform accurate diagnoses and
therapies. Although technology like 3D US imaging has the potential to improve tool
localization and verification, as described in Sec. 1.5.1.4, 2D US is still the clinical standard
at most institutions for image-guided interventions. Thus, clinical needs for improving
guidance still exist for providing optimal therapy while minimizing risks to healthy tissue
and to avoid adverse events like local cancer recurrence.111 By using technology like
image-based segmentation for automatic tool segmentation, a low-cost solution with the
potential for widespread accessibility could be provided in these situations without the need
for additional equipment, signal processing, and operating room set-up. Once tools are
accurately identified, additional information can also be displayed, such as providing
ablation volumes relative to the tip location in focal liver ablation therapies to predict
therapeutic margins during applicator insertion, which could potentially improve clinical
workflow and reduce the need for repeated adjustments and reinsertions.
Recent efforts focusing on automatic image-based tool segmentation in 2D US images have
investigated the use of data-driven approaches, like CNNs, to provide robust methods with
fast computation times for image-guided interventions.112,113 Using annotated datasets for
training deep learning networks, applications in procedures with steep needles112 and
kidney biopsy113 have shown promising results for using CNN approaches. Although tools
in many interventional procedures have similar needle-like appearances, most approaches
for image-based tool segmentation in 2D US images are application-specific and lack
evidence for generalizability, such as evaluation on other anatomical applications, US
systems and acquisition settings, and variable tool visibility.
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1.5.2

Hypothesis

The central hypothesis of this thesis is that the incorporation of 3D US and advanced image
processing techniques will increase the accuracy and reduce the user variability of imageguided interventions in the management of prostate and liver cancer.

1.5.3

Objectives

The objectives of this thesis are to:
1. Develop an automatic motion correction algorithm approaching the frame rate of
an US system to be used in fusion-based 3D TRUS prostate biopsy systems.
2. Develop a pre-insertion automatic deep learning-based approach to segment the
prostate for biopsy and brachytherapy applications in 3D TRUS images.
3. Develop a geometrically variable 3D US mechanically assisted system to guide and
verify the placement of therapy needle applicators in focal liver tumor therapy.
4. Develop a semi-automatic approach for identifying therapy needle applicators in
3D US images from focal liver tumor therapies.
5. Develop a general and automatic deep learning-based approach for identifying
needle-like tools in 2D US images from various image-guided interventional
procedures.

1.6

Thesis outline

The overarching goal of this thesis is to address the specific thesis objectives in five
manuscripts (Chapters 2 to 6).
Chapter 2: Real-time registration of 3D to 2D ultrasound images for image-guided
prostate biopsy
Patient motion can be continuous or intermittent throughout MR-TRUS prostate biopsy
procedures and causes misalignment of the MR-derived targets during targeted biopsy
workflows. This chapter describes our work to develop a real-time and continuous motion

22

compensation algorithm for automatic registration of 2D and 3D TRUS images.
Retrospective patient images were used for adapting, developing, and optimizing the realtime capabilities of a previously published approach58 through the use of a GPU, image
downsampling, 2D area-of-interest cropping, and optimization search space direction
initialization. The optimized algorithm was implemented on a 3D TRUS-guided system
and evaluated on a tissue-mimicking prostate phantom with embedded spheres. This
phantom was mounted on a translation and rotation stage to compare the real-time
registration method against a single user-initiated correction for known displacements.
The optimized continuous registration method was shown to significantly reduce
registration times compared to a user-initiated method and resulted in sub-millimeter and
sub-degree registration errors for both approaches. By continually registering images,
optimization search spaces are often small between subsequent image frames and led to
reduced iterations for convergence. This work was novel as it developed the first approach
to achieve 2D to 3D TRUS image registrations that resulted in computation times
approximately at the frame rate of an US system. This provided an approach to improve
clinical workflow during image-guided prostate biopsy procedures.
Chapter 3: Automatic prostate segmentation using deep-learning on clinically diverse
3D transrectal ultrasound images
3D TRUS imaging has been shown to benefit needle-based procedures for diagnosing and
treating prostate cancer (i.e., biopsy and brachytherapy); however, these images require the
physician to manually or semi-automatically segment the prostate, which is timeconsuming and difficult, often occurring while the patient is under sedation or anesthesia.
This novelty and literature contributions of this chapter focuses on the development of a
new deep learning-based approach to automatically segment the prostate in a clinically
diverse 3D TRUS dataset. Modifications were made to a previously published deep
learning U-Net architecture114 and 3D TRUS images were acquired from different
procedures (biopsy and brachytherapy), acquisition geometries (end-fire and side-fire), and
ultrasound systems. We developed a 3D segmentation method involving deep-learning
predictions on 2D radial slices, followed by reconstruction into a 3D surface, to exploit the
utility of the 3D TRUS dataset and take advantage of the approximately spherical nature
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of the prostate. This method was compared to fully 3D approaches and evaluations were
performed on an extensive variety of metrics to provide a comparison to other published
methods and a baseline for future comparisons.
The automatic prostate segmentation method performed with significant improvement over
fully 3D approaches and other recently published methods. The automatic prostate
segmentation method on 3D TRUS images was shown to be fast, accurate, and
generalizable, providing promising results for clinical translation and application to other
3D TRUS geometries (i.e., pull-back 3D TRUS images). This method has the potential to
decrease overall clinical procedure times and anesthesia risks during prostate biopsy and
brachytherapy.
Chapter 4: Geometrically variable three-dimensional ultrasound for mechanically
assisted image-guided therapy of focal liver cancer tumors
Image-guided focal liver ablation procedures provide numerous benefits compared to other
liver cancer therapeutic techniques, such as reduced recovery times and complication rates;
however, insufficient targeting and coverage of ablation volumes have been shown to limit
these procedures and the scope of eligible patients. This chapter is on the development and
evaluation of a novel geometrically variable 3D ultrasound scanner, mechanically assisted
system, and 3D-printed therapy applicator guide to provide methods for imaging and
guiding focal ablations to the diverse anatomical locations and presentations of liver
tumors. The system was evaluated for image reconstruction with a grid phantom, tracking
system accuracy when compared to optical tracking, image-guidance using three different
navigation approaches in end-to-end mock ablation phantom procedures, and clinical
feasibility through healthy volunteer imaging.
The system resulted in ≤3% mean geometric reconstruction errors, <7% volumetric
reconstruction errors, and <2 mm mean tracking system errors. A combined navigation
approach that used the scanner motors and tracking system for in-plane image corrections
resulted in the best performing mean needle targeting errors with <4.3 mm based on
external cone-beam CT imaging. Healthy volunteer imaging resulting in good qualitative
images and evidence for sufficient clinical feasibility. Our system provides approaches for
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improving liver tumor therapy targeting and has the potential for application to other
abdominal interventions and widespread accessibility to developing countries.
Chapter 5: Three-dimensional therapy needle applicator segmentation for
ultrasound-guided focal liver ablation
The 3D US system described in Chapter 4 can benefit from the addition of software tools
to improve clinical workflow and improve localization of applicators in focal liver tumor
ablation therapies. Local cancer recurrence remains high in these procedures and current
limitations still exist for verifying applicator positions in 3D US liver images. This arises
since localization accuracy is impacted by factors including the applicator insertion angle,
depth, and size, in addition to the choice of the transducer and local anatomic acoustic
reflections. This chapter focuses on the development and evaluation of a new 3D US semiautomated therapy applicator segmentation algorithm for in-vivo 3D US clinically imaged
applicators used in focal liver tumor ablations. While general needle-like segmentation
algorithms for 3D US have been discussed in the literature and tested on tissue mimicking
models, such as agar, chicken breast, bovine, and porcine tissues, this work is novel as it
provides evaluation on in-vivo clinically acquired 3D US images, which has not been
reported for the unique imaging characteristics of needle applicators used in percutaneous
liver tumor ablations.
The segmentation method aims to provide an intraoperative tool using a single point to
reduce the complexity of the segmentation problem. Optimization was performed on
homogeneous tissue-mimicking phantoms prior to a user study on clinical 3D US images.
Trajectory, axis localization, and tip localization errors were evaluated and suggested the
approach could be useful in a clinical environment when paired with a 3D US system.
Chapter 6: A deep learning method for general needle and applicator segmentation
in two-dimensional ultrasound images from multiple applications and anatomical
regions
Many image-guided interventions rely on the temporal resolution of 2D US to perform
optimal needle-like tool insertions for achieving sufficient diagnoses and treatments of
cancer. Accurate identification of tools in these images can be challenging with previously
investigated software methods developing application-specific approaches for automatic
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tool segmentation. This chapter is on the development of a new general deep learningbased approach with post-processing to automatically segment tools in 2D US images for
a wide range of clinical procedures. This can be paired with other interventional tools, such
as those described in Chapters 4 and 5, to further improve the clinical workflow and
targeting of needle-like tools. Unlike any other approach, this method was evaluated on a
clinically diverse dataset from prostate and gynecologic brachytherapy, liver ablation, and
kidney biopsy and ablation procedures, where tool appearance drastically varies.
Segmentation performed the best when using a random sample consensus post-processing
technique, but at the cost of increased segmentation time. Image-guided interventions with
tools parallel to the US probe surface (i.e., prostate and gynecologic regions) performed
the best due to tool contrast and decreased performance was observed as tool angulation
increased (i.e., in liver and kidney regions). Our method was able to perform predictions
of these tools in near real-time and provides the potential for improving image guidance
during a broad range of cancer interventions.
Chapter 7: Conclusions and future work
This chapter focuses on the overall conclusions of the previous chapters and will discuss
future work that could potentially address remaining unmet needs from this thesis.
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Chapter 2

2

Real-time registration of 3D to 2D ultrasound images for
image-guided prostate biopsy

Real-time registration has the potential to continuously compensate for prostate motion
during 3D TRUS-guided biopsy and may increase the accuracy of targeted biopsy
approaches. The purpose of Chapter 2 is to present on the development of an automatic
registration algorithm for 2D and 3D TRUS images.
The contents of this chapter have previously been published in Medical Physics: Gillies
DJ, Gardi L, De Silva T, Zhao S, and Fenster A. Medical Physics 2017; 44(9):4708-4723.
Permission to reproduce this article was granted by John Wiley and Sons and is provided
in Appendix B – Copyright Releases.

2.1

Introduction

Prostate cancer is a global burden, representing the second highest incidence of
noncutaneous cancer found in men.1 Although prostate biopsy is the current clinical
standard for definitive diagnosis of cancer, the efficacy of the conventional procedure lacks
sensitivity with false negative rates up to 30%.2,3 During the past decade, investigators and
companies have developed improved prostate biopsy techniques over the conventional
transrectal ultrasound (TRUS) based sextant biopsy.4–7 Fusion biopsy is a notable method
that involves an image fusion pipeline, which can register and overlay pre-procedural
magnetic resonance (MR) images and biopsy targets onto a live, intra-operative 2D TRUS
image. This approach typically employs a multi-step image registration process and has the
ability to guide biopsy needles to suspicious localized tissues. With the widespread interest
in fusion biopsy, the method is becoming predominant with the availability of commercial
fusion prostate biopsy systems (e.g., UroNav, Artemis, BiopSee, Urostation, Virtual
Navigator, and HI RVS/Real T time Virtual Sonography). Using these devices and others
like them, many clinical investigations and studies are currently underway to verify if there
is an improvement in cancer diagnosis over the conventional procedure.8–12 As a result of
increased scrutiny, image guidance during prostate fusion biopsies has been identified as a
method to improve the detection rates of cancer and depends on accurate targeting to
correctly grade the aggressiveness of prostate cancer.13,14 To guide biopsy needles to their
intended targets, image fusions resulting from accurate registrations of the preoperative 3D
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MR and 3D TRUS images to the live 2D TRUS images are critical to reap the benefits of
multimodal imaging. Any image misregistration between these planning and intraoperative
images can prevent correct localization or display of intended targets, which can lead to
missed cancer diagnoses.
Methods to improve image guidance have been focused on refining different algorithms
used in the multi-step image fusion pipeline. Previous studies have investigated how to
accurately register preoperative 3D MR images to 3D TRUS images for biopsy target
planning15–17 and also for 3D TRUS to 3D TRUS registration for preprocedural
initialization and intraoperative correction.18,19 However, in an ideal situation where these
registration techniques reduce the error to a negligible amount, needle guidance error
remains hindered by external influences, such as prostate motion. Prostate motion due to
TRUS transducer pressure and patient motion due to needle pain unrelieved by local
anesthesia will cause misregistration of the intended MR identified targets with their actual
locations. In these instances, motion of the prostate can be in the form of sudden, random
reflexes or slow, systematic shifts and develops as procedural time increases. It is during
the live 2D TRUS image registration step when the current image fusion pipeline can fail.
Since the final stage of the current fusion pipeline aims to link all prior data to the live 2D
TRUS image, it is crucial that this registration performs with sufficient accuracy.
Misalignment between live 2D TRUS images and preoperative MR or 3D TRUS images
has been observed up to 10 mm after initialization.19 It has also been shown that the number
of attempts required to sample a clinically significant tumor increases as needle delivery
error of a biopsy system increases.20 Among other techniques, 3D to 2D registration is
invaluable to reduce needle delivery error and has been investigated in a broad spectrum
of interventions.21,22 Therefore, to compensate for misalignment error caused by prostate
motion, two correction methods are feasible: 1) performing a single, intermittent user
initiated registration correction before firing the biopsy needle, and 2) automatic,
continuous correcting for any prostate motion throughout the biopsy procedure. With the
first solution, image fusion would be displayed throughout the procedure, but a user would
determine when to perform a correction based on observed image dissimilarities. Although
a short registration time is acceptable, decreasing the computational time to less than 1 or
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2 seconds is not a priority. Since this approach requires user interaction, current registration
procedures are performed in an acceptable amount of time while the user focuses on
preparation of the biopsy gun and biopsy sample. With a continuous scheme, corrections
can be performed in the background without any user interaction, registering preoperative
image data, targets, and segmentations automatically. Procedures can be completed more
effectively by reducing the number of steps that require user attention, which can reduce
procedure times and patient discomfort. These proposed motion correction methods for the
prostate should not exceed a registration error of 2.5 mm, which has been previously
suggested based on the smallest clinically significant tumors with an approximate 5 mm
radius.19,23 Keeping in mind that clinical translation is the key objective, image corrections
performed at a real-time rate are also necessary to improve overall usability since user
distraction can result if display lag is present. Thus, in the context of a TRUS-guided
biopsy, we define real-time to be at or near the approximate frame rate of a conventional
ultrasound system (i.e., greater than 15 Hz or a new frame less than every 67 ms) typically
used for a prostate biopsy procedure. However, real-time corrections for prostate motion
requires fast and robust live 2D TRUS registration to the 3D TRUS image acquired at the
beginning of the procedure, which contains the MR identified targets. Occasional misregistrations due to lack of robustness may cause large aggregated misalignments in a
continuous approach, whereas in a user-initiated, interactive approach, any unsatisfactory
registrations could be disregarded and repeated at the user’s discretion, possibly acquiring
more useful data.24 Therefore, real-time 2D TRUS to 3D TRUS registration to correct for
any prostate motion while using an automatic, continuous strategy remains a challenging
problem to solve.
Recent work addressing 3D to 2D registration for prostate interventions has been focused
on reducing registration error and improving image guidance by incorporating MR images
and deformation estimation. With the use of a preprocedural 3D TRUS image to manually
initialize the approximate location of a preoperative MRI, Zhang et al.25 proposed an
automatic rigid registration method to fuse preoperative MR images directly to live 2D
TRUS images during brachytherapy. Promising registration results were shown with target
registration errors (TREs) of 1.37 mm and 2.52 mm for phantom and patient studies,
respectively, corresponding to registration times of approximately 1 and 3 seconds
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following their 3D TRUS manual initialization step. Although these registration times were
shorter than previous attempts,7 this is still too slow for continuous real-time performance.
As a solution for deformation occurring during prostate biopsy, Baumann et al.26 presented
a 3D ultrasound based tracking system that performed a two-step registration procedure.
First, rigid registration was performed on patient data with a TRE of 1.4 ± 0.8 mm and an
execution time of approximately 2 seconds. Using deformation estimation to perform a
deformable registration, they showed a reduction in registration error to a TRE of 0.8 ± 0.5
mm with an increased total registration time of approximately 7 seconds. The authors also
provided an excellent discussion on the tracking errors present during targeted biopsy. With
importance focused on accuracy, intra-operative usability is lacking in these techniques
due to computation time restrictions from increased complexity of the algorithms.
Although patient anatomy is deformable, the majority of prostate motion is rigid.27 While
registration error can be decreased with a deformable registration, a recent study compared
deformable and rigid registration methods intra-operatively, concluding no significant
differences were found when detecting clinically significant prostate cancers.28
Considering the feasibility of a rigid registration approach and the current limitation of
computational speed, real-time registration and improved intra-operative usability seems
to be readily achievable through rigid registration methods since they perform at a reduced
computational cost.
Our group has previously shown29 a fully automated intensity-based rigid registration
algorithm to align 3D TRUS images acquired directly before performing a biopsy
procedure to live 2D TRUS images acquired immediately before tissue sampling. Our
algorithm had a TRE of 1.87 ± 0.81 mm when tested on retrospective clinical images with
total registration times of approximately 1.1 s. The algorithm was also tested when
performed every second and was shown to have a reduced TRE of 1.63 ± 0.51 mm. By
reducing the computation time further, it is anticipated a real-time motion compensation
scheme would help improve targeting accuracy and smooth clinical translation when
compared to an intermittent approach to motion compensation. With our previous results
and clinical motivation, an objective of this work was to perform 2D TRUS to 3D TRUS
registration in real-time, defined to be at or near the approximate frame rate of an
ultrasound system (i.e., greater than 15 Hz). Real-time computations approaching the frame
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rate of an ultrasound system are necessary to provide a responsive feedback system,
capable of correcting motion without user interaction to improve image guidance intraoperatively. In this paper, we present image registration and optimization techniques to
reduce registration times and provide a direct comparison to our previous implementation
with patient TRUS biopsy images. After implementing the optimized registration
algorithm on our previously developed biopsy system,4 phantom tests were performed to
evaluate the feasibility and potential real-time motion correction capability of the
algorithm.

2.2
2.2.1

Materials and methods
2D-3D image-based registration

The workflow for our motion compensation technique is shown in Figure 2.1 and is based
on the assumption that preoperative MRI to 3D TRUS registration (with segmentations
and/or annotations) has been accurately completed. Both 2D and 3D TRUS images
acquired during the procedure are loaded into a graphics processing unit (GPU) and a
mechanical tracker transformation30 is used to place the images in a common coordinate
system, referred to as the world coordinate system. The origin of the world coordinate
system is initialized at the tip of the TRUS transducer, establishing the biopsy system that
is based on a remote center-of-motion guidance approach.30 This allows any motion of the
3D TRUS image, 2D TRUS image, and biopsy system to be applied around the initial
TRUS transducer tip location during registration. With the mechanical encoder readings
on the joints of the biopsy system, the 2D image is transformed to the world coordinate
system to initialize its pose as a plane in the 3D image prior to registration.
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Figure 2.1 Proposed automatic image-based registration workflow. All steps in the “2D/3D
registration” box would contribute to the total computation time of the algorithm; image
pre-processing of the 2D image was included in “2D/3D registration” since this step would
need to be completed as the images are being acquired during the procedure. The
normalized cross-correlation is computed between the moving 3D image and the fixed 2D
image for each iteration until termination criteria is reached. When the algorithm
converges, a final rigid transform is generated and applied to the 3D image.
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To compute 3D to 2D registration, a variation of the algorithm previously proposed by De
Silva et al29 was developed to achieve fast and robust performance. A normalized crosscorrelation (NCC)31 similarity metric was optimized with Powell’s method,32 using the
Insight Segmentation and Registration Toolkit (ITK)33 framework, in a rigid search space
comprising of three rotations and three translations. Since rotations and translations
constitute disproportionate units, the scaling between different directions in the search
space was an important parameter during registration optimization. The scaling parameters
were selected based on maximum observed rotational and translational displacements in
our previous study29 such that 6° rotation and 10 mm translation attribute to the same
amount of displacement in the 6 DoF search space. This created a common parameter
space with uniform and unitless spacing, permitting the use of simplified and unitless
termination criteria during optimization.
Since Powell’s method requires multiple iterations to converge, with each iteration
consisting of multiple line optimizations in each DoF, a one-dimensional optimization subalgorithm was necessary. The golden section search (GSS)32 technique was chosen since it
does not require derivative calculations, resulting in a low computational cost. Also, the
GSS is more computationally efficient than a conventional bisection approach since it
recycles previous points when varying the bracketed interval in which the optimum is
predicted to exist in a single line direction. When employing the GSS technique and
minimizing the search space, a parameter step tolerance and an NCC metric tolerance were
defined as termination criteria for optimization. These tolerances were compared to the
change at each DoF (i.e., step taken during optimization) and the change in NCC metric
values at each iteration to terminate when near or at the local optimum. Based on
preliminary tests, parameter step tolerances were set at one-thousandth of the expected
image displacement ranges (i.e., 0.01 mm and 0.006°) and the NCC metric tolerance was
set to 0.0001. In certain circumstances, if the current DoF being searched is initialized at
its optimum, the algorithm will terminate prematurely even with image dissimilarity
present due to misalignment in the remaining DoFs. To avoid this scenario where these
tolerances are reached prematurely due to the lack of progress along a single DoF, the
algorithm was forced to search each DoF at least once to always complete a full cycle when
searching the parameter space. After successful optimization, a 3D rigid transformation
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was output and used to estimate the pose of the 3D TRUS image to correct for any prostate
motion during the procedure, as displayed in the live 2D TRUS image. This enabled the
resulting 2D TRUS plane from the 3D TRUS image to be displayed during the procedure.
To provide continuous motion compensation, the algorithm initialized the 3D pose of the
subsequent images according to the previous image’s resulting registration transformation.
This initialization approach was performed for three reasons: (1) Powell optimization
performs well when adjusting for small corrections near local minima since it is typically
used on unimodal objective functions, (2) an initialization close to the function minimum
increases the speed of convergence, and (3) it is assumed that motion will be minimal
between real-time 2D TRUS images (< 1 mm and < 1°) acquired at 15-50 Hz. This
procedure will henceforth be referred to as the continuous method.

2.2.1.1

Estimating the optimal scale for registration

The optimal amount of image information necessary to accurately perform registration can
vary depending on the available anatomical details, while increasing image size burdens
computational cost. Thus, the optimal scale of the images being registered is an important
parameter considering the tradeoff between accuracy and computational cost. In our
methods, we investigated downsampling of 2D and 3D TRUS images by factors of 2, 4,
and 6 without any averaging (binning). The 2D images were additionally cropped, centred
on the image, to remove information outside an area of interest (AOI) containing the
prostate. The AOI boundaries were chosen outside the approximate prostate anatomical
boundary for the largest prostate sizes. Computation times and registration errors were
computed for each downsample factor to determine the optimal sampling factor that would
decrease the registration time without increasing registration error.

2.2.1.2

Estimating the optimal area of interest

Since the AOI within 2D TRUS images determines the amount of anatomical detail
included in the registration, we investigated the AOI size as a variable in the study by
performing repeated registrations for different AOI sizes and measuring the resulting
registration accuracy and time. After masking the template 2D TRUS images to exclude
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embedded text/annotations, the largest AOI containing ultrasound intensity information
was found to be 570×466 pixels. Using this size as a template and an upper AOI limit, a
constant width to height aspect ratio (1.22:1) was maintained when cropping the 2D image.
Beginning with the smallest AOI at 100×82 pixels, the width was iteratively increased by
12 pixels (with the complementary height) until a final AOI was reached at 568×466 pixels.
Computation times and errors were determined when completing the registration at each
AOI, which included the process of masking and cropping the 2D image, as shown in
Figure 2.1. The registration time encompassed this process to resemble a scenario when
the 2D TRUS image would be acquired from the frame grabber directly from the ultrasound
system during a continuous registration method.

2.2.1.3

Direction search order of optimization

Finding an acceptable registration between images is dependent on how an algorithm
searches through 3D space. Conventionally in Powell’s method, search directions are
updated after each iteration to increase the speed of convergence by predicting the direction
containing the largest improvement of the cost function. Search direction is predicted by
replacing the vector containing the largest improvement with the most similar direction
from the previous iteration in an attempt to avoid linear dependence between search
directions. With this strategy, the method can be used to optimize a continuous function
with an unknown underlying mathematical definition.32 With subsequent iterations
determining search directions empirically, it is generally thought that the method is
insensitive to initial search direction order. Even though the direction search vectors are
updated when the optimization is continued beyond the first iteration, the initial search
vector order of optimization is an important factor that prioritizes certain directions during
search space traversal. Increased initialization misalignments from the target alignment can
make the algorithm more susceptible to converge at a local optima of the NCC metric.29,34
In these instances, it is helpful to avoid these local optima by estimating the line direction
that achieves the target extrema quickly and correctly. To study the effect of initial search
direction order on registration accuracy, two search orders were explored: rotation vectors
initially optimized before translation vectors (referred to as the rotations first scheme) and
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translation vector optimization followed by rotations (henceforth called the translations
first scheme).

2.2.2

Experiments

2.2.2.1

Clinical image acquisition

The image acquisition details have been described in De Silva et al.29 and are summarized
here. Preoperative 3D TRUS images were acquired using our mechanically assisted 3D
TRUS-guided biopsy system. Utilizing encoders, a commercially available end-firing 5–9
MHz TRUS transducer probe (Philips Medical Systems, Seattle, WA) was mechanically
tracked to reconstruct a 3D TRUS image from a series of 2D views. These 2D views were
masked to remove extraneous system information (e.g., patient information, image scale,
etc.) by changing the image intensity data outside the TRUS image field to 0, shown in
Figure 2.2a. After reconstruction, the 3D image was then cropped to a rectangular bounding
box, reducing the image size to 448×448×350 voxels with dimensions of 0.18×0.18×0.19
mm3, shown in Figure 2.2b. The coordinate system initialization and 3D image
reconstruction occurred only once and at the beginning of the procedure, requiring
approximately 3 seconds. After acquiring the 3D TRUS image, 2D TRUS images were
saved before firing the biopsy gun at predefined biopsy target locations. Similar to the 3D
TRUS image, these 2D images were masked to remove extraneous information, resulting
in a total image size of 640×480 pixels and pixel dimensions of 0.18×0.18 mm 2. These
images were inputs for the registration algorithm running on an i7-4770 central processing
unit (CPU) at 3.40 GHz (Intel Corporation, Santa Clara, CA) with Compute Unified Device
Architecture (CUDA) C++ to accelerate the NCC calculation on a GeForce GTX TITAN
GPU (NVIDIA Corporation, Santa Clara, CA). Implementation and computation speed of
the NCC calculation was improved by parallelizing the computations by dividing the total
image matrix into 19,200 blocks with 16 threads per block.

2.2.2.2

Accuracy evaluation

The target registration error (TRE)35 was assessed by calculating the RMS error between
manually annotated corresponding fiducial pairs in the 2D and 3D TRUS images (white
arrows shown in Figure 2.2). A total of 45 intrinsic fiducial pairs were identified from 7
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patients (14 biopsy needles) to calculate TRE with an average of 3 fiducials per image pair.
Since registration is performed using image intensities, the 45 fiducial pairs were chosen
once in the original images (i.e., no downsampling) and provided the same pre-registration
point clouds to be used for post-registration comparisons. Variability (i.e., fiducial
localization error (FLE)) associated with manual localization of the fiducials,35 has been
previously reported to be 0.11 mm in the 2D TRUS images30 and 0.21 mm in the 3D TRUS
images.18,19

(a)

(b)

Figure 2.2 Example (a) 2D and (b) 3D TRUS images after masking and cropping before
registration computations. The hypoechoic bladder can be seen in the superior portion of
the images with the prostate below containing microcalcifications indicated by the white
arrows.

2.2.2.3

Phantom image acquisition

Registration method validation using clinical images was limited to the presence of
calcifications in the 2D TRUS images to define ground truth motion. Since a subset of the
frames in a real-time live 2D TRUS video sequence may not contain such anatomical
landmarks, we performed a phantom study to comprehensively analyze the performance of
the algorithm in compensating for prostate motion in real-time. An agar-based tissuemimicking phantom of a prostate model4 was fabricated that contained beads embedded in
a surrounding agar background to provide texture.6,36 The prostate model, beads, and
background were constructed by adding 7% by mass of glycerol solution with agar powder
to produce a speed of sound similar to that of human tissue (1540 m/s).37 The prostate mold
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model was generated from a segmented 3D TRUS image of a human prostate and enlarged
anisotropically in anterior/posterior, superior/inferior, and left/right dimensions
(77:50:36)38 to a volume of 60 cm3. The agar beads and background material contained
cellulose (15% by weight) and were used to create acoustic backscattering, providing
hyperechoic regions in the TRUS images. The agar beads were created with diameters of
3.18 mm and 4.76 mm from standard spherical molds, cooled, and placed in the prostate
mold before the model was filled with non-cellulose agar. The prostate model was then
suspended in a polycarbonate box using fishing line so the surrounding background agar
could be added in a single pour and allowed to cool for 24 hours. This was performed to
avoid layering interfaces in the background agar typically observed when a suspension
technique is not used.
The primary forms of motion that were encountered during a prostate biopsy included inplane and out-of-plane translations relative to the 2D TRUS image, as well as rotations
around the long axis of the ultrasound probe. The user initiated and continuous registration
methods as described below were investigated using this phantom to assess registration
performance when compensating for translation and rotation motions in real time.

2.2.2.3.1

Translation range testing

Patients are not anesthetized during a prostate biopsy and we have observed some motion
in the form of a translational offset. To simulate these motions, the fabricated prostate
phantom was mounted on an independent and movable stage, as shown in Figure 2.3. This
stage was used to validate the registration accuracy of our algorithm for known in- and outof-plane translations since it was capable of generating 1 micrometer increments in
translation. After positioning the TRUS probe at the centroid of the prostate phantom and
acquiring a 3D image, 3D to 2D registration was performed incrementally (after locking
the tracking system) by translating the phantom and registering the resulting live 2D
images. In a first approach, the registrations were performed manually at each translation
increment, independently of previously performed registrations; this procedure will be
referred to as the user initiated method. The registrations were repeated at 1 mm translation
increments until reaching a maximum measured displacement of 12 mm, which captures a
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range comparable to translation motions observed clinically.19 This process was repeated
over ten trials to assess variability and robustness of the user initiated motion compensation
algorithm. To validate continuous motion correction and provide comparison to the user
initiated method, a similar procedure was performed that added incremental initializations
from previous registrations. At each increment, micrometer translation was paused to
obtain 2D images, transformation matrices, and computation times before continuing to the
subsequent translation. This process was repeated over five trials (due to length of
experimental setup and image acquisition) to assess variability and robustness of the
continuous motion compensation algorithm. After completing data acquisition for one
direction (e.g., in-plane translation), the TRUS probe was rotated by 90°, a new
initialization matrix was generated, and the entire experiment was repeated for both
methods to perform the registration for an additional translation motion.
As an approach to evaluate the error of the registration algorithm, the offset difference from
the initialization matrix to the output registration result was calculated since the translation
distance was known and thus provided a ground truth. This error metric was chosen since
it was less labour intensive and avoided any errors due to manual fiducial selection used to
compute a TRE calculation. Although the translation was intended for a single translation
direction, the RMS displacement was determined from the 3-vector offset difference to
account for any minor setup errors that would cause 3D errors in overall motion. The offset
difference was calculated for each increment to obtain mean differences paired with
corresponding mean computation times. Since we intended to compare the continuous
method directly to the user initiated method, the first corrected transformation matrix
acquired for each increment was used to compute the offset difference from the
initialization matrix. This corrected transformation matrix was determined for each
increment by searching for the first TRUS frame output with no observed motion,
representing the frame when micrometer translation was paused.
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Figure 2.3 Phantom set up during testing of in-plane translation range when using the
continuous motion compensation method (Multimedia view online). The live experimental
setup can be seen on the left where the live 2D TRUS image is taken from the US machine
and shown in the bottom right. After completing 3D to 2D registration, the resulting
registered image plane in the 3D TRUS image is displayed, seen in the upper right.

2.2.2.3.2

Roll rotational range testing

Rotation around the long axis of the TRUS transducer was another type of motion we
observed during prostate biopsy and was another type of motion we simulated to test our
registration algorithm. Since there are no suggested rotational tolerances present in the
literature, a rotational tolerance was justified based on the previous19,23 target TRE of 2.5
mm to determine a target rotational error. Using our image width of 448 pixels with voxel
dimensions of 0.18 mm, if a rotation about the center of the 3D image space is assumed,
then the region most susceptible from a rotational error will be present near the edges of
the image. An error of 2.5 mm located at the edge of the image (i.e., 224 pixels or 40.32
mm from the center) corresponds to a rotational tolerance of 3.55°.
Keeping this target in mind, we performed displacement tests to determine the rotational
motion compensation range of the algorithm. To test rotational motion, the TRUS probe
was positioned at the center of the base of the prostate phantom to acquire a 3D image. The
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initialization transformation matrix was recorded and the mechanical tracking encoders
were disabled to ensure the registration algorithm was performed without updated
initializations. Although tracking was not performed, mechanical encoder values were still
displayed and used to track the rotation of the TRUS probe around its long axis to determine
rotations. This probe rotation was performed instead of a phantom rotation purely for the
ease of operability. Similar to the translation procedure in the previous section, 3D to 2D
user initiated image registration was performed by registering the live 2D image after
incrementally rotating the TRUS probe. After each step, the algorithm was reinitialized
using the original mechanical encoder transformation, without using previous registration
outputs. This reinitialization ensured that the user initiated registration started from the
same position for each subsequent rotational increment. Similar to the translational range
testing, we repeated this registration procedure in approximately 1° increments until
reaching a maximum measured rotation of 15°. Although our expected clinical rotation
was 6°, this limit was chosen to potentially reveal the point of unreliable motion
compensation. Motion compensation was repeated over ten trials to obtain a mean
difference error and computation time for each increment. For comparison with the
continuous motion correction, initialization and corrections were not reset between
registrations, consistent with the translation testing procedure. Rotational motion was
paused at each increment to obtain 2D TRUS images, transformation matrices, and
computation times before continuing to the subsequent increment. This protocol for
continuous motion compensation was repeated over four trials to obtain a mean rotation
difference paired with a mean computation time for each increment.
Since the rotation angle was known, the difference 3 × 3 rotation matrix (𝑻𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 )
between the corrected registration (𝑻𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 ) and initialization (𝑻𝑖𝑛𝑖𝑡𝑖𝑎𝑙 ) rotation
matrices was calculated by
𝑻𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = (𝑻𝑖𝑛𝑖𝑡𝑖𝑎𝑙 )−1 × 𝑻𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 .

(2.1)

The corresponding rotation can be calculated from
𝑡

𝜓 = tan−1 (𝑡2,1 ),
1,1

(2.2)

51

where 𝑡1,1 and 𝑡2,1 are the 𝑻𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 matrix elements in the first and second rows of the
first column.39
Similar to the translation experiment, we compared the continuous method to the user
initiated method by using the first corrected transformation matrix acquired at each motion
increment to compute the rotation difference from the initialization matrix. This corrected
transformation matrix was determined for each increment by searching for the first TRUS
frame output with no observed motion, representing the frame when probe rotation was
paused.

2.2.2.4

Statistical methods

Statistics calculations were performed using SPSS Statistics v.24.0.0.0 (IBM Corp.,
Armonk, NY, USA). To check if our image data followed a normal distribution, normality
was evaluated using a Shapiro-Wilk test. Nonparametric statistical tests were used where
appropriate and are presented in parentheses for the remainder of this section. Results were
considered significant when the probability of making a type I error was less than 5% (p <
0.05).
Since our previously acquired patient images were tested for every downsample factor, a
one-way repeated measures ANOVA (Friedman) test was used as an omnibus test prior to
any post-hoc analysis. If significance was found, a Bonferroni correction was used,
resulting in a significance level set at p < 0.017 for our post-hoc analyses conducted using
Tukey's honestly significant difference (Wilcoxon signed-rank) tests. To determine if there
is an initialization distance correlation with the accuracy of registration, linear regressions
were plotted using Prism 7.00 (Graphpad Software, Inc., La Jolla, CA, USA) to show the
TRE trends. The user initiated and continuous correction methods were compared using ttests (Welch t-tests) after in-plane, out-of-plane, and roll motion corrections for error and
computation time distributions.
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2.3

Results

2.3.1

3D to 2D registration optimization on clinical images

Interaction effects during optimization of the three tested algorithm settings were
investigated and a brief overview of the results are shown in Figure 2.4. Linear regressions
were added to provide an estimate of the trends observed for the TRE distributions as
initialization offset was increased. Although more AOI comparisons were completed, the
smallest error was observed when downsampling by a factor of 4, cropping to an AOI of
356×292, and optimizing the search space by translations first. In the three subsequent
sections, each parameter was investigated independently while holding the other settings
constant. As a reminder and disclaimer for the reader, all presented TRE results in Sections
2.3.1 and 2.3.2 are susceptible to a small bias introduced when manually selecting fiducials.
This should be considered when comparing changes in TRE.

2.3.1.1

Estimating the optimal scale for registration

Estimating the optimal scale for motion compensation was performed with an input AOI
of 356×292, while optimizing the search space by translations first. Normality was tested
using the Shapiro-Wilk test with significance found for factors 2 and 6, for both TRE and
time, suggesting non-normal distributions were present. Nonparametric measures are
shown in Table 2.1 for TRE and computation times after downsampling the 2D and 3D
clinical ultrasound images by factors of 2, 4, and 6. A repeated measures Friedman test was
performed for both TRE and time, which failed to show a statistically significant difference
between the distributions of downsample factors, but showed statistical significance when
comparing computation times (p < 0.001). Post-hoc analysis with the nonparametric
dependent-samples Wilcoxon signed-rank test was conducted between the computation
times for the three downsampling factors. Significant differences (p < 0.01) between all
downsample factor combinations was found. A downsampling factor of 4 was determined
to be the optimum rate for our application since the median and third quartile were below
the 2.5 mm target TRE in addition to a decrease in computation time. The corresponding
median computation time of 55 ms was observed, which is a factor of 20 times smaller than
previously achieved.29 This computation time from registering patient images converts to
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a rate of 18.2 Hz, which is greater than our real-time definition of 15 Hz. Thus, this
reduction in computational time enables motion compensation to be performed as a
background software process to continuously register live, real-time streams of 2D TRUS
images.
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Figure 2.4 An overview of the main interactions observed when optimizing downsampling
factor, cropping AOI, and search order.
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Table 2.1 Effect of downsampling 2D and 3D images on TRE and computation time for
14 patient images.
Image Downsample
Factor

Median TRE
[Q1, Q3] (mm)

Median Computation Time
[Q1, Q3] (ms)

2

1.37 [1.08, 2.24]

97 [92, 137]

4

1.40 [1.14, 2.31]

55 [41, 64]

1.71 [1.17, 2.71]

30 [24, 34]

6

2.3.1.2

Estimating the optimal area of interest

The optimal AOI was determined with an optimal downsampling factor of 4, while
searching translations first. The AOI in the 2D images was iteratively increased from
100×82 pixels with results for computation time and TRE shown in Figure 2.5. A slight
increasing trend in computation times (Figure 2.5a) was observed over the range of AOIs.
When analyzing TRE to find the ideal AOI (Figure 2.5b), a decreasing trend was initially
observed until reaching a minimum at approximately 356×292 pixels, followed by a slight
increase and plateau. The observed minimum of the TRE, reduced variability, and the
minimal change in computation time led to the selection of a 356×292 AOI for the biopsy
application. However, due to the bias in the TRE when manually selecting fiducials, an
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Figure 2.5 Scatter plots of the mean ± standard deviation registration computation time (a)
and median [Q1, Q3] TRE (b) as the AOI size in the 2D image was increased. The
asymmetric area of the AOI was scaled in a width:height ratio of 1.22:1, corresponding to
the aspect ratio of the largest AOI achievable.
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2.3.2

Direction search order of optimization

The main direction search order results are shown in Figure 2.4. When using the whole
image as an input, similar TRE distributions were observed between all downsample
factors when comparing the rotations first strategy. The translation first method was unable
to register large initial offsets when using a downsample factor of 2, but was similar to the
rotation method when comparing the other downsample factors. When using the cropped
AOI input, all translation first TRE results were reduced relative to the whole image input
for each downsample factor. However, cropping had minimal influence when optimizing
rotations first, with an exception at a downsample factor of 4 since it was unable to register
the largest initial offset images effectively.
10
R o ta tio n F irs t

T R E (m m )

8

T ra n s la tio n F irs t

6
4
2
0
1

2

3

4

5

6

7

8

9 10 11 12 13 14

P a t ie n t T r ia l

Figure 2.6 The TRE between translation first and rotation first direction search order
schemes on 14 patient image sets. Images used for registration were downsampled by a
factor of 4 with the 2D images cropped to an image size of 356×292.
When comparing direction search order TREs for downsampling by a factor of 4 and
cropping to an AOI of 356×292 (Figure 2.6), normality was tested using the Shapiro-Wilk
test with statistical significance found for the rotations first scheme (p < 0.05). The median
± interquartile range (IQR) for TRE computed for the rotations first search was 2.18 ± 3.82
mm compared to the translations first median TRE of 1.40 ± 1.17 mm (previously stated
in Section 2.3.1.1). Since we know that the algorithm is susceptible to converge
prematurely when the initialization is further from the target alignment, both search order
schemes were compared to identify any trends using a Spearman's rank-order correlation.
The initialization distances between the 2D and 3D images before registration and the
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corresponding post-registration errors had a strong, positive correlation (0.644) using the
rotations first scheme, which was statistically significant (p < 0.05).
The TREs calculated from fiducials before registration (i.e., following encoder pose
initialization) and after registration for the translations first search scheme was compared
as it yielded better registration performance. Using a Shapiro-Wilk test of normality, the
distribution of image distances before registration was shown to be not normally distributed
(p < 0.05). The TRE frequency distributions before and after registration is shown in Figure
2.7 with a median RMS error before registration of 3.41 ± 3.26 mm with the corresponding
median TRE of 1.40 ± 1.18 mm after registration. Analyzing the post-registration group
further, 10/14 image pairs (71%) were less than a real-time computation time of 67 ms and
13/14 image pairs (93%) were less than a TRE of 2.5 mm. Since there could be some
variability from manual point selection, we investigated a margin around 2.5 mm equal to
the FLE measurement for the 3D TRUS and 2D TRUS images combined in quadrature
(i.e., 0.237 mm). This resulted in a range from 10/14 (71%) of image pairs below a 2.263
mm error to 14/14 (100%) of image pairs below a 2.737 mm error. We used the Wilcoxon
signed-rank test to compare medians of distances to the desired target plane before and
after registration, which showed a statistically significant difference when correcting for

F re q u e n c y

position (p < 0.01).
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Figure 2.7 Histograms of the distance calculated between 2D and 3D image pairs from the
manually chosen intrinsic fiducial markers before (a) and after (b) registration using a
translation first search order after pose initialization.
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2.3.3

Validation: phantom experiment
A summary of the total mean difference from measured displacement and the mean

computation time for both registration methods and the three types of motion is
summarized in Table 2.2.
Table 2.2 Mean differences and computation times of the user initiated and continuous
registration methods for translation (in-plane and out-of-plane) and rotational motion.
Mean Computation
Time (ms)

Method

Motion

Mean Difference

Before registration

Trans
Rot

6.0 ± 3.7 mm
8.0 ± 5.2 °

User initiated

In
Out
Rot

0.4 ± 0.3 mm
0.2 ± 0.4 mm
0.8 ± 0.5 °

108 ± 38
60 ± 23
89 ± 27

Continuous

In
Out
Rot

0.2 ± 0.3 mm
0.7 ± 0.4 mm
1.2 ± 1.0 °

35 ± 8
43 ± 16
27 ± 5

Live 2D TRUS image
registration target

3D TRUS image plane
initialization

3D TRUS image plane
after registration

Out-of-Plane
In-Plane

Figure 2.8 Sample prostate phantom images before and after registration for out-of-plane
and in-plane translational motion. Images from real-time 2D TRUS are shown in the left
column. In the middle column, the initialization 3D TRUS image planes obtained before
registration display image misalignment when compared to the 2D TRUS view. 3D TRUS
image planes in the right column demonstrate motion compensation capabilities after
registration. Grid lines were superimposed following registration to provide spatial
reference between image frames.
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2.3.3.1

Translation range testing

Sample prostate phantom images of the 2D TRUS live view, the 3D TRUS initialization
plane, and the calculated 3D TRUS plane after registration are shown in Figure 2.8.
Example setup and image registration results from the continuous motion compensation
method are also presented in Figure 2.3 (Multimedia view). An error and computation time
comparison between the user initiated method with the continuous method is shown in
Figure 2.9 after testing the in-plane and out-of-plane translational range. The average
difference between the corrected registration translation offset and the measured
micrometer translation is shown for the user initiated method (Figure 2.9a) and the
continuous method (Figure 2.9b). When observing the mean difference errors for both
correction methods, the mean difference error metric never exceeded 1.25 mm over the
entire translation range, falling below half of the 2.5 mm target error. When performing a
user initiated correction, out-of-plane motion displacements were observed to be corrected
with a smaller mean error when compared to in-plane motion. Conversely, the continuous
registration achieved a reduced mean error when correcting in-plane motion. Comparing
the two methods with respect to error for each motion, out-of-plane motion was corrected
significantly better with the user initiated method (p < 0.001) and no difference was found
for in-plane motion. In the same figure, the corresponding computation times are shown
for the user initiated method (Figure 2.9c) and the continuous method (Figure 2.9d). For
the user initiated method, the out-of-plane motion correction computation time had a lower
overall variance and consistently fluctuated around 60 ms. Computation times showed an
increasing trend when correcting for in-plane motion as the translational displacement was
increased, plateauing around 4 mm. From the user initiated method results, all trials for
both motions were below an error of 2.5 mm, but only 20/130 (15%) of in-plane and 97/130
(75%) of out-of-plane trials were less than a real-time computation time of 67 ms. When
performing a continuous registration, all trials for both motions were below an error of 2.5
mm and computation times were significantly lower than the user initiated correction for
in-plane (p < 0.001) and out-of-plane (p < 0.01) motions. In addition, the continuous
method showed 65/65 (100%) of in-plane and 57/65 (88%) of out-of-plane trials less than
a real-time computation time of 67 ms.
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Figure 2.9 Comparison between registration procedures when testing the in-plane and outof-plane translation compensation range. In the top row, Euclidean translational differences
between measured and expected values are shown for the user initiated procedure (a) and
the continuous procedure (b). Dotted lines represent a target tolerance of 2.5 mm. The
corresponding computation time results for the user initiated procedure (c) and the
continuous procedure (d) are shown in the bottom row. Standard deviation error bars are
not shown when shorter than the height of the symbol. The dashed line represents the target
computation time of 15 Hz or 67 ms.

2.3.3.2

Roll rotational range testing

The comparison between the user initiated method and the continuous method is shown in
Figure 2.10 for rotational motion compensation. The average rotation difference between
the corrected registration and the measured encoder angles is shown for the user initiated
method (Figure 2.10a) and the continuous method (Figure 2.10b). In both methods, all
differences were smaller than our rotational tolerance of 3.55° with a maximum mean
difference of 2.3 ± 0.8° observed in the continuous method at a 12° displacement. Although
the continuous method was observed to have an increasing error near the end of the tested
rotations, no overall significant difference was found when compared to the user initiated
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method. This increasing trend also occurs beyond the expected rotations of 6°, making this
finding less of a concern for clinical translation. The computation times for the user
initiated method is shown in Figure 2.10c, and the continuous method in Figure 2.10d. The
user initiated method had an overall computation time of 89 ± 27 ms with a much larger
variance compared to the continuous method with 15/90 (17%) of trials less than an error
of 3.55° and a real-time computation time of 67 ms. Similar to Sec.2.3.3.1, the computation
time for the continuous method was observed to be significantly reduced (p < 0.001) and
nearly constant with a mean computation time of 27 ± 5 ms. The continuous method also
had 36/36 (100%) of trials less than an error of 3.55° and a real-time computation time of
67 ms.
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Figure 2.10 Comparison between registration procedures when testing the roll rotation
compensation around a clinically expected value of 6°. In the top row, rotational difference
results between measured and expected values are shown for the user initiated procedure
(a) and the continuous procedure (b). Dotted lines represent a target tolerance of 3.55°. The
corresponding computation time results for the user initiated procedure (c) and the
continuous procedure (d) are shown in the bottom row. Standard deviation error bars are
not shown when shorter than the height of the symbol. The dashed line represents the target
computation time of 15 Hz or 67 ms.
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2.4

Discussion

In current TRUS-guided prostate biopsies, tracking systems generate transformation
matrices and are used to display corresponding MRI image data, as well as preoperatively
delineated segmentations and annotations that exist in a separate volume. With the use of
a motion compensation module, computational resources will still need to be used for the
existing guidance system. Therefore, motion compensation registration times reported in
this study was shown as the additional time needed for an existing a TRUS-guided
procedure.

2.4.1

Optimal amount of image information for registration

With an optimal downsampling factor, the registration computation time decreased with
statistical significance for our clinical prostate images, without an increase in error
compared to results reported by De Silva et al.29 For our 3D image size of 448×448×350
pixels, a downsample factor of 4 was chosen, which provided a median and third quartile
below a 2.5 mm target TRE (1.40 [1.14, 2.31] mm) and helped to reduce the registration
time from approximately 1.1 s to 55 [41, 64] ms. Since the comparison of TREs failed to
show statistical significant differences, we performed an equivalence test40,41 using an
approximate 90% confidence interval (CI) on the median of differences using GraphPad
Prism 7.00. An equivalence interval of ±0.24 mm was determined by combining the FLE
measurements in quadrature for the 3D TRUS (0.21 mm) and 2D TRUS (0.11 mm) images.
The results in Table 2.3 failed to show statistical equivalence between all downsample
factors and support the decision to determine the optimum downsample factor as 4.
Table 2.3 Equivalence test results of TRE for downsampling factors.
94.26% Median CI

a

Downsample
Factor Comparison

Lower

Upper

2–4
2–6
4–6

-0.1665
-0.4793a
-0.3855a

0.2815a
0.0550
-0.0742

Groups are not equivalent with interval = ±0.24 mm
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Although having a downsample factor reduced the number of NCC computations, it also
reduced the amount of information that needed to be transferred through system memory
from the CPU to the GPU. Therefore, by reducing the amount of image data, a reduction
in computation times arised from a reduction in data transfer from the CPU to the GPU as
well as a reduction in the number of computations. As a reminder for the reader, only TRUS
image data is needed to compute a transformation matrix on the GPU. Once the algorithm
determines the correction matrix, the transformation can be applied on the CPU to any
additional data (i.e., MRI or segmentation data) in a short amount of time that is comparable
to what is currently performed using a tracking system.
Although downsampling may introduce aliasing,42 this was not believed to be a
consequential issue for our registration application since we maintained a median TRE
below 2.5 mm as the downsampling factor was varied. However, even though our TRE
was below an acceptable tolerance of 2.5 mm, reducing the image size used for registration
could be removing fine detail structures and prematurely ending the registration iteration
loop. With these features removed, the observed 1.5 mm registration error could be the
result of emphasized local minima in the NCC cost function. Despite the fact that smaller
downsample factors were not observed to be more accurate, a coarse-to-fine downsampling
technique could be required to decrease the TRE since these methods are usually more
robust to local optima.43
Interestingly, reducing the 2D template image size used for registration to a 356×292 pixels
AOI (64.08×52.56 mm2) showed a decrease in TRE. This AOI is larger than an average
healthy prostate44 length and height of approximately 40×30 mm2 with a volume of 30 cm3;
however, many prostate glands with cancer are often enlarged and can fill this region with
anatomical information. Since there is some variability when manually selecting fiducials,
the chosen AOI would be influenced by an unknown bias in the TRE measurement given
that the TRE was used for AOI selection. Although more image information might
intuitively seem necessary for a more accurate registration, having image data outside of
the prostate seemed to hinder registration performance. This could be due to the low
contrast edges of the bladder or perhaps a lack of acoustic coupling found on the left and
right sides of some images. Bladder is also more prone to deformation that may challenge

63

our rigid registration approach. It should be noted that limiting the area to slightly beyond
the average prostate size did not improve registration for every image pair. Despite the
presence of the bladder when imaging smaller prostate volumes, the AOI reduction
noticeably decreased the overall average error observed.

2.4.2

Direction search order of optimization

To increase the speed of convergence, direction search vectors are typically updated in an
efficient manner after the first iteration of optimization in conventional Powell’s method.
When used in our clinically acquired prostate images, a statistically significant difference
was observed when the search order was changed in the first iteration. Searching translation
directions first before rotational optimization was shown to be superior in terms of
registration accuracy with an overall TRE median ± IQR of 1.40 ± 1.18 mm. A strong
correlation (0.644) between initial misalignment and TRE was observed in the rotations
first scheme, suggesting the registration algorithm was converging at a local optimum of
the NCC function. A primary source of motion we witnessed during prostate biopsy
procedures arose from patients moving away from the biopsy gun once the needle was
inserted into the tissue. This could result in a translational offset that dominated the overall
motion that required compensation. Moreover, if the objective function has quadratic,
convex properties, Powell’s method should converge at the global optimum irrespective of
the initial search direction order. The observed performance dependency on the initial
search order, thus, implies non-convexity of the search space challenging the underlying
assumptions of Powell’s direction set method. The non-convexity of the objective function
could be more severe in the rotational directions and therefore these motions could be more
susceptible to local optima driving the optimizer away from the desired solution during
first steps in the optimization process. A translation first scheme managed to drive the
optimizer close to the global optimum and demonstrated robust performance in our
experiments when downsampling by a factor of 4 and cropping to an AOI of 356×292.
However, there seems to be some interaction effects with downsampling factor, cropped
AOI, and optimization order that are currently unpredictable in addition to the small TRE
variability due to manual selection of fiducials. It should be noted, the manual selection
bias introduced in the TRE can be reduced by having observers select each fiducial multiple
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times. Since we selected each fiducial only once, we used the measured FLE as the bias
when interpreting Figure 2.4 and Figure 2.5b.

2.4.3

Phantom scanning

In the user-initiated method, motion compensation is performed intermittently and the
physician may opt to selectively disregard registration output if it is not satisfactory and
repeat the registration. The continuous method, on other hand, provides a more streamlined
and automatic mode of clinical implementation of the algorithm with less dependence on
manual intervention. However, when implemented on a TRUS-guided biopsy system and
tested on a tissue-mimicking phantom, the registration algorithm performed robustly with
an overall sub-millimeter and sub-degree error when performing both the user initiated and
continuous registration methods. After testing out-of-plane translation, in-plane
translation, and roll rotation compensation, the user initiated correction computation time
only achieved real-time performance when correcting for out-of-plane motions. During
testing of the real-time continuous implementation on the prostate phantom, registration
computation times were significantly lower (p < 0.01) with less variance than the phantom
user initiated correction, overall performing at approximately 36 ± 4 ms (28 Hz). This is
approaching the frame rate of the ultrasound system, which updates images at 51 Hz when
using a depth of 6 cm with one focal zone, providing near real-time feedback that is
sensitive to sudden changes. Results from the user initiated method also supports that the
algorithm can compensate for sudden drastic displacements with a temporary increase in
computation time of 108 ± 38 ms as a tradeoff, using in-plane motion correction as a
reference. The reason for significant difference when testing out-of-plane motion is
unknown, but it is likely due to a lack of image features present at the 9 mm displacement.
Both methods experienced an increase in registration error up to approximately 1 mm from
expected and after scrutinizing the images further, it revealed a minimal presence of agar
beads beyond a 6 mm displacement. From this information, it appears that the user initiated
method was more suitable to correct for motion when there were reduced image features,
but this will need to be investigated further. Although the registration error was
significantly lower when performing a user initiated correction during out-of-plane motion,
continuous registration still performed with a mean registration error of 0.7 ± 0.4 mm,
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which is still below the target error of 2.5 mm. In this case, the clinical benefits provided
from a significantly faster computation would likely outweigh the slight decrease in
registration error. Results from other studies25,29 have shown that an increase in registration
error will be expected when performed on patient images and this expectation has been
alluded to in this study. Since the methods of the clinical image registrations are
comparable to the user initiated procedure on the phantom, it can be observed there are
sources of error that are not completely captured in the phantom experiment that will need
to be investigated in more detailed patient studies. For example, a lack of agar beads could
be the underlying cause for a poor registration when performing the out-of-plane
translation tests. With clinical images, different image features distributed throughout the
acquired 3D TRUS image could potentially lead to different resulting motion compensation
trends. However, these results demonstrate robust and real-time registration performance
on a phantom and yield valuable insights, encouraging the use of a continuous method for
prostate motion compensation during biopsy.
When testing the continuous motion compensation method, variable speeds were not
assessed when moving the phantom. Although this matches our minimal motion
assumptions between image frames, this might not be realistic of what is observed
clinically and could be a potential limitation. In addition, the phantom we fabricated was a
rigid body and was proven to be easily compensated using a rigid registration algorithm.
Although prostate deformation may occur and has been previously reported to not be an
issue for a rigid registration approach,28,29 the real-time continuous method will need to be
verified in patient studies to confirm these findings.

2.5

Conclusions

Real-time registration during prostate biopsy provides key advances by compensating for
arbitrary/intermittent motion that hinder accurate targeting of potentially cancerous tissues,
decreasing needle targeting error, and improving clinical workflow. Using image
downsampling and image cropping with a GPU accelerated optimization, we showed that
a significant decrease in computation time can be achieved when performing 3D to 2D
rigid registration on human clinical prostate images without any substantial degradation of
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registration error. The challenges due to large initialization errors was mitigated after
updating the optimization of the conventional Powell’s method by systematically searching
the image space to avoid local optima. When continuously performing motion
compensation, the error of the registration algorithm was shown to have sub-millimeter
and sub-degree accuracy with significantly lower computation times than a user initiated
correction. Overall registration times of approximately 36 ms were observed, performing
near the frame rate of the ultrasound system. With this utility, preoperative annotations and
biopsy target locations can continuously be displayed and corrected on live 2D TRUS
images, potentially increasing the prostate cancer detection rate of image guided biopsy
procedures.
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Chapter 3

3

Automatic prostate segmentation using deep-learning on
clinically diverse 3D transrectal ultrasound images

Minimizing procedure time with an automatic 3D TRUS prostate segmentation method
could allow for a more accurate and efficient workflow with improved patient throughput
to enable faster patient access to care. The purpose of Chapter 3 is to present on the
development of a general automatic prostate segmentation algorithm for image-guided
interventions that use 3D TRUS images.
The contents of this chapter have been accepted for publication in Medical Physics:
Orlando N and Gillies DJ, Gyacskov I, Romagnoli C, D’Souza D, and Fenster A. Medical
Physics 2020; 47(6):2413-2426. Permission to reproduce this article was granted by John
Wiley and Sons and is provided in Appendix B – Copyright Releases.

3.1

Introduction

Diagnosing and treating prostate cancer continues to burden global populations as it is the
second most common noncutaneous cancer among men worldwide.1 Investigation into
methods to diagnose and treat prostate cancer has shifted towards improved needle-based
approaches that utilize three-dimensional (3D) information intraoperatively. Magnetic
resonance imaging (MRI)-3D transrectal ultrasound (TRUS) guided biopsy is one diagnostic
method that fuses the superior soft-tissue contrast of MRI to accurately localize, target, and
sample suspicious tissue regions for prostate cancer with the real-time, low-cost, and portable
capabilities of ultrasound. In the treatment of prostate cancer, high- and low-dose-rate
(H/LDR) brachytherapy (BT) procedures offer therapeutic benefits for patients by exploiting
radiobiological effects and offering shorter treatment times, while minimizing adverse side
effects. By adding 3D ultrasound intraoperatively, improved spatial context and targeting
can be achieved to further improve the conventional clinical workflow of biopsy and
brachytherapy procedures; however, both procedures rely on accurate segmentation of the
prostate in 3D TRUS images to perform necessary clinical tasks. This includes surface-based
registration approaches with MRI2 and subsequent 3D TRUS images,3 glandular volume
measurements,4,5 and dose-volume calculations,6 especially when using a commercial
guidance system. These segmentations are predominantly performed manually during the
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procedure, which is time-consuming, variable, and often difficult, which can lead to
increased patient risk due to increased anesthesia exposure.7
Minimizing procedure time through fully or semi-automatic 3D TRUS prostate segmentation
has been previously investigated.8–11 Many methods have been shown to be promising, but
have lacked clinical translation due to computational complexity, computation time, and
robustness to diverse clinical datasets. Convolutional neural networks (CNNs) have
received widespread attention in many image processing applications with much work
investigating their accuracy and speed in medical imaging tasks. Prostate segmentation in
3D TRUS is an image processing task that could be an ideal candidate for the data-driven
predictions provided by CNNs, although most existing work has investigated their
application in MRI,12,13 as ultrasound is considered more challenging due to noise and
image artifacts.
Recent work has investigated and provided promising results for the use of CNNs in 2D
TRUS14 and 3D TRUS15,16 prostate segmentation. Ghavami et al.,15 evaluated the
performance of an adapted U-Net on 109 side-fire sagittally-reconstructed (SR) 3D TRUS
images. Predictions were performed on acquired 2D images and varying adjacent
neighboring slices were also investigated to evaluate accuracy due to increasing spatial 3D
context. The best results reported for the 2D Dice similarity coefficient (DSC), 3D DSC,
and boundary distance were 89 ± 12 %, 89 ± 5 %, and 1.68 ± 1.57 mm, respectively. Lei
et al.,16 investigated a multidirectional deeply supervised 3D V-Net with contour
refinement on 44 patient 3D TRUS images. Their method was shown to improve
performance when segmenting the apex and base of the prostate, which is often difficult
due to low image contrast, and reported overall segmentation results for a 3D DSC,
Hausdorff distance (HD), mean surface distance (MSD), and residual mean surface
distance (RMSD) of 92 ± 3 %, 3.94 ± 1.55 mm, 0.60 ± 0.23 mm, and 0.90 ± 0.38 mm,
respectively. However, these methods were tested using cross-validation approaches on 3D
TRUS images from a single ultrasound machine with matched voxel dimensions and sizes,
so further testing is still required on an unseen and variable dataset to provide a complete
understanding of performance while avoiding potential limitations due to information
bleeding.17,18 Furthermore, investigations into generalizability across procedures and
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acquisition geometries have been limited, to our knowledge, which could restrict usability
when applying these techniques across applications.
Our work aims to demonstrate that a diverse image dataset can train a supervised CNN to
provide an accurate, fast, automated, and generalizable 3D prostate segmentation
prediction. We used 206 3D TRUS patient images from two different procedures and
acquisition geometries, two facilities, and four transducers used with three different
ultrasound machine models to modify and train a deep learning-based 2D segmentation
method followed by reconstruction into a 3D surface. Since deep learning approaches often
improve in performance when using large datasets (i.e., >1000 images), we chose to reslice
each 3D image to increase the amount of usable data for prostate segmentation training and
prediction. Testing was performed on 40 unseen 3D TRUS patient images and
segmentation performance was compared to state-of-the-art fully 3D approach’s for
assessing the impact of reducing spatial context. Various metrics are reported in the
literature, and typically vary in choice and quantity between studies, but many metrics are
required to obtain a complete understanding of segmentation performance and to allow for
comparison with previous studies. By using a clinically diverse dataset with variable image
representation and image quality of the prostate, we intend to provide a thorough analysis
of performance for a broader scope of comparison. Once this method is evaluated,
completion of required intraoperative image-guidance tasks can be facilitated for different
needle-based prostate cancer procedures and potentially decrease overall clinical procedure
times and anesthesia risks to patients.

3.2
3.2.1

Materials and methods
Clinical dataset

3D images of the prostate were acquired using end-fire (as used in prostate biopsy) and
side-fire SR (as used in some HDR-BT) mechanical scanning approaches (Figure 3.1).19
Both methods rotate a TRUS transducer around the long-axis to create geometrically
different reconstructed 3D images that are influenced by the transducer array configuration.
The images used in this study were acquired with the C9-5 transducer with the iU22
(Philips, Amsterdam, the Netherlands), the C9-5 and BPTRT9-5 transducers with the ATL

74

HDI-5000 (Philips, Amsterdam, the Netherlands), and the 8848 transducer with the
Profocus 2202 (BK Medical, Peabody, MA, United States) ultrasound machine models.
The total dataset of 246 3D TRUS images consisted of 104 end-fire and 142 side-fire 3D
TRUS images and was split into training, validation, and testing datasets as shown in Table
3.1. Manual 3D prostate segmentations (excluding the seminal vesicles) were performed
by an observer (IG) with approximately 15 years of TRUS prostate image analysis
experience. 3D image sizes ranged from [300⨯400⨯784] to [408⨯441⨯870] voxels with
dimensions of [0.094⨯0.154⨯0.154] to [0.183⨯0.186⨯0.186] mm3/voxel for side-fire
images and from [448⨯350⨯448] to [692⨯520⨯692] voxels with dimensions of
[0.115⨯0.115⨯0.115] to [0.190⨯0.195⨯0.190] mm3/voxel for end-fire images.

Figure 3.1 Mechanical scanning approaches for acquiring 3D TRUS prostate images using
end-fire (left) and side-fire (right) TRUS transducers. 2D images are acquired by rotating
around the long axis of the transducer at known sample spacings to create 3D TRUS
images. Example 3D TRUS images are shown in the bottom row, with the front face
demonstrating the reconstructed image plane and the white lines showing representative
acquisition planes.
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Table 3.1 Clinical 3D TRUS dataset split based on end-fire and side-fire scan geometries
and resulting training, validation, and testing datasets used for deep learning.

3.2.2

Image

Training

Validation

Testing

Total

End-fire
Side-fire
Total

67
98
165

17
24
41

20
20
40

104
142
246

3D segmentation algorithm

A workflow diagram of our proposed method is shown in Figure 3.2. This includes 3D
TRUS prostate image input, radial sampling, prediction using a trained modified U-Net,
3D reconstruction, and 3D prostate surface output.

Figure 3.2 Proposed 3D prostate segmentation workflow. A 3D TRUS prostate image is
used as input, followed by radial sampling to generate 12 2D image planes. Each image
plane was used to predict a prostate boundary with a trained modified U-Net prior to
reconstruction into the 3D prostate surface.

3.2.2.1

Training dataset for modified U-Net

Images from the training and validation split were used to obtain resliced 2D images of the
prostate. These 2D images were obtained at randomized axial, sagittal, coronal, radial, and
oblique image planes with varying rotations and zooms. This resulted in a dataset of 6,773
2D TRUS images with matched manual contours. All 2D images were resized to 256⨯256
pixels with no preprocessing (i.e., despeckling or bias correction) and were separated into
an 80/20 training/validation split for deep learning, resulting in 5418 training and 1355
validation 2D TRUS images.

3.2.2.2

Modified U-Net

The previously published U-Net20 was implemented using Keras21 with TensorFlow22 and
modified by adding 50% dropouts at every block on the expansion section of the network
to increase regularization and prevent overfitting. In addition, transpose convolutions were
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used at each step in the expansion section instead of the standard upsampling followed by
convolution, as this allowed for improved performance in preliminary experiments. Data
augmentation from random combinations of horizontal flips, 2D shifts (up to 20%),
rotations (up to 20°), and zooms (up to 20%) were employed to double the training dataset
to 10,836 2D TRUS images. Preliminary experiments led to the selection of an Adam
optimizer, 0.0001 learning rate, Dice-coefficient loss function, 200 epochs, and 200 steps
per epoch. This network was trained and used for predicting unseen data on a personal
computer with two Xeon E5645 central processing units at 2.40 GHz (Intel Corporation,
Santa Clara, CA, USA), 24.0 GB of memory, and a 6 GB Ge-Force GTX TITAN (NVIDIA
Corporation, Santa Clara, CA, USA) graphics processing unit (GPU).

3.2.2.3

3D reconstruction

Predicted 3D prostate segmentations were obtained by segmenting multiple 2D radial
frames generated by rotation around a central axis, followed by reconstruction to a 3D
surface following a reconstruction method similar to Qiu et al.11 Previous observations
have noted that segmenting the prostate on slices near the apex and base of the prostate can
be challenging due to boundary incompleteness,15 so we chose to radially slice the 3D
prostate image as opposed to transverse slicing in an attempt to improve segmentations at
all boundaries. This choice was motivated by the experience of segmenting the prostate
when the center of the gland is in-plane, which typically presents as an easier image to
accurately define and segment the boundaries on the left and right sides of the 2D image.
In contrast to this, a transverse slicing approach would result in 2D images with the prostate
appearing as a different size and shape, with this difference more pronounced at the prostate
apex and base, and when comparing end-fire and side-fire image geometries. Difficulty
arises, predominantly in side-fire geometries, when segmenting the ends of the prostate
along the axis of acquisition (when using a 2D approach) due to the changes in prostate
appearance and size. Thus, radially slicing and segmenting the prostate in these views
allows for a method that can train and predict on images containing similar structural
shapes, across different acquisition geometries.
Reconstructing a 3D contour was accomplished by radially slicing a 3D image in equal 15°
spacings around the approximate central axis of the prostate (Figure 3.3) to produce 12 2D
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images for prediction. These 12 images were predicted using the trained modified U-Net
to produce 2D prostate segmentations, and 204 equally spaced points were sampled around
the boundary of each 2D image. Since the original spatial location of the input 2D image
in the 3D volume was known, each predicted 2D segmentation was placed appropriately
back into the 3D volume and the boundary points on each segmentation were connected to
the adjacent slices. The intermediate surface was smoothed by a windowed sinc filter,
resulting in a final reconstructed 3D contour.

(a)

(b)

(c)

Figure 3.3 (a) Method for acquiring radially sliced 2D TRUS image planes (dotted lines)
from previously acquired 3D TRUS images. The axis of rotation (red) is approximately at
the central axis of the prostate and in the anterior-posterior direction. (b) 12 image slices
were obtained to perform prostate segmentation. For an end-fire 3D TRUS image, 2D
images are about the axis of image acquisition. (c) The majority of image slices obtained
from side-fire 3D TRUS images are across many acquisition slices and are subject to
increased interpolation, except for one slice, which matched the original acquired 2D
TRUS image.

3.2.3

Evaluation and comparison

Our algorithm was evaluated on a test data set of 20 unseen end-fire and 20 unseen sidefire 3D TRUS images of the prostate. Standard pixel map comparisons (DSC, recall,
precision) were computed for both 2D radial slice segmentations and the reconstructed 3D
segmentation for each prostate to obtain an understanding of the prediction quality and
reconstruction accuracy. We also computed absolute area/volume percent differences
(A/VPD), absolute mean surface distances (MSD), and absolute Hausdorff distances (HD),
as well as signed A/VPD (sA/VPD), signed MSD (sMSD), and signed HD (sHD) for all
2D predictions and reconstructed 3D segmentations. The signed metrics, while not
commonly reported, are important as they provide information on the segmentation bias
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and whether the prostate boundary is over or underpredicted. The inclusion of these metrics
will provide a more complete understanding of the performance of our proposed method.
All pixel map comparisons and 2D MSD/sMSD and HD/sHD distance metrics were
computed using MATLAB R2019a (MathWorks, Natick, MA, United States). The 3D
MSD/sMSD and HD/sHD metrics were computed by measuring the distances between all
points of the automatically predicted segmentation to the closest point on the manual goldstandard segmentation (CloudCompare v2.10.2).23 For comparison purposes, the MSD
reported here is similar to the boundary distance15 and mean surface distance16 presented
previously. Computation times were recorded for 2D slice segmentation, 3D
reconstruction, and overall 3D segmentation time.
The performance of our algorithm was compared against three state-of-the-art fully 3D
predicting CNNs (V-Net,24 Dense V-Net,25 and High-resolution 3D-Net26) using an opensource implementation on the NiftyNet platform.27 It is often assumed that performing a
prediction based on 3D information allows for an improved result due to increased spatial
context, so we completed a direct comparison on the same test dataset to investigate this
hypothesis. Similar to our proposed method, the same 165/41 3D TRUS images (Table 3.1)
were used for training/validation, respectively. The 3D V-Net was chosen to optimize
hyperparameters, including loss function, due to its widespread use and performance in
preliminary experiments. For simplicity, these hyperparameters were also used for the
Dense V-Net and High-resolution 3D-Net. Parameters were chosen to maximize the spatial
window size and usable memory on the GPU with optimized hyperparameters shown in
Table 3.2. Previous work has shown improved performance with a hybrid loss function,16
so we compared performance between a Dice loss function and a Dice plus cross-entropy
(DiceXEnt) loss function, as provided in NiftyNet, using the 3D V-Net. Although NiftyNet
offers a patch-based analysis, preliminary experiments resulted in 3D segmentations with
many flat surfaces throughout the prediction corresponding to patch edges. Since we had
one structure of interest (i.e., the prostate), we did not perform a patch-based analysis and
predictions were performed on a resized image to match the spatial window. Data
augmentation was employed to double the training dataset to 330 3D TRUS images. The
chosen hyperparameters for the Dense V-Net and High-resolution 3D-Net were the same
as shown in Table 3.2 (with the DiceXEnt loss function). These networks were trained and
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used for predicting unseen data on a personal computer with an Intel Core i7-4770 central
processing unit at 3.40 GHz (Intel Corporation, Santa Clara, CA, USA), 32.0 GB of
memory, and a 6 GB Ge-Force GTX TITAN (NVIDIA Corporation, Santa Clara, CA,
USA) graphics processing unit (GPU). Training and 3D segmentation computation times
were recorded.
Table 3.2 Hyperparameter selection when employing the V-Net in NiftyNet.

3.2.4

Hyperparameter

Value

Optimizer
Loss function
Activation function
Learning rate
Spatial window size
Mini-batch size
Weighted L2-decay

Adam
Dice and Dice + cross-entropy
PReLU
0.0001
[64, 64, 64]
2
0.0001

Statistical analysis

Statistical calculations were performed in GraphPad Prism 8.3 (Graphpad Software, Inc.,
San Diego, CA, USA). The normality of distributions was evaluated using the ShapiroWilk test and led to the use of nonparametric statistical tests when the assumption was
violated. The corresponding nonparametric alternative tests are presented in parentheses
for the remainder of the section. The significance level for statistical analysis was chosen
such that the probability of making a type I error was less than 5% (p < 0.05), with
statistically significant differences denoted simply as significant for the remainder of this
manuscript.
2D radial slice segmentation and 3D reconstructed segmentation accuracy as well as Dice
and DiceXEnt 3D V-Net loss functions were compared using two-tailed paired t-tests
(Wilcoxon matched-pairs signed-rank tests). Comparisons between our proposed
algorithm and three fully 3D CNNs were performed using two-tailed paired t-tests
(Wilcoxon matched-pairs signed-rank tests) with a Bonferroni multiple-comparison
correction, which adjusted the significance level to p < 0.0167. Comparisons between
segmentation accuracy for end-fire and side-fire 3D TRUS images on each network were
completed using two-tailed unpaired t-tests (Mann-Whitney tests).
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3.3
3.3.1

Results
Reconstructed modified U-Net

The results of our modified U-Net for 2D prostate segmentation and the effects of
reconstruction on 3D surface generation are shown in Table 3.3 and Table 3.4 for the
absolute and signed evaluation metrics, respectively. Overall, our proposed method
generated 3D surfaces with a median [first quartile (Q1), third quartile (Q3)] 3D DSC,
recall, and precision of 94.1 [92.6, 94.9] %, 96.0 [93.1, 98.5] %, and 93.2 [88.8, 95.4] %,
respectively, for the pixel map comparison metrics. Absolute VPD, MSD, and HD metrics
resulted in 5.78 [2.49, 11.5] %, 0.89 [0.73, 1.09] mm, and 2.89 [2.37, 4.35] mm with signed
metrics of 2.38 [-2.98, 11.0] %, 0.11 [-0.24, 0.58] mm, and 2.02 [-3.34, 2.88] mm,
respectively. All metrics, aside from the absolute and signed HD metrics, showed
significant differences between the 2D predictions and 3D reconstructed segmentations.
Interestingly, recall and MSD metrics were observed to significantly improve in
performance after 3D reconstruction, with the HD metric improving as well when
evaluating all unseen images. These findings agreed when splitting the results into end-fire
and side-fire 3D TRUS images, other than end-fire A/VPD and the signed metrics. For
end-fire images, absolute VPD increased after 3D reconstruction, although this was not
significant, while the signed metrics significantly improved after 3D reconstruction. For
side-fire images, the opposite was true, with signed metrics significantly improved for 2D
slice segmentations. When comparing the performance of our proposed method between
end-fire and side-fire 3D TRUS images, we found there was no significant difference in
any metric for both 2D radial segmentations and 3D reconstructed segmentations. Mean
computation times were observed to be 0.029 s for each 2D segmentation (i.e., 12 images)
and 0.27 s for reconstruction into a 3D surface, resulting in a total throughput time of 0.62
s from 3D image input to generated 3D surface.
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Table 3.3 Absolute median [Q1, Q3] results comparing 2D radial slice segmentation to 3D
reconstructed segmentation on an unseen test dataset of 20 end-fire and 20 side-fire 3D
TRUS images of the prostate.
Acquisition

End-fire

Side-fire

Overall

Segmentation

DSC (%)

Recall (%)

94.5
95.0
[93.6, 95.6] [92.7, 97.2]
3D Reconstruction
94.3
96.0
[93.1, 95.2] [93.2, 98.7]
p-value
0.0052*
0.0102*

Precision (%) A/VPD (%) MSD (mm)

HD (mm)

2D Radial

95.9
[92.2, 97.4]
94.6
[88.8, 95.8]
<0.0001

1.16
3.64
4.71
[1.71, 7.32] [0.95, 1.37] [3.11, 4.47]
5.18
0.99
3.41
[1.62, 11.2] [0.78, 1.18] [2.49, 4.41]
0.0532
<0.0001*
0.5217

2D Radial

94.9
[92.6, 96.4]
91.6
[87.8, 94.8]
<0.0001*

0.95
3.15
4.05
[1.07, 6.23] [0.82, 1.26] [2.51, 4.27]
5.89
0.78
2.61
[3.17, 11.9] [0.67, 0.98] [2.32, 4.01]
0.0441
<0.0001
0.3683

2D Radial

95.6
[92.6, 96.7]
93.2
[88.8, 95.4]
<0.0001

1.06
3.34
4.34
[1.60, 6.77] [0.85, 1.32] [2.61, 4.41]
5.78
0.89
2.89
[2.49, 11.5] [0.73, 1.09] [2.37, 4.35]
0.0061
<0.0001*
0.2766

95.3
94.6
[92.7, 95.4] [90.6, 96.9]
3D Reconstruction
93.5
96.2
[91.1, 94.6] [92.5, 98.4]
p-value
0.0037
0.0215
94.9
94.9
[93.2, 95.5] [91.9, 97.0]
3D Reconstruction
94.1
96.0
[92.6, 94.9] [93.1, 98.5]
p-value
<0.0001
0.0005

DSC, Dice similarity coefficient; A/VPD, area/volume percent diff.; MSD, mean surface dist.; HD, Hausdorff dist.
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error.

Table 3.4 Signed median [Q1, Q3] results comparing 2D radial slice segmentation to 3D
reconstructed segmentation on an unseen test dataset of 20 end-fire and 20 side-fire 3D
TRUS images of the prostate.
Acquisition

Segmentation

sA/VPD (%)

sMSD (mm)

sHD (mm)

End-fire

2D Radial
3D Reconstruction
p-value

-1.39 [-3.82, 5.82]
-0.05 [-2.98, 11.2]
0.0011*

-0.13 [-0.50, 0.71]
0.06 [-0.38, 0.85]
<0.0001*

-0.91 [-2.74, 2.81]
-0.34 [-3.82, 3.28]
0.9563

Side-fire

2D Radial
3D Reconstruction
p-value

-0.57 [-5.24, 3.27]
3.20 [-2.96, 10.1]
0.0001*

0.09 [-0.46, 0.31]
0.20 [-0.22, 0.46]
<0.0001*

-0.31 [-1.83, 1.72]
2.25 [-2.53, 2.81]
0.2305

Overall

2D Radial
3D Reconstruction
p-value

-0.91 [-4.93, 4.20]
2.38 [-2.98, 11.0]
<0.0001*

-0.09 [-0.46, 0.37]
0.11 [-0.24, 0.58]
<0.0001*

-0.91 [-2.15, 2.02]
2.02 [-3.34, 2.88]
0.3611

sA/VPD, signed area/volume percent diff.; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist.
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error.
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3.3.2

3D CNNs and V-Net optimization

Table 3.5 Absolute median [Q1, Q3] results comparing a standard 3D V-Net with a Dice
similarity coefficient loss function to a Dice similarity plus cross-entropy (DiceXEnt) loss
function on an unseen test dataset of 20 end-fire and 20 side-fire 3D TRUS images of the
prostate.
Acquisition

End-fire

Loss function

DSC (%)

Recall (%)

Precision (%)

VPD (%)

MSD (mm)

HD (mm)

Dice

89.5
[84.6, 92.0]
91.7
[89.0, 93.2]
0.0037

97.8
[94.6, 98.3]
91.7
[86.8, 94.6]
<0.0001

83.7
[75.1, 88.4]
94.3
[87.1, 95.8]
<0.0001

17.8
[7.57, 30.7]
7.94
[2.95, 12.5]
0.0021

1.79
[1.43, 2.47]
1.32
[0.99, 1.77]
0.0009

8.64
[7.53, 10.8]
6.95
[5.06, 9.10]
0.0172

90.6
[89.1, 93.2]
91.2
[87.4, 92.8]
0.2943

94.5
[91.1, 96.0]
89.5
[80.7, 92.9]
<0.0001

92.8
[89.9, 96.9]
95.0
[90.8, 97.5]
0.0001

9.08
[4.35, 14.0]
7.71
[3.55, 15.9]
0.7012

1.16
[0.89, 1.46]
1.11
[0.84, 1.47]
0.7562

5.81
[3.85, 9.61]
4.92
[4.28, 6.55]
0.2305

90.3
[86.5, 92.1]
91.3
[88.6, 93.1]
0.1538

95.5
[92.5, 97.8]
90.0
[85.6, 93.3]
<0.0001

87.8
[81.0, 91.7]
94.5
[90.0, 96.5]
<0.0001

11.4
[4.66, 19.3]
7.94
[3.55, 13.4]
0.0356

1.46
[1.16, 2.07]
1.27
[0.92, 1.61]
0.0147

7.99
[5.34, 10.4]
6.18
[4.51, 7.82]
0.0067

DiceXEnt
p-value
Dice

Side-fire

DiceXEnt
p-value
Dice

Overall

DiceXEnt
p-value

DSC, Dice similarity coefficient; VPD, volume percent difference; MSD, mean surface dist.; HD, Hausdorff dist.
*Normal distribution = paired t-test; Bolded metrics highlight the loss function with reduced relative error.

Table 3.6 Signed median [Q1, Q3] results comparing a standard 3D V-Net with a Dice
loss function to a Dice plus cross-entropy (DiceXEnt) loss function on an unseen test
dataset of 20 end-fire and 20 side-fire 3D TRUS images of the prostate.
Acquisition

Loss function

sVPD (%)

sMSD (mm)

sHD (mm)

End-fire

Dice
DiceXEnt
p-value

17.8 [7.57, 30.7]
-2.16 [-8.47, 6.10]
<0.0001*

1.51 [0.85, 2.23]
-0.07 [-0.71, 0.68]
<0.0001*

7.99 [5.37, 10.84]
-0.05 [-7.33, 6.50]
0.0009

Side-fire

Dice
DiceXEnt
p-value

5.02 [0.93, 11.5]
-5.50 [-15.6, -0.62]
<0.0001*

0.43 [0.16, 0.80]
-0.30 [-0.88, 0.02]
<0.0001*

5.34 [3.18, 9.61]
-4.52 [-6.27, -3.04]
<0.0001

Overall

Dice
DiceXEnt
p-value

9.63 [3.90, 18.9]
-3.66 [-9.25, 3.34]
<0.0001*

0.83 [0.35, 1.78]
-0.13 [-0.73, 0.26]
<0.0001*

6.91 [3.35, 10.31]
-4.16 [-7.04, 4.76]
<0.0001*

sVPD, signed volume percent difference; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist.
*Normal distribution = paired t-test; Bolded metrics highlight the loss function with reduced relative error.
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Results of the NiftyNet 3D V-Net with a Dice and DiceXEnt loss function on 20 unseen
end-fire and 20 unseen side-fire 3D TRUS images are shown in Table 3.5 and Table 3.6
for the absolute and signed evaluation metrics, respectively. When comparing 3D V-Net
performance with Dice and DiceXEnt loss functions on the full testing dataset, all metrics,
aside from DSC, showed significant differences. Precision, VPD/sVPD, MSD/sMSD, and
HD/sHD were significantly improved with the DiceXEnt loss function, while recall was
significantly improved with the Dice loss function. Although there was no significant
difference in the DSC metric, the DiceXEnt loss function showed an improved median
DSC. When considering end-fire and side-fire images individually, identical trends were
observed for precision, recall, sMSD, and sHD. For the DSC, VPD, MSD, and HD metrics,
we observed a significant and nonsignificant increase in performance with the DiceXEnt
loss function for end-fire images and side-fire images, respectively. For end-fire images,
the sVPD metric improved significantly with the DiceXEnt loss function, while the sVPD
metric improved significantly with the Dice loss function for side-fire images. When
comparing the 3D V-Net performance with DiceXEnt between end-fire and side-fire 3D
TRUS images, we found no significant differences in any metric except HD, where sidefire images had a significantly reduced median value compared to end-fire images. Overall,
the 3D V-Net showed improved performance with the DiceXEnt loss function and
produced 3D segmentations with median [Q1, Q3] 3D DSC, recall, and precision results
of 91.3 [88.6, 93.1] %, 90.0 [85.6, 93.3] %, and 94.5 [90.0, 96.5] %, respectively, for the
pixel map comparison metrics. Absolute VPD, MSD, and HD metrics resulted in 7.94
[3.55, 13.4] %, 1.27 [0.92, 1.61] mm, and 6.18 [4.51, 7.82] mm with signed variants of 3.66 [-9.25, 3.34] %, -0.13 [-0.73, 0.26] mm, and -4.16 [-7.04, 4.76] mm, respectively.
Mean computation times were observed to be 3.43 s for a full 3D segmentation.
Results of the Dense V-Net and High-resolution 3D-Net with a DiceXEnt loss function on
20 unseen end-fire and 20 unseen side-fire 3D TRUS images are shown in Table 3.A1 and
Table 3.A2 in Supplement A for the absolute and signed evaluation metrics, respectively.
Compared to the 3D V-Net, the High-resolution 3D-Net showed a reduction in median
performance for all metrics, while the Dense V-Net showed a reduction in performance for
all metrics except recall. In contrast with our proposed method and the 3D V-Net, we
observed significant differences in segmentation performance for several metrics when
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comparing end-fire and side-fire 3D TRUS images using the Dense V-Net and Highresolution 3D-Net. For the Dense V-Net, improved performance was observed on side-fire
images for every metric except recall, with significant differences observed for the
precision, recall, VPD/sVPD, and sMSD metrics. For the High-resolution 3D-Net,
improved performance was observed on end-fire images for every metric except precision
and HD, with significant differences observed for the DSC, precision, recall, VPD/sVPD,
and sMSD metrics. Mean 3D segmentation times for the Dense V-Net and High-resolution
3D-Net were observed to be 2.98 s and 2.83 s, respectively.

3.3.3

Comparison of reconstructed modified U-Net and 3D CNNs

Sample segmentation results from the 20 unseen end-fire and 20 unseen side-fire 3D TRUS
images from our proposed method compared against the 3D V-Net with a DiceXEnt loss
function and manual segmentations are shown in Figure 3.4 and Figure 3.5, respectively.
A comparison of segmentation performance between our proposed method and a standard
3D V-Net is shown in Table 3.7 and Table 3.8 for the absolute and signed evaluation
metrics, respectively. Overall, our proposed method had significantly improved DSC,
Recall, sVPD, MSD/sMSD, and HD when compared to the 3D V-Net. Absolute VPD and
sHD, while not significantly different, were reduced for our proposed method. The only
evaluation metric where the 3D V-Net outperformed our proposed method was precision,
where the 3D V-Net showed a nonsignificant increase. Considering segmentation
performance for end-fire and side-fire 3D TRUS images separately, similar trends hold.
For end-fire images, our proposed method had better performance in all metrics except
sHD, with DSC, recall, sVPD, MSD, and HD showing significant differences, and
precision, VPD, and sMSD showing nonsignificant improvements. However, for side-fire
images our proposed method was superior in all metrics except precision. Significant
improvements were shown for DSC, recall, sVPD, MSD/sMSD, and HD/sHD, while the
3D V-Net had significantly improved precision. As was observed in the overall case, our
proposed method showed a nonsignificant decrease in VPD compared to the 3D V-Net for
both end-fire and side-fire images.
Overall, our proposed method significantly improved performance on all metrics when
compared to the Dense V-Net and showed improved performance on all metrics when
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compared to the High-resolution 3D-Net, with significant differences observed for all
metrics except precision, sMSD, and sHD, where our method showed a nonsignificant
improvement.

Table 3.7 Absolute median [Q1, Q3] results comparing a standard 3D V-Net to our
proposed reconstructed modified (rm) U-Net on an unseen test dataset of 20 end-fire and
20 side-fire 3D TRUS images of the prostate.
Acquisition

End-fire

Segmentation

DSC (%)

Recall (%)

Precision (%)

VPD (%)

MSD (mm)

HD (mm)

V-Net

91.7
[89.0, 93.2]
94.3
[93.1, 95.2]
0.0003*

91.7
[86.8, 94.6]
96.0
[93.2, 98.7]
<0.0001*

94.3
[87.1, 95.8]
94.6
[88.8, 95.8]
0.5459

7.94
[2.95, 12.5]
5.18
[1.62, 11.2]
0.4980

1.32
[0.99, 1.77]
0.99
[0.78, 1.18]
0.0003*

6.95
[5.06, 9.10]
3.41
[2.49, 4.41]
<0.0001

91.2
[87.4, 92.8]
93.5
[91.1, 94.6]
0.0073

89.5
[80.7, 92.9]
96.2
[92.5, 98.4]
0.0002

95.0
[90.8, 97.5]
91.6
[87.8, 94.8]
0.0153

7.71
[3.55, 15.9]
5.89
[3.17, 11.9]
0.2611

1.11
[0.84, 1.47]
0.78
[0.67, 0.98]
0.0027

4.92
[4.28, 6.55]
2.61
[2.32, 4.01]
0.0001

91.3
[88.6, 93.1]
94.1
[92.6 , 94.9]
<0.0001

90.0
[85.6, 93.3]
96.0
[93.1, 98.5]
<0.0001

94.5
[90.0, 96.5]
93.2
[88.8, 95.4]
0.1499

7.94
[3.55, 13.4]
5.78
[2.49, 11.5]
0.1701

1.27
[0.92, 1.61]
0.89
[0.73, 1.09]
<0.0001*

6.18
[4.51, 7.82]
2.89
[2.37, 4.35]
<0.0001

rmU-Net
p-value
V-Net

Side-fire

rmU-Net
p-value
V-Net

Overall

rmU-Net
p-value

DSC, Dice similarity coefficient; VPD, volume percent difference; MSD, mean surface dist.; HD, Hausdorff dist.
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error.

Table 3.8 Signed median [Q1, Q3] results comparing a standard 3D V-Net to our proposed
reconstructed modified (rm) U-Net on an unseen test dataset of 20 end-fire and 20 side-fire
3D TRUS images of the prostate.
Acquisition

Segmentation

sVPD (%)

sMSD (mm)

sHD (mm)

End-fire

V-Net
rmU-Net
p-value

-2.16 [-8.47, 6.10]
-0.05 [-2.98, 11.2]
0.0030*

-0.07 [-0.71, 0.68]
0.06 [-0.38, 0.85]
0.0444*

-0.05 [-7.33, 6.50]
-0.34 [-3.82, 3.28]
0.7942*

Side-fire

V-Net
rmU-Net
p-value

-5.50 [-15.6, -0.62]
3.20 [-2.96, 10.1]
0.0001*

-0.30 [-0.88, 0.02]
0.20 [-0.22, 0.46]
0.0025*

-4.52 [-6.27, -3.04]
2.25 [-2.53, 2.81]
0.0107

Overall

V-Net
rmU-Net
p-value

-3.66 [-9.25, 3.34]
2.38 [-2.98, 11.0]
<0.0001*

-0.13 [-0.73, 0.26]
0.11 [-0.24, 0.58]
0.0003*

-4.16 [-7.04, 4.76]
2.02 [-3.34, 2.88]
0.0408

sVPD, signed volume percent difference; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist.
*Normal distribution = paired t-test; Bolded metrics highlight the method with reduced relative error.
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Figure 3.4 End-fire prostate segmentation results comparing manual (red), our proposed
reconstructed modified (rm) U-Net (blue), and V-Net (yellow) 3D surfaces. The columns
from left to right show the 25th, 50th, and 75th percentile results, respectively, based on DSC
metrics. Segmentations in the axial plane, sagittal plane, 45° oblique radial plane, and
reconstructed 3D surface error are shown in the respective rows from top to bottom.
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Figure 3.5 Side-fire prostate segmentation results comparing manual (red), our proposed
reconstructed modified (rm) U-Net (blue), and V-Net (yellow) 3D surfaces. The columns
from left to right show the 25th, 50th, and 75th percentile results, respectively, based on DSC
metrics. Segmentations in the axial plane, sagittal plane, 45° oblique radial plane, and
reconstructed 3D surface error are shown in the respective rows from top to bottom.
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3.4
3.4.1

Discussion
Reconstructed modified U-Net

We proposed a new 3D TRUS prostate segmentation method, which utilizes a modified UNet to segment 12 2D radial slices, which are then reconstructed into a 3D surface. We
first compared segmentation accuracy in these 2D radial slices to segmentation accuracy
following 3D reconstruction. In general, the performance was better on the 2D radial slice
segmentations compared to the reconstructed 3D surface, but interestingly, our
reconstruction method improved recall, MSD, and HD metrics when compared to 2D slice
segmentation. When considered in combination, the reduced MSD and HD metrics showed
better mean and irregular boundary accuracy, with the improved recall metric implying a
reduction in underprediction (since decreasing underpredicted pixels, i.e., false negatives,
will increase recall). The reduction in underprediction is contrasted with our method
tending to overpredict, supported by the slight positive bias in the signed metrics and
reduced precision. In the metrics where performance was worse for our 3D reconstructed
segmentations, such as DSC and VPD, the difference in median values were less than 1%
and 1.5% respectively. Thus, we saw that our 3D reconstruction method did not drastically
reduce performance of the evaluation metrics when compared to our 2D segmentations,
with the 3D reconstruction improving performance on select metrics. Examining the signed
metrics shown in Table 3.4, we observed that sVPD, sMSD, and sHD are reduced
compared to their absolute metrics, with median sVPD reduced to only 2.38 %, median
sMSD reduced to 0.11 mm, and median sHD reduced to 2.02 mm. This demonstrated that
our algorithm was not significantly biased to over or underpredict the prostate boundary.
As our proposed network was trained and tested on both end-fire and side-fire 3D TRUS
images, we directly compared the performance of our method on each image type
observing no significant difference between performance for end-fire and side-fire images
on any metric. Both independent image geometries also followed the same trends as the
total dataset, aside from a reduced signed bias in the end-fire images following
reconstruction. These results demonstrated the effectiveness of radially sampling 3D
TRUS prostate images to produce similar 2D images for prediction and the ability to
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accurately segment the prostate in different 3D TRUS image geometries without the need
for multiple trained networks, which, to our knowledge, is the first time this has been
shown.

3.4.2

3D CNNs and V-Net Optimization

The initial publication describing the V-Net architecture by Milletari et al.24 proposed the
use of a Dice coefficient-based loss function, but recent leave-one-out validation, described
in Lei et al.,16 has advocated for the use of hybrid loss functions that combine standard
logistic loss, such as the cross-entropy loss metric,20 with the Dice loss metric. We
implemented a 3D V-Net with both a Dice loss function and a hybrid DiceXEnt loss
function in order to compare performance between loss functions, as well as to directly
compare performance to previously published V-Net implementations16 on an unseen
dataset. Our results reiterate what has been previously reported, with the hybrid DiceXEnt
loss function significantly improving performance on all metrics except DSC and recall,
where we observed a nonsignificant increase in performance and a significant decrease in
performance, respectively. Similar trends held when examining the results for end-fire and
side-fire 3D TRUS images individually. Comparing 3D V-Net performance when using a
DiceXEnt loss function between end-fire and side-fire 3D TRUS images showed similar
results to our proposed network, as there was no significant difference in any metric except
HD.
Similar segmentation performance on end-fire and side-fire 3D TRUS images for all three
3D CNNs and our proposed 3D segmentation method demonstrated that we could
potentially train a single network to accurately segment the prostate in geometrically
variable 3D TRUS images. This was demonstrated predominantly with our approach and
the 3D V-Net as the Dense V-Net and High-resolution 3D-Net were observed to have
significant differences between several metrics when comparing end-fire and side-fire
segmentation performance. Interestingly, performance differed between the Dense V-Net
and High-resolution 3D-Net for different image geometries, with better predictions
performed on side-fire and end-fires images, respectively. Although our method performed
the best, the 3D V-Net outperformed the other two 3D CNNs investigated in this study.
This improved performance on 3D US prostate segmentation could be due to the number
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of parameters trained by the network since the 3D V-Net has approximately two orders of
magnitude more parameters relative to the Dense V-Net and High-resolution 3D-Net.
Although the latter networks are more efficient and required less computation time, we
found this did not benefit performance.
Although Lei et al.16 reported on a deep supervision method with contour refinement, they
also reported on the use of a standard 3D V-Net with a hybrid DiceXEnt loss function to
segment the prostate in side-fire 3D TRUS images, showing a 3D DSC, precision, recall,
HD, MSD, and RMSD of 90.5 ± 3.0 %, 88.1 ± 6.0 %, 93.5 ± 3.5 %, 4.643 ± 1.926 mm,
0.657 ± 0.270 mm, and 0.977 ± 0.410 mm, respectively. Comparatively, a standard 3D VNet with a DiceXEnt loss function trained on our dataset and predicted on side-fire images
resulted in a 3D DSC, precision, recall, HD, and MSD of 91.2 [87.4, 92.8] %, 95.0 [90.8,
97.5] %, 89.5 [80.7, 92.9] %, 4.92 [4.28, 6.55] mm, and 1.11 [0.84, 1.47] mm, showing
very similar performance. Investigating the differences between mean and median values
showed our V-Net implementation demonstrated improved 3D DSC and precision, while
Lei et al.16 demonstrated improved recall, HD, and MSD. Although VDP or any signed
metrics were not reported, this demonstrated similarity in performance. Thus, we suggest
future comparisons should use a standardized V-Net, like the NiftyNet open-source
implementation, to provide a baseline for comparing network performance on different
datasets.

3.4.3

Comparison with 3D V-Net and previously published methods

For an identical training and testing dataset, our proposed method performed significantly
better than the standard 3D V-Net with a hybrid loss function, with DSC, recall, sVPD,
MSD/sMSD, and HD/sHD showing significant improvement. Our proposed method also
demonstrated a reduced median VPD, although this difference was not significant. Similar
differences in performance were observed when considering end-fire and side-fire 3D
TRUS images separately. Figure 3.4 and Figure 3.5 show this difference in performance
qualitatively for both image geometries, with the 3D V-Net often over or underpredicting
the correct prostate boundary. This difference is readily apparent in the side-fire middle
50th percentile column of Figure 3.5. The V-Net is shown to have incorrectly contoured
part of the bladder as the prostate, drastically affecting the overall segmentation accuracy.
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In contrast, our proposed method was able to correctly avoid the bladder, resulting in a
more accurate segmentation. A similar result is shown in the left column of Figure 3.4 as
well as in Figure 3.6, where we show that the 3D V-Net mistakenly underpredicted the
prostate boundary due to the presence of a hyperechoic calcification artifact in the TRUS
image, whereas our proposed method was typically able to avoid artifacts of this nature.
We demonstrated a mean 3D segmentation time of 0.62 s with our proposed method, over
five times faster than the 3D V-Net, which required an average of 3.43 s per segmentation.
All segmentations were completed with the same NVIDIA GeForce GTX TITAN GPU
with 6 GB of memory.

Figure 3.6 A sample end-fire prostate segmentation result comparing manual (red), our
proposed algorithm (blue), and V-Net (yellow) 3D surfaces in the presence of a
hyperechoic calcification image artifact.
Recent work by Ghavami et al.15 and Lei et al.16 report on automatic prostate segmentation
in 3D TRUS images, with Ghavami et al.15 reporting best results for 2D DSC, 3D DSC,
and boundary distance of 89 ± 12 %, 89 ± 5 %, and 1.68 ± 1.57 mm, respectively, and Lei
et al.16 reporting overall segmentation results for 3D DSC, precision, recall, HD, MSD, and
RMSD of 91.9 ± 2.8 %, 90.6 ± 5.5 %, 93.8 ± 4.3 %, 3.938 ± 1.550 mm, 0.599 ± 0.225 mm,
and 0.900 ± 0.377 mm, respectively. Our proposed method demonstrated overall
segmentation results for 2D DSC, 3D DSC, precision, recall, HD, and MSD of 94.9 [93.2,
95.5] %, 94.1 [92.6, 94.9] %, 93.2 [88.08, 95.4] %, 96.0 [93.1, 98.5] %, 2.89 [2.37, 4.35]
mm, and 0.89 [0.73, 1.09] mm, respectively, outperforming the network reported by
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Ghavami et al.15 on all reported metrics, and outperforming the network reported by Lei et
al.16 on all metrics except MSD. In addition, our paper reports on metrics not used in the
studies described here, including VPD, and signed variants of VPD, MSD, and HD,
providing additional insight into the performance of our network that is otherwise not
present when these metrics are excluded. Lei et al.16 reported segmentation times of
approximately 1-2 s for a U-Net, V-Net, and their proposed network, with segmentations
completed using an NVIDIA TITAN XP GPU with 12 GB of memory. Comparatively, our
V-Net implementation in NiftyNet had a mean segmentation time of 3.43 s, while our
proposed method had a mean segmentation time of 0.62 s, with segmentations completed
using an NVIDIA GeForce GTX TITAN GPU with 6 GB of memory. Although our V-Net
had slower segmentation times, our proposed method was one and a half to three times
faster, using a GPU with half the memory, demonstrating the advantage of our proposed
method regarding segmentation time.
Studies reported by Ghavami et al.15 and Lei et al.16 are also limited by their use of crossvalidation approaches, in addition to their dataset consisting of only one image geometry
and a single ultrasound machine with matched voxel dimensions and sizes. In contrast, we
used a clinically diverse dataset of 3D TRUS images of different image geometries,
generated by several different ultrasound transducers used with different machine models,
and used in distinct procedures. This dataset contains images with varying voxel
dimensions, size, and image quality, and we have employed no pre-processing before
training to reduce process complexity. To our knowledge, the use of a dataset with different
image geometries, ultrasound transducers, ultrasound machine models, voxel dimensions,
and image sizes for 3D TRUS prostate segmentation is unique and may allow for a more
robust and generalizable segmentation method. In addition, we have not used a crossvalidation approach, instead testing our algorithm on 3D TRUS images that were
completely unseen by the network, which we believe strengthens the significance of our
results and may result in improved generalizability.

3.4.4

Limitations and future work

Although we have demonstrated excellent performance with our proposed algorithm, a
parameter that may be interesting to explore in future work is the step angle for radial slice
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generation. Specifically, it would be interesting to investigate whether a decreased step
angle and thus an increased number of radial slices would significantly increase
performance, or whether a decreased number of slices could be used while maintaining
similar performance. An increased number of radial slices would increase computation
time, which motivated our choice of a 15° step angle for the proposed method. When
training the 3D CNNs for performance comparison, hyperparameters were optimized on
the V-Net and were used for the other two networks. Even though we investigated other
combinations and found these hyperparameters to perform the best on the Dense V-Net
and High-resolution 3D-Net, a rigorous optimization was not performed and has the
potential to increase performance. Another limitation of our study is the use of only one
observer for providing ground truth segmentations. This meant we could not directly assess
inter-observer variability for our dataset. In addition, we did not directly assess intraobserver variability over several time points. Inter- and intra-observer variability in endfire 3D TRUS images were previously assessed by our group,11 and are summarized here.
To assess intra-observer variability, one observer segmented 15 3D images five times each,
resulting in a 3D DSC of 93.0 ± 2.1 %. To assess inter-observer variability, three untrained
observers segmented 15 3D images three times each, resulting in a DSC of 93.5 ± 2.1 %,
92.6 ± 3.1 %, and 92.3 ± 3.2 %, with an ANOVA demonstrating no significant difference.
Inter- and intra-observer variability in side-fire 3D TRUS images were also assessed by
our group,28 reporting 5.1 % variability and 99 % reliability in intra-observer prostate
volume estimates, and 11.4 % variability and 96 % reliability in inter-observer estimates,
for a study of eight observers measuring 15 prostate images twice. This variability is
comparable to the reported DSC of our proposed method in this work, showing that our
algorithm is performing at the level of intra-observer variability in the ground truth
segmentations. Due to the demonstrated variability between different observers when
segmenting 3D TRUS images, segmentations from other observers should be incorporated
into our testing dataset to further improve the robustness of our proposed method.
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3.5

Conclusions

This study investigated the development of a 2D deep learning with 3D reconstruction
approach for automatic prostate segmentation in 3D TRUS images. Multiple facilities,
ultrasound machine models, and acquisition geometries were investigated to evaluate
robustness and generalizability, with comparisons performed against multiple 3D CNNs.
A fast, accurate, and generalizable automatic prostate segmentation algorithm could reduce
physician burden and procedure time, offering potential workflow benefits for fusionguided prostate biopsy, tumor-targeted HDR-BT, and TRUS-guided whole-gland BT.
Reducing the time a patient is under anesthesia, as in HDR-BT, also promotes a potentially
safer procedure with fewer adverse side effects.
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3.7

Supplement A

Table 3.A1 Absolute median [Q1, Q3] results comparing a Dense V-Net (DenseNet) and
High-resolution 3D Network (HighRes3dNet) on an unseen test dataset of 20 end-fire and
20 side-fire 3D TRUS images of the prostate.
Acquisition

Segmentation
DenseNet

End-fire
HighRes3dNet

DenseNet
Side-fire
HighRes3dNet

DenseNet
Overall
HighRes3dNet

DSC (%)

Recall (%)

Precision (%)

VPD (%)

MSD (mm)

HD (mm)

87.9
[84.9, 90.4]
90.0
[87.3, 91.4]

95.4
[92.9, 97.0]
91.7
[84.6, 94.9]

82.2
[77.4, 86.5]
89.3
[87.0, 93.7]

15.6
[9.42, 20.8]
6.88
[4.30, 15.7]

2.11
[1.55, 2.85]
1.62
[1.41, 2.08]

10.0
[7.82, 12.5]
8.95
[7.56, 11.2]

88.7
[81.6, 90.7]
86.2
[84.3, 88.7]

89.1
[86.0, 95.1]
80.5
[76.8, 86.0]

89.6
[82.8, 91.9]
94.9
[90.9, 96.1]

6.38
[4.22, 12.6]
15.3
[9.77, 20.0]

1.47
[1.26, 2.56]
1.64
[1.36, 1.93]

8.96
[5.93, 13.8]
7.82
[6.67, 9.31]

88.2
[84.3, 90.6]
87.5
[85.5, 90.3]

93.0
[88.9, 96.1]
85.4
[79.8, 92.1]

84.8
[79.2, 90.2]
92.3
[88.4, 95.8]

11.0
[5.96, 19.3]
11.8
[4.68, 18.0]

2.00
[1.36, 2.63]
1.63
[1.40, 1.97]

9.23
[7.00, 13.2]
8.37
[6.89, 10.9]

DSC, Dice similarity coefficient; VPD, volume percent difference; MSD, mean surface dist.; HD, Hausdorff dist.

Table 3.A2 Signed median [Q1, Q3] results comparing a Dense V-Net (DenseNet) and
High-resolution 3D Network (HighRes3dNet) on an unseen test dataset of 20 end-fire and
20 side-fire 3D TRUS images of the prostate.
Acquisition

Segmentation

sVPD (%)

sMSD (mm)

sHD (mm)

End-fire

DenseNet
HighRes3dNet

15.6 [9.42, 20.8]
2.86 [-6.42, 8.86]

1.44 [0.92, 2.18]
0.37 [-0.46, 0.93]]

9.13 [7.19, 12.3]
6.47 [-8.97, 9.71]

Side-fire

DenseNet
HighRes3dNet

0.36 [-4.91, 7.07]
-13.8 [-20.0, -7.55]

0.38 [-0.15, 1.03]
-0.76 [-1.23, -0.08]

8.67 [-2.86, 13.8]
-6.69 [-8.40, 4.38]

Overall

DenseNet
HighRes3dNet

8.77 [-2.84, 18.3]
-6.89 [-16.4, 4.09]

0.95 [0.29, 1.61]
-0.24 [-1.15, 0.58]

8.87 [5.72, 13.2]
-5.84 [-8.46, 8.32]

sVPD, signed volume percent difference; sMSD, signed mean surface dist.; sHD, signed Hausdorff dist.
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Chapter 4

4

Geometrically variable three-dimensional ultrasound for
mechanically assisted image-guided therapy of focal liver
cancer tumors

The use of 3D information during interventional procedures has the potential to improve
the accuracy needed for sufficient clinical outcomes. The purpose of Chapter 4 is to present
on the development of a novel 3D US system to provide a safe, cost-effective, and accurate
intraoperative approach for focal liver tumor therapies.
The contents of this chapter have been accepted for publication on June 28, 2020 in Medical
Physics: Gillies DJ, Bax J, Barker K, Gardi L, Tessier D, Kakani N, and Fenster A.

4.1

Introduction

Liver cancer is the second and sixth most frequent cause of cancer mortality in men and
women, respectively, and its incidence is continuing to increase globally.1 The high
prevalence of this disease is observed in underdeveloped and developing countries due to
the increased incidence of Hepatitis B and C, but rates are also increasing globally from
factors including exposure to aflatoxins, metabolic syndrome, and alcohol.1 Without
accessible and practical therapy options, the prognosis for the majority of patients
diagnosed with liver cancer remains grave. Conventional therapy is often provided in the
forms of transplantation and hepatic resection, but patient eligibility is often low due to
disease exclusion criteria such as the number of tumors, size, location, and presence of
metastases.2,3 Even in circumstances when a patient is eligible, serious complications can
occur in up to 26-33% of procedures.4
Image-guided interventions are less invasive alternatives to open surgery that focus on
relating preoperative data and images of a patient in an intraoperative setting.5 Smaller
surgical incisions often lead to reduced recovery times and complication rates, which
directly benefit a patient’s quality-of-life and healthcare costs. Three main techniques for
image-guided interventions in the treatment of liver cancer have been investigated:
embolization, irreversible electroporation, and ablation, such as cryoablation, ethanol
injection, microwave ablation (MWA), and radiofrequency ablation (RFA). In recent years,
MWA and RFA have been regarded as the best treatment options for small and
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unresectable liver tumors,6,7 which use needle-like therapy applicators guided to the tumor
location to deliver a lethal thermal dose to the tumor.
Image-guidance during ablation procedures varies globally and has been predominantly
performed using x-ray computed tomography (CT), magnetic resonance imaging (MRI),
and ultrasound (US). In many developed countries, access to CT provides a good depiction
of liver tumors and the ablation applicators, but the limited access to the patient in the CT
gantry often extends procedure time and can limit complex applicator access angles.8 Since
MR guidance is often limited to institutions with compatible equipment, US is regarded as
the most efficient modality for tumors that can be targeted adequately8 with developing
countries often using this approach.9 Conventional US guidance is a real-time, two-handed
approach using a plan based on preoperative CT or MR images where one hand positions
and orients a conventional US probe while the other hand performs therapy applicator
insertion. However, this approach requires extensive training as the physician must: (1)
mentally integrate two-dimensional (2D) imaging to form an appreciation of the complex
3D anatomy of the liver, (2) approximate the tumor volume and spatial extent, (3) align the
2D image plane directly with the applicator to detect and track its placement at the tumor
location, and (4) be cognizant of the surrounding anatomy to avoid puncturing unnecessary
anatomical structures and organs-at-risk, such as the gallbladder. This time-consuming and
challenging task with its compounding forms of mental burden can lead to increased
variability in applicator placement and ultimately insufficient tumor ablation. In addition
to the high local tumor recurrence that has been observed when ablation margins are less
than 5 mm,10–12 tumors with diameters larger than 5 cm are often avoided as the incidence
of local tumor progression is higher due to the accuracy required for placing and
repositioning multiple applicators with overlapping ablation volumes.13 Therefore, there is
a clinical need to improve the imaging guidance and placement verification of needle
applicators during MWA and RFA procedures.
Investigations into guidance techniques for planning, targeting, monitoring, and controlling
ablation therapies and other needle-like procedures have focused on incorporating CT
image guidance,14 MR image guidance,15 and tracking systems16,17 into the intraoperative
clinical workflow. Incorporating three-dimensional (3D) visualizations can lead to
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complete ablations and higher clinical success rates on the first ablation attempt, as well as
fewer sessions overall relative to 2D US when subsequent attempts are required.16,18 CT
images can provide 3D multiplanar images to visualize the needle-like applicators, but
repeated CT scans are performed at the cost of increased procedure time and radiation dose
to the patient. MR imaging has been used as it offers advantages such as improved softtissue contrast and the potential for real-time treatment monitoring, but can again increase
procedure time and is not readily accessible in many countries due to the sophisticated
technology required.19 Electromagnetic tracking systems have been used to place multiple
needle applicators by registering and fusing preoperative CT images with live 2D US
images;20 however, these systems do not often rely on the intraoperative imaging data and
are susceptible to environmental limitations that can degrade targeting accuracy.
An alternative approach for real-time image-guided therapy is the use of three-dimensional
(3D) US.21 This approach includes 2D US freehand scanning with optical or
electromagnetic position tracking,22 2D array probes,23 or 2D US with mechanical
scanners.24 These images can offer real-time or near real-time multiplanar imaging in an
accessible and portable manner, which is an important consideration for widespread
dissemination. If combined or fused with preoperative CT images using image registration
methods, lesion identification and procedural plans25 can be incorporated into the
intraoperative workflow for an augmented and targeted image-guided procedure. Needle
guides can improve placement of applicators over freehand approaches22 and repeat 3D US
images can be obtained safely to inform the physician if the therapy applicator placement
is sufficient or repositioning is required with the use of segmentation algorithms,26 without
the need for ionizing radiation exposure and a significant increase in procedure time. When
performing guided insertions, 3D US imaging can improve the targeting accuracy of needle
applicator placements over freehand 2D US22,27 and has been observed to detect
unacceptable applicator placements in up to 45% of procedures.28 Additionally, 3D US has
been observed to improve operator confidence and visualization of the positional
relationship between needle applicators and nearby critical structures.29 Although therapy
monitoring can be difficult on conventional B-mode imaging, intraoperative ultrasound
elasticity imaging has the potential to provide real-time monitoring and verification of
thermal ablation volumes.30
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We propose the use of 3D US imaging to provide guidance and localization of ablation
applicators in current focal liver tumor ablation therapies. We have previously developed
a system capable of providing 3D US images using a mechanical scanning approach for
linear, tilt, and hybrid motions of the US probe, which resulted in accurate geometric 3D
reconstruction and good agreement with clinical CT patient liver images when assessing
tip and trajectory errors.24 Since the liver is a large internal organ that is partly sheltered by
the ribs, flexibility in 3D US acquisition geometries can allow for small physical footprints
(i.e., tilt scanning) that are beneficial for intercostal imaging, as well as wide field-of-view
(FOV) subcostal imaging (i.e., hybrid scanning) to capture large volumes of the liver. We
chose to pursue a mechanical scanning approach as it is cost-effective since any clinically
available US system can be used with this approach, the motor assembly can predefine and
control probe motion with high accuracy, environmental constraints are minimal, and
advances in US imaging probes can be easily integrated into the system without any
changes in the scanning mechanism. This work will further expand the design and use of
the system by incorporating and evaluating a novel scanning mechanism for increased
image size and improved usability, a mechanical tracking system for probe placement
reproducibility and freehand needle applicator guidance, and a needle applicator insertion
workflow using a custom needle applicator guide for targeted image-guided procedures.
Evaluation of the new scanner has been previously discussed briefly,31,32 but is expanded
here to provide context for evaluation of the tracking system and needle applicator insertion
workflow performed on 48 phantom 3D US images. A healthy volunteer was also imaged
to provide evidence for clinical feasibility. These evaluations aim to give insights on
clinical utility for improving applicator placement and reducing local cancer recurrence
during interventional procedures treating liver cancer.

4.2

Materials and methods

Our proposed 3D US system (Figure 4.1) consists of four components: (1) a three-motor
3D US scanner, (2) a counterbalanced tracking system, (3) a 3D-printed applicator guide,
and (4) software for image acquisition, visualization, and guidance. The stabilizing system
also contains electromagnetic brakes, which are disengaged using a foot pedal to improve
clinical usability and workflow, for locking the system to limit device motion during 3D
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US acquisition and insertion of therapy applicators. The stabilizing system is mounted on
a portable cart, which contains a foot-released vertical motion column to accommodate
large differences in patient sizes, a power supply, and a personal computer with a monitor
to interface with custom visualization and guidance software.

Figure 4.1 Proposed 3D US system consisting of a three-motor 3D US scanner and a
counterbalanced stabilizing system mounted on a portable cart. A 3D-printed needle
applicator guide and custom visualization and guidance software were developed for this
system to perform targeted needle applicator insertions.

4.2.1

3D US scanner design and validation

The proposed 3D US system has been previously discussed and is summarized here.31
Custom 3D-printed holders were designed to match 2D US probe casings and provide a
universal male mating connection for any commercially available US probe. A standard
clinical workflow requirement when performing US-guided procedures is the need for
patient scout imaging to localize the tumor using freehand US imaging. Once the tumor is
localized, a beneficial clinical utility would allow the 2D US probe to maintain its
localization position while a 3D enabling scanner is brought to the probe. For this reason,
the scanner was created with a female mating spring-loaded quick connection and used
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three-motors to manipulate the attached 2D US probe. The configuration of the motors was
designed such that the bulk of the scanner was away from the probe face, which maintained
the physician’s conventional hand position used during freehand US imaging. The
connection and scanner design choices allowed for accessibility for any healthcare facility
using commercial US systems, easy transition to freehand US (which is often important for
patient scout imaging), and a scanner design that provided a more natural feel for the
physician as it was able to accommodate their experience and training with regard to hand
positioning and the 2D imaging technique. Three-motors were used to manipulate the probe
in two linear degrees-of-freedom (DoF) and one rotational DoF to provide a large scanning
FOV with consistent image spacing for repeatable 3D US image generation. The large FOV
allows for more anatomical landmarks and targets to be captured for reference and potential
registration to a planning CT image. These motors controlled horizontal, vertical, and
rotational motions up to extents of 98 mm, 19 mm, and 90°, respectively, to form different
acquisition geometries, including linear, tilt, and or hybrid. Linear refers to the activation
of a single motor for translation of the probe, whereas tilt and hybrid incorporate all three
motors to either form a 3D image by rotating a 2D probe about the face of the probe (i.e.,
tilt) or during translation (i.e., hybrid) to form a wide FOV acquisition, similar to previous
methods.24 3D image reconstruction was performed by moving the probe in the desired
geometry while images were acquired from the US system using a Digital Visual Interface
(DVI) to Universal Serial Bus (USB) video frame grabber (Epiphan Systems Inc., Ottawa,
Canada). Current implementation focused on clinical simplicity and offers a set of predefined 3D scanning directions and ranges, but variable control of each independent motor
is possible.
The three-motor scanner used to perform 3D image reconstruction was previously
validated for geometric error and volumetric error. Geometric imaging experiments were
performed on a grid phantom of known geometry, which resulted in mean geometric errors
of ≤0.2%, ≤2.3%, and ≤3.0% for lateral, axial, and elevational image dimensions
respectively.31 Volumetric imaging experiments were performed to further evaluate image
reconstruction to assess the combined error contributions of each image dimension. Tissuemimicking phantoms with spherical structures were used to compute mean volumetric
errors of -5.85 ± 6.18%, -6.12 ± 4.82%, and -6.82 ± 3.56% for linear (range: 65 mm to 98
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mm scans), tilt (60° scans), and hybrid (range: 40 mm + 40° to 80 mm 60°) image
geometries respectively.33

4.2.2

Mechanical tracking system and evaluation

The scanner was mounted on a spring-loaded counterbalanced stabilizing system that
included a “wrist” with three rotational DoF via a gimbal design and an “arm” with two
links for 29.3 cm vertical motion and 115º horizontal rotational range (arc length of 27.2
cm), improving the overall range of motion and working space. The arm incorporated a
four-bar parallelogram linkage to avoid an arcing path and provide parallel vertical motion,
which limits the propagation of error to downstream joint axes as motion is limited to one
Cartesian axis. These components provide a total of five DoF, which are tracked using five
electromagnetic encoders, which allow tracking of the US probe in space by detecting joint
angles necessary to compute forward kinematics. To compute the orientation of the
tracking system end-effector (i.e., 2D US probe), a known position with corresponding
joint encoder values was required to initialize the coordinate system of the tracking system.
This position was achieved by forcing the joints into a known reference position using a
mechanical jig (Figure 4.2A) to obtain the initialization encoder readings on the tracked
joints (Figure 4.2B). Forward kinematics of the mechanical stabilizing system are given in
Table 4.1 using the Denavit-Hartenberg convention.
Table 4.1 Denavit-Hartenberg parameters of the mechanical stabilizing system using
electromagnetic encoders (i).
ai
(mm)

i
(º)

i
(º)

di
(mm)

254

0

0

0

0

-/2

0

0

Sway

135.7

-/2

1

0

Wrist Roll

0

-/2

2

0

Wrist Pitch

0

-/2

3

0

Wrist Yaw

0

0

4

366.4

Link
Parallelogram
(Adjacent)
Parallelogram
(Vertical)
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B
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1

4
3
2

Figure 4.2 (A) A jig (dashed box) was used to place the stabilizing system into a reference
position to produce the initialization encoder positions. (B) Axes of rotations that are
tracked using the electromagnetic encoders (i) and used to compute forward kinematics
using the Denavit-Hartenberg parameters.
Assessing the accuracy of the tracking system was completed by comparing displacements
computed by the system to displacements observed by an independent external Polaris
Vicra optical tracking system (NDI, Waterloo, Canada). An optical tracking system was
chosen as an external method for comparison due to its high accuracy, ease of use with a
setup that avoided line-of-sight limitations, and it avoided the need to disassemble the
system, which is typically necessary for conventional joint analysis. Since forward
kinematics were computed by choosing the 2D US probe tip as the termination point of the
tracking system, comparisons were achieved by replacing the 2D US probe with a
commercial stylus via a 3D printed attachment that maintained the 2D US probe tip
termination point using the tip of the stylus. The position of the stylus was set using a height
gauge and was confirmed by optically tracking the probe while only the gimbal wrist was
manipulated. This generated a spherical cloud of points that could be fit34 and used to
compare the radius and the expected stylus height.
The five electromagnetically tracked joints were evaluated independently prior to a
compound joint motion assessment. After determining an initial position in space near the
center of the system’s range of motion, a single joint was advanced and stopped to allow
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for matched data collection between the mechanical and optical tracking systems. Since
the initialization position of each joint was in the center of its range of motion,
measurements were acquired on either side of the initialization position to assess the entire
range of the joint (Table 4.2). The vertical and horizontal joints on the arm were able to be
manipulated without engaging other joints, but the gimbal wrist always incorporated and
released all three rotation axes due to the manual locking mechanism used. The benefit of
using optical tracking as an evaluation tool was that the 3D displacements could be easily
and readily measured, allowing for a direct method of comparison to our system without
the need for disassembly or additional manufactured tools for restricting the gimbal wrist
axes. Although this method was valuable for evaluation, the manual locking mechanism
prevented perfect suppression of the other gimbal joints during investigations of the
independent wrist motions. However, due to the range of motions and displacements
investigated (Table 4.2), error assessments for each wrist axes were assumed to be
independent with minimal contributions from other axes. Since liver diameters are
typically less than 15 cm but can range up to approximately 21 cm,35 we evaluated our
system with motion up to 25 cm when testing the compound joint kinematics to ensure the
typical working volume of the tracking system was tested.
Quantification of the tracking system error was performed by computing the difference in
displacements determined by our mechanical system and the optical tracking system. The
center of the system’s range of motion was used to create a reference position for
computing displacements during subsequent manipulations. Simultaneous transformation
matrices were computed by our mechanical system and optical tracking, which determined
the moving tip location in their respective coordinate systems as our system was
manipulated. Euclidean distances between the new tip location and the initialization
position were computed in each tracking system’s coordinate system and the difference
was used for error quantification.

4.2.3

Mock applicator insertion

The expected clinical accuracy of our 3D US guidance system was evaluated using an endto-end workflow from 3D US image acquisition for target planning to targeted placement
of a needle-like object with errors validated from CT imaging external to our system. A
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tissue-mimicking phantom was made using a mixture of agar and glycerol diluted in
deionized water (35 g/LH2O and 80 mL/LH2O, respectively) to create a speed-of-sound of
approximately 1540 m/s.36 This mixture was heated to approximately 65°C and provided
an approximately hypoechoic background under US imaging once cooled. Agar spheres
were fabricated using molds with diameters of 3.18 mm, 4.76 mm, and 9.53 mm to provide
visible fiducials for image-based registration. The spheres contained 10 g/LH2O of
SigmaCell cellulose to provide acoustic backscatter for US imaging and 10 g/LH2O of
Tungsten (monocrystalline powder, 0.6-1 micron, 99.9+%) to create CT contrast. These
spheres provided a unique spatial distribution for image registration without any shadowing
artifacts or speed-of-sound distortions. A 3D-printed needle guide was made to provide our
guidance software with a known geometry that could be used in a targeting workflow
(Figure 4.3). This guide was fabricated to match the casing of a C5-1 US probe (Philips,
Eindhoven, The Netherlands) and provided known trajectories in a range from 15-60° from
the long-axis of the probe and in the plane of the image.

Figure 4.3 A custom 3D-printed needle guide provided known insertion trajectories over
a 15-60° range relative to the US probe axis. A detachable face (top-left) allows for the
removal of the guide after insertion of a needle into a volume, enabling 3D US imaging
without affecting the inserted needle.
Needle targeting was achieved by acquiring a pre-insertion 3D US image, selecting a target
in the image, navigating to the target using our system, and inserting a needle. A
commercially available iU22 US system with a C5-1 US probe (Philips, Eindhoven, The
Netherlands) was attached to the system to acquire a 60° tilt scan or a 60 mm + 60° hybrid
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scan. The fabricated phantom allowed for relevant imaging up to a depth of 14 cm, which
resulted in image and voxel sizes of 692 × 542 × 542 voxels and 0.25 × 0.25 × 0.25 mm3,
respectively, for the tilt geometry and 692 × 542 × 584 voxels and 0.25 × 0.25 × 0.34 mm3
for the hybrid geometry.
Three different modes of navigation were investigated that required varying levels of user
interaction: (1) relying predominantly on the system by using only the motors on the
scanner for US probe navigation, (2) a freehand approach that only used the mechanical
tracking system for navigation, and (3) a mixed navigation approach that used the scanner
motors for image plane navigation and the tracking system for in-plane correction. The
targeting accuracy of the system was evaluated using eight independent stainless steel
needle insertions per 3D US acquisition geometry (i.e., tilt or hybrid) paired with a target
navigation technique (i.e., motors only, tracking system only, or a mixed motor plus inplane tracking system correction) for a total of 48 needle insertions using the 3D US
system.

Figure 4.4 Experimental set-up for a 3D US image-guided needle insertion with an O-arm
providing external imaging comparison for targeted needle placements.
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3D US needle image-guidance was evaluated using a post-insertion 3D US scan and an
external cone-beam computed tomography (CBCT) O-arm imaging system (Medtronic,
Dublin, Ireland). The portable CBCT scanner (Figure 4.4) was used to acquire images
using imaging parameters of 100 kV, 20 mA, and 150 mAs using a high definition preset.
Higher resolution images of 1024 × 1024 × 384 voxels with voxel dimension of
0.22 × 0.22 × 0.43 mm3 were generated by post-processing the raw images.37
Analyzing the needle targeting accuracy was completed by registering all images to the
same coordinate system and comparing the needle identified in the 3D US and CT images
to the intended target location giving 3D US tip error and CT tip error, respectively. 3D
fiducial registration was performed by manually selecting five agar sphere centroids in the
pre-insertion 3D US image (i.e., containing the target coordinates) and transforming the
post-insertion 3D US image and post-insertion CT image using the matched unique
fiducials. This enabled computation of the fiducial registration error (FRE). Needle tips
were manually identified in the post-insertion images prior to fiducial registration to reduce
any user bias on targeting error. Euclidean distances between the target location and
transformed needle tip locations were computed to assess targeting tip errors when using
the system, but the distance between needle tips identified in 3D US and CT were also
compared to verify image modality agreement (i.e., tip agreement).

4.2.4

Clinical feasibility

Our system was used to acquire images of a volunteer under a study approved by the
Institutional Review Board of Western University to qualitatively assess expected clinical
image quality and usability. This was performed using a breath-hold technique to reduce
respiratory motion artifacts during image acquisition and improve liver visibility while
reducing the amount of shadowing artifacts produced from the volunteer’s ribs. A 2D US
image depth of 14 cm was chosen to visualize the liver from the surface of the skin to the
subject’s diaphragm and compared against 3D images generated using a commercial X6-1
3D US probe (Philips, Eindhoven, The Netherlands).
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4.2.5

Statistical analysis

Statistical calculations were performed in GraphPad Prism 8.4.0 (Graphpad Software, Inc.,
CA, USA). The normality of distributions were evaluated using the Shapiro-Wilk test and
were followed by unpaired t-tests or Mann-Whitney tests, depending on the normality of
the error distributions. Linear regressions were performed to determine any spatial
dependencies on targeting errors using the 3D US and CBCT images. The three navigation
approaches were also compared using a one-way analysis of variance (ANOVA) with
multiple comparisons performed using a Tukey’s test if a significant difference was
computed. The significance level for statistical analysis was chosen such that the
probability of making a type I error was less than 5% (p < 0.05).

4.3
4.3.1

Results
Tracking system accuracy
A

B

Figure 4.5 Optical tracking stylus height assessment. (A) An optical tracking stylus was
mounted to our system using a 3D-printed holder with a slight tilt to avoid collision with
the three-motor scanner. (B) A sphere was fit to the point cloud generated during
manipulation of the mechanical system gimbal joint to confirm the stylus’ height and tip
location.
The height of the stylus (Figure 4.5A) was confirmed by fitting a sphere to the point cloud
generated during manipulation of the three DoF gimbal joint on the mechanical tracking
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system (Figure 4.5B). The radius of the sphere was computed to be 366.0 mm, resulting in
a difference of 0.4 mm (0.1 %) from the expected 366.4 mm. Following confirmation of
the stylus tip location, each joint on the tracking system was manipulated independently
and in compound joint motions with errors shown in Table 4.2.
Table 4.2 Mean ± standard deviation of Euclidean distance differences between our
mechanical tracking system and an optical tracking system. The five tracking system joints
were evaluated using independent ranges prior to compound joint motions in a 25 cm range
of evaluation.
Joint

Joint Range (º)

Displacement Range (mm)

Mean Error (mm)

Vertical
Sway
Wrist Pitch
Wrist Roll
Wrist Yaw

±30º
±30º
-45º, 60º
±30º
±90º

6.9, 128.1
9.9, 119.1
42.2, 172.5
20.3, 33.0
137.4, 421.3

0.81 ± 0.55
0.22 ± 0.18
2.06 ± 2.63
2.40 ± 1.16
2.69 ± 1.62

Compound

—

52.4, 346.0

1.85 ± 1.33

4.3.2

Applicator insertion into phantoms

4.3.2.1

Motor navigation

An example phantom needle insertion with registered 3D US and CBCT images resliced
to display the entire needle trajectory is shown in Figure 4.6. When using the three-motor
scanner for needle targeting, mean ± standard deviation (SD) tip errors based on the US
and CT images were 4.44 ± 3.08 mm and 4.04 ± 2.79 mm, respectively (Table 4.3). Due
to the consistency of the motorized approach returning to the image origin, manual
registrations were not necessary between the pre-insertion and post-insertion 3D US
images. Although navigation when using a hybrid geometry appeared to result in larger tip
errors, no statistically significant differences (p > 0.05) were observed between the tilt and
hybrid scan geometries for FRE, 3D US/CT tip agreement, 3D US tip error, and CT tip
error. However, there was a significant, moderate correlation between image depth and
error based on tip identification in both the 3D US (Figure 4.7A) and CT images (Figure
4.7D). Each image geometry was investigated separately for the CT tip errors and after
removal of a low tip error outlier for the tilt geometry, strong correlations were observed
for the hybrid geometry (p = 0.0079, r2 = 0.72) and tilt geometry (p = 0.0196, r2 = 0.78).

113

Table 4.3 Needle tip targeting errors when using a motor, tracking system, and mixed
motor with in-plane correction navigation approaches. Mean ± SD are reported for fiducial
registration error (FRE) between the pre-insertion 3D US and post-insertion 3D US image,
FRE between the pre-insertion 3D US and CT image, post-insertion 3D US to CT manual
tip location distance (agreement), needle tip to pre-insertion target distance error based on
the US image, and needle tip to pre-insertion target distance error based on the CT image
as the gold standard.
Navigation
Approach

Acquisition
Geometry

US/US FRE
(mm)

US/CT FRE Tip Agreement 3D US Tip
(mm)
(mm)
Error (mm)

CT Tip
Error (mm)

Motor

Tilt
Hybrid
Total

—
—
—

1.12 ± 0.29
0.93 ± 0.36
1.02 ± 0.33

1.37 ± 0.49
1.27 ± 0.86
1.32 ± 0.69

3.36 ± 1.93
5.01 ± 3.77
4.44 ± 3.08

2.73 ± 1.74
5.19 ± 3.13
4.04 ± 2.79

Tracking
System

Tilt
Hybrid
Total

0.52 ± 0.16
0.71 ± 0.26
0.61 ± 0.23

0.62 ± 0.15
0.76 ± 0.21
0.69 ± 0.19

2.76 ± 1.45
1.78 ± 0.61
2.27 ± 1.19

5.71 ± 1.86
8.46 ± 2.94
7.08 ± 2.86

7.00 ± 1.49
8.68 ± 2.87
7.84 ± 2.37

Mixed

Tilt
Hybrid
Total

0.34 ± 0.09
0.33 ± 0.10
0.33 ± 0.09

0.65 ± 0.16
0.50 ± 0.14
0.58 ± 0.17

1.73 ± 0.42
1.74 ± 0.34
1.73 ± 0.37

3.40 ± 1.94
4.14 ± 2.64
3.77 ± 2.27

4.28 ± 2.02
4.25 ± 3.00
4.27 ± 2.47

Figure 4.6 Manually registered 3D US (A) and CBCT (B) images of needles inserted into
an agar-based tissue-mimicking phantom. The agar spheres contained cellulose and
tungsten to provide targets for fiducial registration.

4.3.2.2

Tracking system navigation

Errors associated with needle targeting using the tracking system navigation are shown in
Table 4.3. The total mean ± SD tip targeting errors using the 3D US and CT images were
7.08 ± 2.86 mm and 7.84 ± 2.37 mm, respectively. Aside from a statistically significant
difference (p < 0.05) observed for the 3D US tip error, no statistically significant
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differences were observed between tilt and hybrid geometries. However, a statistically
significant larger error was observed for the 3D US (p < 0.05) and CT (p < 0.001) tip errors
using the tracking approach compared to the motorized navigation approach (Sec. 4.3.2.1).
No significant correlations were observed between tip errors and image depth (Figure
4.7B&E).

4.3.2.3

Mixed navigation

Table 4.3 also shows the needle targeting errors for the combined motor and tracking
system navigation approach. Total mean ± SD tip targeting errors using the 3D US and CT
images were 3.77 ± 2.27 mm and 4.27 ± 2.47 mm, respectively. No statistically significant
differences (p  0.05) were observed between tilt and hybrid geometries for any of the
recorded metrics. ANOVA of the tip errors for the motorized navigation approach (Sec.
4.3.2.1), the tracking system approach (Sec. 4.3.2.2), and the mixed navigation method
showed a statistically significant difference calculated using 3D US (p < 0.01) and CT
images (p < 0.0001). Tukey’s multiple comparisons test showed a significantly larger error
when using the tracking system compared to the motor approach (p < 0.001) and the mixed
navigation approach (p < 0.001), but no statistically significant differences were observed
between the motorized approach and the mixed navigation method. Unlike the motor only
approach, no statistically significant correlation was observed between 3D US (Figure
4.7C) or CT (Figure 4.7F) tip error and image depth. However, strong correlations were
observed for the hybrid geometry when 3D US (p = 0.0316, r2 = 0.56) and CT (p = 0.0122,
r2 = 0.68) tip errors were separated by acquisition geometry.

4.3.3

Clinical feasibility

Example 3D US images of a healthy volunteer are shown in Figure 4.8. Important
anatomical structures, including the portal vein, diaphragm, gallbladder, and right kidney,
were clearly reconstructed with few artifacts due to uncorrected scanner or tissue motion.
The full inspiration breath-hold was a successful approach for this volunteer as shadowing
artifacts from the rib cage were avoided in the reconstructed 3D US images, generating
clinically useful images as assessed by an interventional radiologist (N.K). Hybrid (60 mm
+ 60º) and tilt (60º) images were acquired in 12 s.
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Figure 4.7 Scatter plots showing the 3D US (A-C) and CT (D-F) needle tip targeting error
as image depth increases for motor (A, D), tracking system (B, E), and mixed motor with
in-plane correction navigation approaches (C, F). Hybrid and tilt image acquisition
geometries were used for targeting experiments and linear regressions (solid) are shown
with 95% confidence bands (dotted).

Figure 4.8 3D US images of a volunteer’s liver using (A) a commercial X6-1 probe, (B) a
hybrid scan geometry using our proposed system, and (C) a tilt scan geometry using our
proposed system.

4.4
4.4.1

Discussion
Tracking system accuracy

The mechanical tracking system was assessed using optical tracking to evaluate the error
associated with determining a US probe orientation relative to our proposed system. After
evaluating the error of each joint independently, a mean positioning error of 1.85 ± 1.33
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mm was observed when performing compound joint manipulations in motions expected
during interventional focal ablation of liver tumors. Since this error encompasses the
tracking system error from the system cart to the 2D US probe, this has the potential to
provide sufficient accuracy for initializing position dependent algorithms, such as a 3D US
image stitching algorithm to generate a larger view of the liver. This also motivated
targeted needle insertions, so a 95% confidence interval was computed to assess the
maximum tumor diameter that could reliably be targeted using
𝑑𝑚𝑎𝑥 = 2 (𝑥̅ +

1.96𝜎
√𝑁

) [𝑚𝑚],

(4.1)

where 𝑥̅ is the mean positioning error, 𝜎 is the standard deviation, and 𝑁 is the number of
measurements. This resulted in a tumor diameter of 5.54 mm with 95% confidence if no
other errors were present. Thus, we believe this diameter to be sufficient for clinical use as
most treated liver tumors are between 20 mm and 50 mm. However, since we chose to use
magnetic encoders in the tracking system that detect the perpendicular component of the
magnetic field of the rotary shaft in the radial-transverse cylindrical plane (for a reduced
size advantage), any manufacturing error in the magnetic field alignment with the rotary
encoder shafts would increase the measured joint errors due to the nonlinear nature of the
detected magnetic field. Although we believe the accuracy we achieved to be sufficient,
calibration of each encoded joint could be completed during assembly of the system 38 to
reduce this error as the off-axis magnetic field is still extremely consistent and repeatable.

4.4.2

Mock applicator insertion

The motor-only navigation method approach resulted in a needle tip guidance error of 4.04
± 2.79 mm when evaluated with a registered CT image and was observed to have the lowest
mean error of the three approaches, although not statistically significant. Tip targeting
errors when using the three-motor scanner approach are likely acceptable for targets
located at a depth <75 mm, but the main source of error was likely due to the custom needle
guide. Moderate correlations were observed with image depth and tip error, with a strong
correlation specifically for the hybrid imaging geometry. Since angular sampling will result
in larger distances between available needle guide trajectories proportional to depth, this
observation possibly suggested that the needle guide increments of 5° were too large for
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deeper targets without an in-plane correction. Since no adjustment was performed to align
the target with one of the nearest projected needle guide tracks, an error of 2.5° (i.e.,
directly in between needle guide trajectories) was assumed to be the maximum error
contribution from the needle guide. Taking into account the 10.69 mm template height
offset from the US probe tip, a maximum error contribution from the needle guide alone
(shown in Figure 4.9) for an image depth of 𝑥 mm was determined (Eq. 4.2).
𝑀𝑎𝑥𝑇𝑒𝑚𝑝𝑙𝑎𝑡𝑒𝐸𝑟𝑟𝑜𝑟 = 0.0436𝑥 + 0.466

(4.2)

Figure 4.9 Scatter plot showing the needle targeting error using the three-motor approach.
The maximum possible error due to the needle template geometry is shown as a dashed
line.
Performing guided needle insertion with the tracking system was the worst approach with
a statistically significantly higher tip error of 7.84 ± 2.37 mm when compared against the
other two methods. Although the mean positioning error reported using optical tracking
was less than 3 mm, the increased error observed with needle insertion suggests that there
is a small angular miscalibration in the tracking system as the needle tip point of
measurement is much further from the US probe tip. In addition, some error from the threemotor scanner could contribute to tracking system error since the scanner must return to
the assumed final axis of the tracking system after image acquisition, but this additional
source of misalignment is likely minimal. Since no correlations were observed with depth,
the needle guide appears to perform as expected as the user could place the target directly
on a projected needle trajectory.
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A combined approach for navigation that incorporated the motorized movement for outof-plane motion and the tracking system for in-plane correction resulted in a mean tip error
of 4.27 ± 2.47 mm. This approach was not statistically significantly different from a motor
only approach and the in-plane correction did not appear to account for the observed
correlation between image depth and tip error when using a hybrid image geometry. This
mean error and SD suggests a target with a diameter of 10.96 mm can be hit with a 95%
confidence, which is on the order of the recommended 5-10 mm margins for image-guided
interventions in the liver.39–41 One caveat of the navigation errors reported in this study is
the ideal nature of the needle insertion experiments, which did not contain expected clinical
issues such as liver motion. Image registration methods have been investigated for other
3D US-guided procedures42,43 and could be incorporated into our proposed system to
perform coordinate system corrections required to maintain targeting accuracy.
Nevertheless, the combined US-based navigation approach could provide an accessible
method to motivate further development of stereotactic interventional radiology
approaches that use multiple applicator insertions for treating tumor diameters larger than
50 mm.

4.4.3

Clinical feasibility

The healthy volunteer images provided good feedback about anatomical structures relevant
for focal liver tumor therapies. The increasing need and potential for accurate image
guidance during minimally invasive therapy is also supported by the need for accurate
tissue sampling during biopsy procedures. Since cancer is complex and often comprises of
multiple genotypic pathologies, more accurate diagnostic biopsy procedures in the
abdominal area could likely improve the information given to the clinician and provide
more specific pathology data for better informed therapeutic decision trees. Therefore, our
system has the potential to improve a wide range of minimally invasive procedures.
One downside of using US imaging for guiding needle applicator insertions in the
abdominal area is the low image contrast of some tumors. This can be challenging using
conventional clinical workflows using 2D US as insertions must be performed using other
anatomical landmarks for approximating tumor locations. A beneficial approach would be
to perform an image registration between pre-operative CT images containing tumor
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locations with real-time intra-operative US images for guidance, but the multi-modality
and difference between 2D and 3D imaging present as a challenge. In addition, patient
positioning may change and US probe pressure could introduce deformations, requiring
deformable image corrections. With the incorporation of 3D US and our system, a multimodal 3D image registration could be facilitated as the additional spatial context is
available relative to conventional 2D US imaging. By registering the CT image to the 3D
US image domain, the navigation approaches presented could be used to target low contrast
tumors in US using CT-derived tumor localization.
Avoiding critical structures and organs-at-risk, like the gallbladder, is also an important
clinical constraint for maintaining low complication rates. A registration process between
pre-operative CT and intra-operative 3D US could allow for pre-operative planning where
tumor locations and critical structures can be identified for optimizing the optimal needle
applicator trajectories.25 Model views can be generated intra-operatively using
segmentation software available on our system31 and used with our needle guide predicted
trajectory for real-time avoidance of critical structures. If a freehand insertion is performed
without a needle guide, an alternative solution could include a 2D US real-time needle
segmentation method for comparing tip and trajectory information to the identified
structures.

4.5

Conclusions

A mechanically tracked system with geometrically variable 3D US during minimally
invasive liver cancer diagnostic or therapeutic procedures provides a utility that enables
enhanced applicator guidance, placement verification, and improved clinical workflow
without the need for additional radiation exposure. With this device, intraoperative
assessment and applicator adjustments can be performed to potentially decrease the liver
cancer recurrence rates associated with minimally invasive procedures and demonstrate a
step towards stereotactic interventional approaches.
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Chapter 5

5

Three-dimensional therapy needle applicator
segmentation for ultrasound-guided focal liver ablation

The use of 3D information during interventional procedures has the potential to improve
the accuracy needed for sufficient clinical outcomes, but increased procedure times, patient
radiation dose, and costly interventional suites can limit widespread adoption. The purpose
of Chapter 5 is to present on the development of a novel 3D US system to provide a safe,
cost-effective, and accurate intraoperative approach for focal liver tumor therapies.
The contents of this chapter have previously been published in Medical Physics: Gillies
DJ, Awad J, Rodgers JR, Edirisinghe C, Kakani N, and Fenster A. Medical Physics 2019;
46(6):2646-2658. Permission to reproduce this article was granted by John Wiley and Sons
and is provided in Appendix B – Copyright Releases.

5.1

Introduction

Minimally invasive percutaneous interventional techniques are increasingly being adopted
throughout the body for a wide range of diagnostic and therapeutic procedures, such as
aspiration, biopsy, brachytherapy, and ablation. These techniques are often image-guided
procedures and offer promising alternatives to open surgical practices as they have shown
decreased patient recovery times and complications due to more localized treatments.1,2
Minimally invasive focal ablation of liver tumors has received significant attention as liver
cancer is the second and sixth most frequent cause of cancer mortality worldwide in men
and women, respectively, with high prevalence in under developed and developing
countries.3 Although liver transplantation and resection are the gold standard curative
therapy options for cancer with a 5-year survival rate of approximately 40%,4 these open
surgical procedures are often followed by long patient recovery times. Occasionally,
serious problems can arise, including organ (graft) rejection, infection, bile duct
complications, and immunosuppression related issues, leading to a traumatic
hospitalization experience for approximately 26% of liver resection patients and 33% of
liver transplant patients.5 In addition, only 10 to 20% of patients are candidates for surgery
based on strict inclusion criteria including the number and location of tumors, malignant
spread of the disease or lymph node involvement, and a range of patient factors (e.g., size,
age, and existing medical conditions such as cirrhosis of the liver).6,7 Minimally invasive
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techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and
irreversible electroporation (IRE), have become alternative therapies for early-stage liver
cancer with the most common treatment performed on hepatocellular carcinoma.8 Due to
availability of commercial ablation systems, e.g., the EvidentTM MWA system (Medtronic,
Dublin, Ireland), the StarBurst RFA system (AngioDynamics, Inc., NY, USA), and the
Nanoknife IRE system (AngioDynamics, Inc., NY, USA), these procedures have become
more clinically feasible and are increasingly being regarded as primary treatment options.
Although a minimally invasive technique offers advantages relative to open surgery, some
procedural limitations have prevented its adoption as the gold standard. A majority of the
operators using these percutaneous techniques use x-ray computed tomography (CT)
images for planning, two-dimensional (2D) ultrasound (US) for intraoperative guidance of
the ablation needle applicator(s) into the center of the tumor, and either additional CT or
2D US images to perform further modifications and verify needle applicator placements.
Depending on the number and size of tumors, which can typically range from 1 cm to 5 cm
in diameter,8 as well as the type of ablation (radiofrequency vs. microwave), one to four
needle applicators are typically required to cause the ablation zone to completely cover the
borders of the tumor and allow for adequate treatment coverage. Unfortunately, these
procedures have higher local recurrence rates than resection due to insufficient or
inaccurate local tumor ablation.9 One cause for poor ablation coverage has been associated
with subjective 2D US guidance and verification, which leads to variability in needle
applicator targeting accuracy due to high operator dependence when using 2D US images
for 3D spatial localization. Important anatomical markers and structures are difficult to
visualize in a single frame when using 2D imaging,10 which increases complexity and
requires the physician to track both the ablation needle applicator and surrounding
structures to avoid unnecessary damage.11 Malposition of the needle applicators can not
only lead to unwanted complications, but can increase procedure times and patient
radiation dose, from the additional US and CT needed to correct the positions. Thus, if
needle applicator targeting accuracy is to be increased without increasing procedure time
and minimizing excess radiation dose, a non-ionizing radiation intraoperative imaging
workflow is needed to improve upon the conventional 2D US spatial localization method.
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Intraoperative magnetic resonance (MR) and three-dimensional (3D) US imaging
techniques have been investigated to reduce complexity for the physician, increase
visualization of surrounding tissues, and enable accurate localization of the ablation needle
applicator into the liver.12–14 Although MR images can provide superior soft-tissue contrast,
3D US techniques have the advantage of providing real-time or near real-time imaging
with an imaging system that is portable and affordable, ultimately addressing major
concerns for centres in developing countries where liver cancer incidence is high.3 Since
preoperative contrasted CT images provide a sufficient method for lesion identification and
planning, image registration can be performed to transfer the locations of the cancerous
tissues to the 3D US image.15 These resulting fusion images can then allow for accurate
planning and verification of the needle applicators’ location. Unfortunately, current
limitations still exist for visualizing and verifying needle applicator positions in 3D US
liver images as the visibility can change with needle applicator insertion angle, depth, and
size, in addition to the choice of transducer (i.e., curvilinear) and local anatomical acoustic
reflections that result in complicated images containing shadows and reverberation artifacts
with unclear line-like interfaces.16,17 Attempts have been made using a variety of needle
applicator enhancing techniques to address these localization concerns for the physician by
incorporating additional features like echogenic coatings,18 magnetic or optical tracking
systems,19 robotic needle steering,20 augmented reality,21 and US beam steering.22
Although many options seem promising, all of the above choices add increased cost and
complexity relative to the conventional procedure, which can be a limiting factor for
widespread dissemination.
Image-based needle applicator segmentation is an alternative option that aims to localize
inserted needle applicators to provide an efficient and low-cost method to inform
physicians when needle applicator adjustments are required. By employing a segmentation
algorithm, the time for intraoperative identification of the needle applicators can be reduced
to improve the overall efficiency of the clinical workflow and reduce mental demand of
the physician when trying to accurately ablate the cancerous lesions. Segmenting needlelike objects in 3D US has been used in a broad range of interventional procedures with
varying requirements influenced by object orientation with respect to the US probe, object
flexibility, and US image quality, which in turn is affected by a variety of sources, including
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the commercial system, acquisition settings, imaging artifacts from the medical tools,23 and
anatomical imaging challenges (e.g. depth of lesion and acoustically visible internal
structures contributing to image clutter).
Applications for 3D US needle-like segmentation have been focused on procedures in
prostate,24–28 breast,29–31 heart32,33 and anesthetic administration,34 but these approaches do
not readily translate to liver interventions. This is primarily due to deep insertions into the
liver that require needle applicators up to 30 cm in length and large angles relative to the
transducer face resulting in poor specular reflections back to the transducer. More specific
to liver imaging, Zhao et al.35 have investigated a four-dimensional (4D) US micro-tool
localization approach by employing a region-of-interest strategy to a random sample
consensus (RANSAC) and Kalman filter localization algorithm. When imaging ex vivo
porcine liver, they reported root-mean-squared tip errors between 0.6 and 2.4 mm with
maximum component trajectory errors less than 3.5°. For needle steering approaches, 2D
power Doppler has been used with a vibration module20,36 for 3D segmentation of curved
needles. Experiments performed on ex vivo bovine liver20 showed mean tip errors of 0.92
± 0.93 mm for a centred, orthogonal, straight needle at a 600 Hz vibration frequency. Beigi
et al.37 reported on a 3D needle segmentation from multiple images to detect intensity
variations while using a moving stylus inside a hollow cannula. Trajectory errors of 1.4 ±
0.7° and tip identification errors of 0.8 ± 1.1 mm were found when imaged on ex vivo
bovine liver. While general needle-like segmentation algorithms for 3D US have been
discussed in the literature and tested on tissue mimicking models, such as agar, chicken
breast, bovine, and porcine tissues, evaluation on in-vivo clinically acquired 3D US images
has not been reported for the unique imaging characteristics of needle applicators used in
percutaneous liver tumor ablations.
We propose the use of 3D US imaging paired with an intraoperative image-based needle
applicator segmentation algorithm to provide localization of ablation needle applicators in
current focal liver tumor ablation therapies. Needle applicators for these procedures
typically have a diameter of 1.5 to 2.8 mm (12 to 17 gauge) and range in length from 12 to
30 cm to accommodate for the variety of patient thicknesses and depth of lesions.38 These
procedures are most commonly performed as a two-handed approach where one hand is
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used for positioning and orienting the US transducer and the other is used for needle
applicator insertion. Due to the free-hand nature of the conventional approach, a wide range
of needle applicator insertion angles with respect to the US transducer are observed,
ranging from 10 to 80° from the transducer face. In our approach, we assume needle
applicators to be rigid and straight, relying on the assumption of minimal bending within
the tissue. This assumption was chosen based on a recent clinical CT study where 93% of
ablation applicators (inserted in a range from 32 – 182 mm) were observed to have less
than 3 mm of deflection with an overall average deflection of 1.3 mm.39 Since the majority
of these deflection measurements are less than the diameter of the ablation applicators (i.e.,
1.5 to 2.8 mm), a straight assumption would likely be appropriate to capture the trajectory,
and more importantly tip location, for the majority of observed clinical cases. Furthermore,
we used a supervised approach to reduce the complexity of the algorithm and provide a
method for the physician to control the algorithm. Our algorithm was optimized and
evaluated against manual segmentations of an EvidentTM MWA antenna (Medtronic,
Dublin, Ireland) needle applicator inserted in plain homogeneous agar phantoms to test
idealized imaging conditions. This optimization was followed by needle applicator
segmentations in 16 retrospective patient 3D US images to evaluate performance on a
clinical dataset. Multiple users with a range of US experience performed segmentations
with the algorithm to assess robustness and inter-operator variability of the algorithm.
These evaluations aim to provide insights on clinical utility and represent an opportunity
for improving needle applicator localization for interventional procedures treating liver
cancer.

5.2
5.2.1

Materials and methods
3D therapy needle applicator segmentation algorithm

The overall workflow of the 3D needle applicator segmentation algorithm is shown in
Figure 5.1, which is primarily based on voxel intensity thresholding and clustering. After
acquiring a 3D US image, the user provides the location of a single point to the algorithm,
which is assumed to fall along the trajectory of a visible needle applicator in the 3D US
image with unknown insertion angle 𝜃 (Figure 5.2a). This initial seed point is used to
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generate test points in a spherical coordinate system and creates the search space of
potential needle applicator trajectories. Since the locations of the generated test points in
the search space coordinate system (b) are influenced by the radius of the sphere and the
number of points in the longitudinal (polar angle spacing ∆𝜃) and latitudinal (azimuthal
angle spacing ∆𝜑) axes, investigation of these parameters are discussed in Sec. 5.2.2.

Figure 5.1 Proposed 3D US-based therapy needle applicator segmentation workflow. Line
segments are created from a spherical search space to compute the most probable trajectory
using a signal-to-background intensity threshold. The Otsu threshold is computed for the
most probable trajectory to determine the needle applicator’s tip, completing the
segmentation.
The second step to find the most probable needle applicator trajectory requires the
generation of testable trajectories. Line segments are created for each test point on the
sphere and drawn through the initial user seed point to span the diameter of the sphere.
Searching diameters of the sphere reduced the testable search space in half as anything
beyond the superior hemisphere would result in redundant line segments. Since
interventional liver procedures are typically performed with oblique insertion angles on
either the left or right side of the US transducer, the range of possible needle applicator
slopes was restricted to the sphere’s polar angle range 𝜃 = 10-80° from the longitudinal
axis (i.e., axial axis of the 3D US image). In addition, we also assumed the needle
applicators were visualized in the 3D US image approximately in-plane and thus
constrained the sphere’s azimuthal angle range (i.e., lateral axis of the 3D US image) to 𝜑
= 0 ± 60° and 180 ± 60°, as shown in Figure 5.2c.
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Figure 5.2 (a) Sample 3D US image plane of a needle applicator inserted in a homogeneous
phantom with the needle applicator insertion angle (θ) and 2D US axes labelled. (b)
Spherical 3D coordinate system to generate test points with 3D US axes labelled for
reference. (c) Generated spherical test points used to determine the most probable needle
applicator trajectory after incorporating intraoperative assumptions overlaid on the sample
3D US image plane in (a) displayed with a 45° rotation.
The needle applicator’s trajectory is determined by maximizing the sum and number of
voxels along a line segment that exceeds an intensity threshold. The chosen intensity
threshold was selected as the signal-to-background intensity ratio (SBR) that minimized
the trajectory error when segmenting needle applicators in phantom images, as described
in Sec. 5.2.2. Each potential line segment in the search space is sampled at a spacing
equivalent to the average of the lateral and axial in-plane voxel dimensions of the 3D
image, which was approximately 0.37 mm. The sum (𝑆𝑢𝑚𝑖 ) and total count (𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑖 )
of all voxels on a line segment 𝑖 that are greater than the intensity threshold are saved and
used as the metrics to determine the most probable line segment for the needle applicator.
The most probable needle applicator trajectory (𝑇) is computed from all possible line
segments (𝑛) after normalizing all line segment parameters to the maximum of the
computed metric values (i.e., 𝑆𝑢𝑚𝑚𝑎𝑥 and 𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑚𝑎𝑥 ) as:
𝑆𝑢𝑚𝑖

𝑇 = max {(𝑆𝑢𝑚
𝑖∈𝑛

𝑚𝑎𝑥

𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑖

) + (𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦

𝑚𝑎𝑥

)}.

(5.1)

Once the trajectory is selected, the needle applicator tip is determined by employing a
second intensity threshold along the computed one-dimensional vector starting from the
manually selected seed point. Under the assumption that a needle applicator (hyper-

131

intense) and background (hypo-intense) could be represented with a bi-modal histogram of
intensities, the Otsu threshold40 is determined to maximize the interclass variance between
the intensity populations. Since the line segment chosen for the needle applicator trajectory
would mostly contain voxels corresponding to the needle applicator, the selected line
segment is extended by an additional 10 mm to increase the number of background voxels.
This aims to approximately equalize the needle applicator and background voxel
populations in the intensity distributions, which minimizes uncertainty when determining
the Otsu threshold.41 After determining the Otsu intensity threshold, all voxels along the
entire extended needle applicator trajectory with intensity values below the threshold are
eliminated. Finally, the last remaining voxel along the trajectory is selected as the tip
location.
This complete algorithm was compiled using C++ and ran on an i7-6700K central
processing unit (CPU) at 4.0 GHz (Intel Corporation, CA, USA) with the trajectory
localization parallelized on 8 threads using OpenMP. This utilized a 3D Slicer42 user
interface to allow for selection of points and passing of voxel coordinates to the
segmentation algorithm. Completed segmentations were displayed using the physical
dimensions of a 13-gauge ablation needle applicator with a length of 17 cm (Medtronic,
Dublin, Ireland).

5.2.2

Phantom images

Since we only had access to 16 patient 3D US images, we used images of needle applicators
inserted in phantoms to optimize various parameters required for the algorithm. These
optimized parameters were then used to perform segmentations of needle applicators in the
patient image dataset. Homogeneous block phantoms were made with distilled water
(87.7% by mass), glycerol (8.8% by mass; Sigma-Aldrich, MO, USA), agar (3.1% by mass;
Sigma-Aldrich, MO, USA), and cellulose (0.4% by mass; Sigma-Aldrich, MO, USA) for
acoustic backscatter.43 An EvidentTM MWA antenna (Medtronic, Dublin, Ireland) was
inserted through a custom-made template,14 which allowed for insertions with one degree
of rotational freedom when seated in a compatible box (Figure 5.3). The needle applicators
with a length of 17 cm (containing a 3.7 cm radiating tip) and a diameter of 2.1 mm (13
gauge) were inserted through the template into the phantom in a clinically relevant range
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of oblique insertion angles with a mounted protractor for approximating visual guidance,
but not used for evaluation. 3D US images were captured by employing a freehand
approach using the commercially available iU22 US machine with an X6-1 matrix probe
(Philips, Amsterdam, NL). The freehand approach was chosen to resemble an
interventional procedure where the physician tries to visualize the applicator in the imaging
plane while inserting the applicator at various angles depending on the location of the
tumor. Since the task of imaging in a single plane is difficult, 3D trajectories were assessed
in two degrees of freedom and required the 3D image to be resliced on oblique trajectories
to visualize the entire needle. 3D US images containing needle applicators were acquired
with a 30% gain, depth of 10 cm, and a 55° angular field of view that resulted in an image
size of 512 × 407 × 220 voxels with voxel dimensions of 0.314 × 0.258 × 0.461 mm3. The
needle applicator insertion angles (Figure 5.2a) and insertion depths are provided in Table
5.1. These imaging details were manually determined using the voxel corresponding to the
entrance of the needle applicator in the US image and the voxel at the needle applicator’s
tip location across 10 different insertions.

Figure 5.3 (a) Sample MWA needle applicator inserted in a homogeneous phantom
through a custom-made template with one degree-of-freedom. (b) Close up perspective on
the needle applicator’s insertion angle approximated by an attached protractor.
Following 3D image acquisition, manual segmentations of the needle applicators were
performed to provide a comparison to the algorithm. The manual segmentations were
completed prior to the algorithmic method to ensure an unbiased comparison was provided
when quantifying the error of the segmentation algorithm. Manual segmentations were
acquired by selecting one point at the visible tip of the needle applicator and a second point
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located approximately halfway along the visible shaft. Manual tip locations were
repeatedly selected over five different time points, separated by a minimum of 24 hours, to
obtain a manual user variability and an average tip location. The second point selected was
chosen at the approximate centre of the needle applicator’s shaft to ensure the computed
trajectory was through the core of the needle applicator. This second point not only
provided the necessary information to compute a manual trajectory, but also provided the
seed point required to initialize and generate the segmentation from the semi-automated
algorithm. Five of these seed points were selected for each phantom 3D US image to
investigate if initialization variability affected segmentation performance. With this
workflow, a direct comparison between the two methods of segmentation could be
achieved to optimize and assess the segmentation algorithm.
Table 5.1 Visualized needle applicators in 3D US images of a homogenous agar phantom.

Mean
Standard Deviation
Minimum
Maximum
a

Imaged Insertion
Anglea (°)

Imaged Insertion
Depth (mm)

41.1
16.2
17.4
65.9

68.6
8.4
55.5
81.1

Insertion angle was measured from the axial axis of the US image.

The phantom image dataset was first used to perform optimization of parameters for the
trajectory selection component of the segmentation algorithm. The test point spacing,
which can be influenced by the spherical radius of the search space, was a major factor to
consider when searching for the best trajectory (Figure 5.4). One option could be to choose
a large spherical radius to capture all the needle applicator voxels in the image to maximize
the trajectory metric in Eq. (5.1). This would also be beneficial since the needle applicator
has a non-negligible thickness and capturing points further apart could result in fewer
probable trajectories that would maximize the trajectory metric, resulting in a better
approximation for the trajectory. However, employing a radius too large could
unnecessarily increase computation time and potential for failure on shallow insertions
since there would be an increased probability of background voxels that could exceed the
static SBR threshold, creating maxima in the trajectory metric. Conversely, choosing a
small radius would reduce the number of samples acquired and computation time, but could
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result in an increased number of incorrect probable trajectories. Therefore, we optimized
for test point spacing by investigating the interaction between coarse, medium, and fine
uniformly distributed test point spacings (i.e., ∆𝜃 and ∆𝜑) of 2.4°, 1.2°, and 0.6° with small,
intermediate, and large spherical search spaces represented by radii of 15, 30, and 45 mm.
The choice of these three radii was influenced by the average appearance of needle
applicators (i.e., mean insertion depths of approximately 70 mm) in the patient dataset
(Table 5.2).

Figure 5.4 Spherical radius influence on most probable trajectory. (a) Since the applicator
appearance has a non-negligible thickness, the range and number of potentially acceptable
trajectories from the seed point (red) decreases as the spherical search space radius
increases from small (purple) to large (green). (b) If a radius search space is too large, an
increased probability exists to choose an incorrect trajectory for shallow needle insertions
using a larger SBR threshold as the most probably trajectory metric can be increased with
larger pixels quantities.
After creating the spherical search space, a background intensity threshold was used as a
coarse method to enhance the needle visibility in the 3D US images. Since the user selects
a seed point along the shaft of the needle applicator, a single intensity of the needle
applicator is known and can be used as an approximation for the entire needle applicator
mean intensity level, 𝜇𝑎𝑝𝑝 . Using an SBR ratio defined as:
𝑆𝐵𝑅 =

𝜇𝑎𝑝𝑝
,
𝜇𝑏𝑔

(5.2)
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the background image intensity, 𝜇𝑏𝑔 , can be solved for a chosen SBR, thus, determining
the required intensity threshold (𝜇𝑏𝑔 ). The SBR was used as an optimization variable to
investigate the influence of different background intensity thresholds when determining
the needle applicator’s most probable trajectory.
After optimizing the trajectory parameters, tip localization error and variability were
investigated resulting from the Otsu threshold. As described in Sec. 5.2.1, an extension was
added to the selected trajectory to approximately equalize voxel populations of the needle
applicator and background. However, since the locations of the manual initialization seed
points and the insertion depths of the needle applicators were variable, preliminary
observations suggested the distribution of the needle applicator’s voxel intensities were
overrepresented on average. This overrepresentation led to computation of larger than
desired intensity thresholds, which led to shallow predictions of the needle applicator’s tip
location. Thus, preliminary experiments led to a threshold adjustment that reduced the
computed Otsu threshold by 5.

5.2.3

Retrospective patient images

After determining the optimal parameters for the segmentation algorithm from the phantom
images, 15 3D US images were acquired on six patients undergoing MWA in the liver.
These images were acquired using an iU22 US machine and X6-1 matrix transducer
(Philips, Amsterdam, NL) in a study approved by the Human Subjects Research Ethics
Board of Western University. All images were acquired post needle applicator insertion,
but prior to ablation. Since the physical size of patients was variable, chosen US imaging
depths were also variable and resulted in an image size range of 480 × 372 × 218 to 512 ×
404 × 222 voxels with a range in voxel dimensions from 0.248 × 0.194 × 0.336 mm3 to
0.428 × 0.386 × 0.630 mm3. 14 3D images contained only one needle applicator prior to
ablation with 13 images showing a needle applicator approximately in the axial-lateral US
plane and one image showing a needle applicator approximately in the axial-elevational
US plane. The fifteenth 3D image contained two needle applicators visualized
approximately in the axial-lateral US plane, resulting in sixteen needle applicators in total
that were visualized and segmented. Needle applicator insertion angle and insertion depth
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in the US image are provided in Table 5.2. Similar to the phantom images, these
characteristics were manually determined using the voxel corresponding to the entrance of
the needle applicator in the US image and the voxel at the needle applicator’s tip location.
Table 5.2 Visualized needle applicators in 3D US images of patients undergoing liver
tumor MWA.

Mean
Standard Deviation
Minimum
Maximum
a

Imaged Insertion
Anglea (°)

Imaged Insertion
Depth (mm)

44.1
14.1
23.3
77.2

71.7
20.9
30.4
99.0

Insertion angle was measured from the axial axis of the US image.

Since our algorithm required initialization, performance is influenced by the location of the
user selected seed point. Variability of the algorithm between four trained users of varying
US image analysis experience was assessed on these images. The users included: a trained
user with four years experience (TU1), a trained user with three years experience (TU2)
supervised by the interventional radiologist (N. K.) that acquired the clinical 3D US
images, an interventional radiologist 2 years post-fellowship (IR1), and an interventional
radiologist 10 years post-fellowship (IR2). All users performed manual identification of the
tip prior to generating the algorithm segmentations and determined the mean manual tip
locations. Following tip identification from all users, the mean consensus applicator tip
location from two or more users was used as the manual annotation for quantifying error,
as described in Sec. 5.2.4. All users were instructed to select the shaft seed points near the
tip to ensure the location would fall within the spherical search space of the algorithm.

5.2.4

Determination of needle applicator tip and axis errors

The performance of the segmentation algorithm was compared to the manually segmented
needle applicator to determine the algorithm segmentation error. The manual trajectory
was determined by creating a vector between the user-selected seed point on the shaft and
the manually determined mean consensus tip location. Variability in tip localization was
calculated by a fiducial localization error (FLE)44 for all users selected when determining
̅̅̅̅̅̅𝑖𝑛𝑡𝑒𝑟 ) and for two
the consensus tip location to characterize inter-subject variability (𝐹𝐿𝐸
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̅̅̅̅̅̅𝑖𝑛𝑡𝑟𝑎 ). This was
users (i.e., TU1 and TU2) to characterize intra-subject variability (𝐹𝐿𝐸
calculated by using the variance (𝜎 2 ) for the 𝑥, 𝑦, and 𝑧 coordinates of the selected tips (𝑖)
in all images (𝑁) over the users in agreement for inter-subject variability and over five
trials with 24 hour intervals for the intra-subject variability. Using the definition for FLE
of one needle applicator tip as:
𝐹𝐿𝐸𝑖2 = 𝜎 2 (𝑥𝑖 ) + 𝜎 2 (𝑦𝑖 ) + 𝜎 2 (𝑧𝑖 ),

(5.3)

the mean FLE for all tips was computed as:
2
̅̅̅̅̅̅ = √∑𝑁
𝐹𝐿𝐸
𝑖 𝐹𝐿𝐸𝑖 ⁄𝑁 [𝑚𝑚].

(5.4)

Variability in the manual identification of the applicator’s trajectory was computed across
all users after determining the 3D trajectories created between the consensus tip location
and the user-specific shaft locations for all patient images.
Three metrics were used to quantify the algorithm’s segmentation error when compared to
the manual segmentations. The angular difference (∆𝑇) between the algorithm (𝑣⃑𝑎𝑙𝑔 ) and
manually (𝑣⃑𝑚𝑎𝑛 ) segmented trajectories was quantified as:
∆𝑇 = cos−1 (

𝑣⃑𝑎𝑙𝑔 ∙ 𝑣⃑𝑚𝑎𝑛
‖𝑣⃑𝑎𝑙𝑔 ‖ ∙ ‖𝑣⃑𝑚𝑎𝑛 ‖

) [°].

(5.5)

The second metric to describe segmentation error has been previously defined by Uherčík
et al.29 as the axis localization accuracy (ALA). This metric measures the orthogonal
projected distances of the entrance (E) and tip (T) points from the manual to the algorithm
segmentation trajectory axes, and reports the maximum of the two distances (i.e., DE or
DT ), as shown in Figure 5.5. The needle applicator tip error (ATE) between manual
(𝑣⃑𝑚𝑎𝑛,𝑡𝑖𝑝 ) and segmented (𝑣⃑𝑎𝑙𝑔,𝑡𝑖𝑝 ) needle applicator tips was quantified as the Euclidean
distance between their coordinates:
𝐴𝑇𝐸 = ‖𝑣⃑𝑎𝑙𝑔,𝑡𝑖𝑝 − 𝑣⃑𝑚𝑎𝑛,𝑡𝑖𝑝 ‖ [𝑚𝑚].

5.2.5

(5.6)

Statistical analysis

Statistical calculations were performed in GraphPad Prism 7.00 (Graphpad Software, Inc.,
CA, USA). Normality of distributions were evaluated using the Shapiro-Wilk test and led
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to the use of nonparametric statistical tests when the assumption was violated. The
corresponding nonparametric alternative tests are presented in parentheses for the
remainder of the section. The significance level for statistical analysis was chosen such that
the probability of making a type I error was less than 5% (P < 0.05). The multi-user error
distributions from the patient dataset for trajectory, ALA, and ATE were compared using
a one-way repeated measures ANOVA (Friedman) omnibus test, followed by post-hoc
analysis using Tukey’s honestly significant difference (Dunn’s) tests if the omnibus test
was significant.

Figure 5.5 Illustration of the axis localization accuracy (ALA) metric simplified to a 2D
example for clarity. The entrance and tip locations of the needle applicator from the manual
segmentation are used to compute orthogonal distances to the algorithm segmentation axis,
which produces the entrance-to-axis distance DE and the tip-to-axis distance DT . The
maximum of these distances is reported as the axis localization accuracy (ALA).

Figure 5.6 Sample oblique plane in a 3D US image of a needle applicator obliquely
inserted at 44⁰ in a homogeneous tissue mimicking agar phantom before (a) and after (b)
segmentation. The 3D US image was resliced to visualize the entire segmentation for
clarity.
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Results

5.3
5.3.1

Phantom testing

The imaging characteristics of the needle applicators in the phantom images is shown in
Table 5.3 with a sample phantom image and segmentation shown in Figure 5.6. Using the
five trials of manually localizing the tips in the 3D US images, the mean FLE was found
to be 0.43 ± 0.09 mm, which corresponds to approximately one or two voxels.
Table 5.3 Needle applicator imaging characteristics in phantom 3D US images.
Image Characteristic

Mean ± Standard Deviation

Applicator Intensity
Background Intensity
SBR

178 ± 10
145 ± 5
1.22 ± 0.08

The influence of intensity thresholding for three radii sizes and three test point spacings
are shown in Figure 5.7. For the largest radius (i.e., 45 mm), ∆𝑇 increased as the SBR
threshold was increased and resulted in mean errors greater than 5° for SBR thresholds
greater than 1.3 for all test point spacings. The trends observed for radii of 15 mm and 30
mm were similar across all spacings. These results led to the choice of a 30 mm radius and
an SBR threshold of 1.2 for further experiments as it was the combination that led to one
of the lowest trajectory errors while still allowing for some variability in the needle
applicator’s voxel intensity range. A less restrictive intensity threshold was considered
useful and potentially more robust in the patient images as there were more observed
artifacts and increased variability in the needle applicator intensities, as shown in Sec.
5.3.2. The mean trajectory computation times for spacings of 2.4°, 1.2°, and 0.6° were
0.233 ± 0.006 s, 0.506 ± 0.043 s, and 1.61 ± 0.04 s, respectively. Since a 30 mm radius and
an SBR threshold of 1.2 resulted in similar trajectory errors across all spacing sizes, a 2.4°
spacing was chosen since it was associated with the lowest computation time. Using the
three selected trajectory parameters, the corresponding ALA failed to pass a normality test
(P = 0.0005) and was observed to have a median [first quartile (Q1), third quartile (Q3)]
value of 1.3 [0.8, 2.1] mm.
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Figure 5.7 The influence of different spherical search space radii and test point spacings
on segmentation trajectory error for varying signal-to-background intensity ratio
thresholds. Standard deviation error bars are shown for each measurement.
The optimal parameters determined from the phantom images are summarized in Table
5.4. These parameters resulted in an overall mean algorithm segmentation time of 0.246 ±
0.007 s on the phantom images, which encompassed input of the user selected point to the
algorithm until display of the segmentation. This sub-second computation time was
considered acceptable for intraoperative use and the phantom optimized parameters were
used to create segmentations for the clinical dataset as described in Sec. 5.3.2.
Table 5.4 Needle applicator segmentation parameters optimized on phantom images.

5.3.2

Parameter

Value

Test Point Spacing
Spherical Radius
SBR Threshold
Tip Threshold

2.4°
30 mm
1.2
Otsu - 5

Retrospective patient experiments
Table 5.5 Needle applicator imaging characteristics in patient 3D US images.
Image Characteristic

Mean ± Standard Deviation

Applicator Intensity
Background Intensity
SBR

159 ± 34
75 ± 21
2.2 ± 0.5

We first evaluated the imaging characteristics and appearances of the needle applicators in
the patient images, shown in Table 5.5. Compared to the phantom images, the standard
deviation of mean intensities along the needle applicator was three times greater with an
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approximate two-fold increase in the SBR. A sample oblique plane taken from a patient
3D US image with the corresponding segmentation is shown in Figure 5.8. Intensity
profiles of a needle applicator taken from a phantom image (Figure 5.9a) and patient image
(Figure 5.9b) are shown to further emphasize the appearance differences of the observed
needle applicators in-vivo.

Figure 5.8 Sample oblique plane in a 3D US image of an MWA needle applicator inserted
in a patient’s liver before (a) and after (b) segmentation. The 3D US image was resliced to
visualize the entire segmentation for clarity.

Figure 5.9 Sample intensity profiles of the manually segmented needle applicator
trajectory in a phantom image (a) and patient image (b). These line profiles of needle
applicators in the phantom and patient images correspond to the images in Figure 5.6 and
Figure 5.8, respectively.
Figure 5.10 shows the needle applicator trajectory, axis localization, and tip segmentation
errors of the four users and all the patient 3D US images. Error distributions for ∆𝑇 for
TU1, ALA for TU2, and ATE across all users failed to pass a Shapiro-Wilk normality
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test, so non-parametric statistical testing was performed for the remainder of the analysis.
A Friedman omnibus test was first performed on the ∆𝑇 distributions (Figure 5.10a) and
showed a statistically significant difference (p < 0.0001) between the users. Investigating
multiple comparisons revealed significant differences between TU1-TU2 (p < 0.05) and
TU2-IR2 (p < 0.0001). Median ∆𝑇s of 4.1 °, 1.6 °, 3.9 °, and 4.9 ° were observed for the
TU1, TU2, IR1, and IR2 users, respectively. The ALA measurements (Figure 5.10b) also
showed a statistically significant difference (p < 0.01) between users when performing a
Friedman test with multiple comparisons revealing a significant difference between TU2IR2 (p < 0.05). Median ALA measurements of 1.4 mm, 1.2 mm, 2.0 mm, and 2.0 mm
were observed. ATE measurements (Figure 5.10c) also showed a statistical significant
difference (p < 0.05) between users when performing a Friedman omnibus test with
multiple comparisons repeating significant differences between TU1-TU2 (p < 0.05) and
TU2-IR2 (p < 0.05). Median ATEs of 3.6 mm, 1.0 mm, 1.8 mm, and 3.7 mm were
observed for the TU1, TU2, IR1, and IR2 users, respectively. The mean intra-subject FLE
values over five trials for the TU1 and TU2 users and mean inter-subject for all users in
consensus agreement are provided in Table 5.6. Finally, the overall segmentation
computation time across all users (Table 5.6) was 0.303 ± 0.026 s, which was similar to
segmentations performed in the phantom images.
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Figure 5.10 Box plots for the resulting trajectory (a), axis localization (c), and tip (b) errors
after using the needle applicator segmentation algorithm. These results were performed on
16 patient images for two trained users (TU) and two interventional radiologists (IR). The
centre lines represent the distribution median value with the boxes showing the 25% and
75% percentiles.
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Table 5.6 Inter- and intra-subject manual applicator tip localization, manual trajectory
variability, and algorithm segmentation computation times in 16 patient 3D US images.
User

̅̅̅̅̅̅𝑖𝑛𝑡𝑟𝑎 ± std (mm)
𝐹𝐿𝐸

TU1
TU2
IR1
IR2

0.99 ± 1.40
0.89 ± 0.77
—
—

5.4
5.4.1

̅̅̅̅̅̅𝑖𝑛𝑡𝑒𝑟 ± std (mm)
𝐹𝐿𝐸

Manual Trajectory
Variability ± std (°)

Segmentation
Time ± std (s)

1.56 ± 0.75

0.308 ± 0.025
0.296 ± 0.022
0.310 ± 0.028
0.303 ± 0.029

1.37 ± 1.19

Discussion
Phantom experiments

Since access to patient 3D US images containing needle applicators was limited, we
performed optimization of the proposed segmentation algorithm on phantom images to
utilize all available clinical images for evaluation. The selected parameters optimized on
the homogenous agar phantom images (Table 5.4) with seed points selected by an expert
user resulted in ∆𝑇, ALA, and ATE median [Q1, Q3] measurements of 2.1 [1.1, 3.6] °, 1.3
[0.8, 2.1] mm, and 1.3 [0.7, 2.5] mm, respectively, with an overall algorithmic computation
time of 0.246 ± 0.007 s. The manual variability in localizing the needle applicator tip
locations in the phantom images (i.e., ̅̅̅̅̅̅
𝐹𝐿𝐸 ) was 0.43 ± 0.09 mm, which was less than two
voxels when referenced against the in-plane voxel dimensions of our 3D US images. This
could represent a major cause of the observed variability for the three metrics as it is
approximately equal to the measured interquartile ranges. However, since we used the
average tip location over five trials when performing comparisons to manual
segmentations, we believe the impact of FLE on the measured metrics is reduced with
minor contributions to the overall errors observed. This belief still falls under the caveat
that comparisons are performed to manual segmentations, which assumes that the tip
position is visible and can be accurately estimated. Nonetheless, since the phantom images
were primarily used for parameter tuning, the visibility of the applicator in ultrasound is
adequate for manual segmentation accuracy evaluation.
The investigated test point spacings of 2.4°, 1.2°, and 0.6° did not have a large effect on
trajectory error when observing the interaction between different radii and SBR thresholds.
Although the fine test point spacing of 0.6° yielded the smallest median observed trajectory
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error (i.e., 1.9 [1.2, 3.4]°) with a radius of 30 mm and SBR threshold of 1.1, computation
time increased by approximately 6.5 times (i.e., 1.58 ± 0.04 s) and was considered too large
for only a minor decrease in observed error. A radius of 45 mm performed the worst across
all test point spacings when increasing the SBR thresholds beyond 1.3, which is most likely
due to the increasing number of voxels contributing to the most probable trajectory metric
in Eq. 5.1. When searching with a radius of 45 mm, line segments along the needle
applicator trajectory would be more likely to extend beyond the imaging limits, thus,
negatively impacting the 𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦𝑖 measurement in the most probable trajectory metric
(Eq. 5.1).
Determining the tip location was performed with the Otsu threshold since we assumed a
bimodal intensity distribution when assessing the selected most probable trajectory. Based
on the small standard deviation in needle applicator and background intensity values (Table
5.3) and the appearance of the observed line profiles (Figure 5.9a), we believe this was a
good approximation for needle applicators in the acquired phantom images. When
computing the Otsu threshold without adjustment, thresholds were often determined too
high and resulted in needle tip identifications that fell short of the actual position. Shifting
the computed threshold by 5 intensity units was chosen as the ideal threshold to determine
the tip location as it was observed to have a significantly reduced tip error. Since the Otsu
threshold determines a threshold based on the histogram of the intensity distribution to
maximize interclass variance, this implied that the maximum interclass variance along the
line profile did not encompass enough needle applicator voxel intensities to accurately
determine the tip location. Although an extension to the most probable trajectory was added
to equalize the intensity population distributions of the needle applicator and background,
overlap of the populations may be too great in low SBR imaging conditions to rely on
interclass variance alone. Providing an adjustment to the Otsu threshold therefore captured
more of the needle applicator’s intensity distribution, which appears to be necessary for tip
localization. We have shown acceptable results using a fixed adjustment of 5 intensity
units, but it is possible the adjustment is influenced by the needle applicator’s SBR in the
US images and could warrant further investigation.
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The visibility and tool SBR in 3D US can greatly influence the success of a segmentation
algorithm and typically gets worse as SBR decreases.45 The effect of background noise has
been previously investigated by Barva et al.31 for an automated parallel integral projection
(PIP) algorithm to segment straight electrodes in 3D US. They used a signal-to-noise
(SNR) ratio defined as:
𝜇 2 +𝜎2

𝑆𝑁𝑅 = 10 log 𝜇2𝑒𝑙+𝜎𝑒𝑙2 [𝑑𝐵],
𝑏𝑔

(5.7)

𝑏𝑔

2
which used the mean 𝜇𝑒𝑙 and variance 𝜎𝑒𝑙
of simulated electrode voxels and the mean 𝜇𝑏𝑔
2
and variance 𝜎𝑏𝑔
of background voxels. Using this definition with needle applicator voxels

in lieu of electrode voxels, the SNR observed for our needle applicators in the phantom
images was 1.8 ± 0.5 dB. This was of particular interest since previous work31 had observed
rapid increases in ATE as SNR decreased below 10 dB, which reported an ATE of 2.7 mm
at a minimum reported SNR of 7 dB. In comparison to our measured ATE of 1.3 mm at an
SNR of 1.8 dB, our algorithm appears to perform well and provide added utility at low
SNR levels.
In more recent methods using simulated data,29 the SBR has been investigated to observe
trends in the performance of automated segmentation algorithms. Since an acceptable error
has never been strictly defined for algorithms performing segmentation of therapy
applications used in liver ablation, previous work considered segmentations a failure if the
tip error (i.e., ATE) or axis localization error (i.e., ALA) were greater than or equal to 3
mm. Using these thresholds for failure, segmentations in our phantom images resulted in a
failure rate of 26% (13/50). Since the SBR for our phantom images was 1.22 ± 0.08, our
method appears to be useful in imaging conditions with low tool SBR since failure rates
were observed to be greater than 80% for many recent automated methods.29

5.4.2

Retrospective patient experiments

Since adjustments to the US system scanning parameters (e.g., time-gain-compensation,
depth, focal zone depth, etc.) when acquiring an US image can be subjective and often
depend on external factors, such as experience and environment, a wide range of image
qualities are observed in clinical settings. An increase in needle applicator SBR was shown
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when imaging needle applicators in patients compared to the phantom images described
previously. In addition, the visible needle applicators and background intensities were
observed to have increases in variability, resulting from an increased number of anatomical
structures causing image clutter and artifacts. Using the definition of SNR in Eq. 5.7, the
needle applicator appearance across all patient images was 6.4 ± 1.9 dB, further supporting
the increase in SBR relative to the phantom images. When comparing intensity line profiles
between the phantom and patient images along the needle applicator trajectories, many line
profiles contained a bimodal distribution of intensities and resulted in more consistent and
accurate segmentations across users (Figure 5.11a). However, the time-gain compensation
adjustment to the US machine appeared to be overlooked during acquisition in some cases,
leading to an intensity gradient in the image background and increases in segmentation
complexity (Figure 5.11b). More than half of all cases (9/16) violated the bimodal intensity
distribution assumption of our segmentation algorithm and could partially explain the
increase in resulting ∆𝑇, ALA, and ATE median [Q1, Q3] measurements of 4.5 [2.4, 5.2]°,
1.9 [1.7, 2.1] mm, and 5.1 [2.2, 5.9] mm, respectively, compared to the phantom results.
Although there were image quality differences, the overall mean computation time was
similar to phantom experiments at 0.303 ± 0.026 s across all users, which is suitable for an
intraoperative implementation.
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Figure 5.11 Examples of simple (a) and complex (b) intensity profiles of needle applicators
for the segmentation algorithm. Line profiles were acquired from two manually segmented
trajectories in MWA patient images.
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Significant differences between users for all error metrics when using the segmentation
algorithm were observed with the most consistent difference between users TU2 and IR2.
Currently, the algorithm is not robust to poor initializations, which is a potential source of
differences between the different users. Variability in the manual trajectories was observed
to be 1.56 ± 0.75 ° and represents a considerable portion of the observed trajectory errors.
This implies that localizing the central axis of the needle applicator shaft in 3D US is not
trivial and could motivate the need for a central axis localization technique that is able to
adjust user selected points to better approximate the applicator’s shaft coordinates. Since
the algorithm assumes the seed point is along the trajectory of the needle applicator, if the
initialization point was not centered correctly, the segmentation would result in an incorrect
trajectory and subsequently cause increases in the measured tip localization error. Image
features that were observed to cause increased errors across most users were large gaps
along the needle applicator shaft (4/16) and the presence of arteries and veins causing
similar acoustic reflection intensities (5/16).
The observed user variability in localizing the needle applicator tips and trajectories further
emphasizes the increased difficulty of identifying applicators due to image quality
variability when performing deep and oblique needle applicator insertions in the clinical
setting. An increase in tip localization error was observed when intra-subject variability
(i.e., ̅̅̅̅̅̅
𝐹𝐿𝐸𝑖𝑛𝑡𝑟𝑎 ) was compared against phantom experiments, which rose from 0.43 ± 0.09
mm to 0.99 ± 1.40 mm and 0.89 ± 0.59 mm (approximately the size of 4 voxels in-plane)
for the TU1 and TU2 users, respectively. When compared across users, the inter-subject
̅̅̅̅̅̅𝑖𝑛𝑡𝑟𝑎 ) was observed to be larger at 1.37 ± 1.19 mm.
tip localization variability (i.e., 𝐹𝐿𝐸
Unlike the phantom segmentations, these FLE measurements are approaching the
magnitude of the measured errors for the four users and is likely contributing a nonnegligible amount to the measured errors even though the average position of the identified
tip was used. Nevertheless, measured median errors appear to be acceptable for
interventional liver procedures where tumors range from 1 cm to 3 cm in diameter.
Interventional procedures in the liver can be performed with slight alterations in workflow,
which could offer additional usable information for the segmentation algorithm. Our
clinical dataset in this study was obtained from a free-hand insertion approach where no
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needle applicator guides were used, increasing the potential search space where needle
applicators could be found. One alternative to the current approach to reduce error could
utilize a needle applicator guide for insertions, which could increase the a priori knowledge
that could be taken into account to reduce the potential search space for the trajectory of
the needle applicator. By incorporating an initialization for the segmentation, a reduction
in the search space would not only reduce computation time further, but it would likely
reduce error since a tighter constraint would reduce potential solutions and outliers.
Curved needle applicator segmentations in US images have been previously
investigated36,46–49 for procedures using flexible needles and offers further potential for this
algorithm with some investigation into workflow changes. For example, instead of creating
a single straight line segment through the user selected point, a spline approach could be
performed superior and inferior to the selected point. This could potentially be
implemented with multiple, smaller spherical search spaces with searched trajectory
solutions reduced after the first few completed line segments by constricting the search
space around the locally determined trajectory. With increasing interest in IRE procedures,
which use thinner diameter electrodes (16 to 19 gauge)50 that are more susceptible to
deflection during insertion, this possible solution could provide a method for improving
needle applicator placements with increased imaging complexity.

5.5

Conclusions

A semi-automated 3D US needle applicator segmentation during minimally invasive liver
cancer diagnostic or therapeutic procedures provides a utility that enables enhanced needle
applicator guidance, placement verification, and improved clinical workflow without the
need for additional radiation exposure. Using a posteriori knowledge of the current
procedural workflow, we employed constraints on a heuristic intensity-based algorithm to
perform 3D needle applicator segmentations in less than 0.31 s. Homogeneous agar
phantom images containing needle applicators were used to optimize the trajectory and tip
localization parameters of the algorithm prior to investigation on retrospective 3D US
images of patients who underwent liver MWA. Median trajectory, axis localization, and
tip localization errors across four users were less than or equal to 5°, 2 mm, and 4 mm,
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respectively, suggesting this approach could be useful for the clinical environment. With
this tool, intraoperative segmentations can be performed to assess and adjust needle
applicator placements, potentially decreasing the liver cancer recurrence rates associated
with minimally invasive procedures.
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Chapter 6

6

A deep learning method for general needle and applicator
segmentation in two-dimensional ultrasound images from
multiple applications and anatomical regions

2D US is widely used for real-time imaging during insertion of interventional tools, but
accurate identification is necessary for desired clinical outcomes and is often dependent on
subjective physician interpretation. The purpose of Chapter 6 is to present on the
development of a general needle-like tool segmentation algorithm for improving
intraoperative identification during interventional procedures without the need for
additional equipment or operating room set-up.
The contents of this chapter have been submitted for publication in Medical Physics and
are currently under peer-review: Gillies DJ and Rodgers JR, Gyacskov I, Roy P, Kakani
N, Cool DW, and Fenster A.

6.1

Introduction

Ultrasound (US) imaging is often used during interventional procedures to provide
portable, accessible, and real-time imaging of anatomy and instruments. This is particularly
advantageous for guidance during minimally invasive percutaneous interventional
techniques, which offer reduced recovery times and complications relative to open surgery.
Despite these benefits, one factor that has limited the guidance accuracy of these techniques
is the ability to localize needle-like interventional tools, such as needles and therapy
applicators, quickly and accurately in the standard two-dimensional (2D) US images while
in the intraoperative environment.1,2 Diagnostic and therapeutic cancer procedures where
accurate localization is essential include brachytherapy, solid organ ablation, and biopsy.
High-dose-rate interstitial brachytherapy of prostate or gynecologic malignancies delivers
internal radiation via multiple needles (typically about 5–24)3,4 that are inserted into the
tumor and surrounding area, thereby requiring correct needle placement to deliver optimal
treatment and reduce risks to nearby structures. In ablation procedures, commonly used in
liver and kidney cancers, one to four applicators, such as radiofrequency electrodes or
microwave antennae, are inserted into tumors to heat the tissue and destroy malignant cells.
Applicators must be accurately placed within the tumor to achieve adequate therapy and
minimize local recurrence risk.5 Similarly, during biopsy procedures, accurate insertion of
the biopsy needle into a suspicious mass is essential to ensure proper tissue sampling for
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histopathological assessment. In this paper, we use the term “tools” to refer generically to
needle-like interventional instruments, including electrodes, antennae, applicators, and
needles. Identifying these tools in 2D US images can be challenging, with their precise
position difficult to distinguish once placed inside the tissue. Visualization requires the tool
to be coplanar with the US probe and localization is often operator-dependent, associated
with subjective 2D US guidance.1 Additionally, anatomical features, such as the body
habitus of the patient, fat, and blood vessels in the liver, or artifacts, such as air gaps or
needle reverberation in some brachytherapy images, can affect the appearance of the tool
and obscure portions of the tool path or confound identification of the tool’s tip position.
Implementation of a real-time or near real-time method to automatically identify and
segment interventional tools on intraoperative live US images might improve clinicians’
ability to guide, adjust, and verify tool positions, allowing these positions to be refined and
misalignments to be corrected without disrupting clinical workflow or extending procedure
time.
Image-based approaches for tool guidance, avoiding the requirement for additional
equipment, signal processing, and set-up, have been proposed for general tool
segmentation in US images, leveraging techniques based on image properties, including
projections,6–9 random sample consensus (RANSAC),10–12 filtering,11,13–15 and Hough or
Radon transforms,16–20 or physical properties, such as analyses of motion,20–24 beam
steering,25 and circular wave generation.26 Many of these algorithms were developed for
three-dimensional (3D) US images;6–13,18,19,21 however, 2D US is the clinical standard for
image-guided minimally invasive interventions at most institutions and therefore is the
focus of our work presented in this study. Many of the published approaches were tested
only on phantom or ex vivo tissue images,6–22,24–26 in vivo on an anesthetized porcine
model,18,23 or, in some cases, US images from one clinical application, such as breast
biopsy8,10,16 or nerve block imaging.25 Therefore, the generalizability of the algorithms to
multiple applications, particularly given the idealized nature of phantom conditions,
requires further investigation.
Image-based approaches may suffer from a lack of robustness and longer processing times
when used on more complex clinical images.27 To address these limitations, recent
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developments by Pourtaherian et al.28 and Arif et al.27 have employed convolutional neural
networks (CNNs) for needle detection in 3D US images. The method presented by
Pourtaherian et al.28 used patch classification and semantic segmentation techniques with
CNN architectures, testing their approach on chicken breast and porcine leg ex vivo datasets
with data augmentation. This method achieved tip localization errors of < 0.7 mm. Arif et
al.27 also proposed a CNN-based method using a V-Net model to localize needles in 3D
US phantom and liver images, demonstrating a mean tip error of 1 mm and angular error
of 2°. Both methods demonstrated the potential of CNNs to accurately localize needles in
US images; however, neither were assessed on 2D US images and investigation of their
applicability on a range of clinical images has not been performed.
In recent work, Lee et al.29 proposed segmentation of kidney biopsy needles in 2D US
images using a deep learning approach based on a LinkNet architecture with the addition
of a concurrent spatial and channel “Squeeze and Excitation” method to independently
weight spatial and feature map characteristics. This method used images acquired at three
frames per second from eight patient US videos to create a dataset for training and testing,
achieving a Dice similarity coefficient (DSC) of 56.65 %, root-mean-square (RMS)
distance error of 9.5 pixels, and RMS angular error of 13.3°.29 Although this approach is
susceptible to information leakage since many images were acquired per patient, this study
demonstrates many of the challenges associated with localizing needles in kidney images
and the extension of this method to applications other than kidney biopsy has not been
explored. Mwikirize et al.30 investigated an algorithm using a fully convolutional network
with a fast region-based CNN for interventional applications requiring quick localization
of mid-to-steeply inserted needles (40–75°) and deep insertions (up to 9 cm) in 2D US
images. This study demonstrated accurate localization with recall and precision rates > 99
%, a mean tip error of 0.23 mm, and a mean angular error of 0.82° with a processing time
of 0.58 s.30 Further investigation of this approach is necessary to assess its generalizability,
as the initial study was limited by only using in-plane (or slightly out-of-plane) insertions
of a single tool type (17-gauge epidural needle) in ex vivo bovine/porcine tissues and
phantoms with recall and precision only assessed on images acquired from a single US
system and probe, matching the system used for training.
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In this study, we have developed and evaluated a deep learning method using a CNN with
a U-Net architecture to segment general needle-like interventional tools from 2D US
images from multiple anatomical regions and various interventional procedures in near
real-time. The proposed algorithm was trained and tested on augmented datasets using 2D
US images and manual segmentations from phantom experiments and five different clinical
cancer procedures: prostate brachytherapy, gynecologic brachytherapy, liver ablation, and
kidney ablation and biopsy.

6.2
6.2.1

Materials and methods
CNN model

The proposed CNN in the U-Net architecture was adapted from Ronneberger et al.31 and is
shown in Figure 6.1. Accommodation of all anticipated image sizes was performed by
resizing all images to 256⨯256 pixels. Convolution kernels were 3⨯3 pixels with a
rectified linear unit (ReLU) activation function and optimization of network weights was
performed using an Adam optimizer with a DSC loss function. Regularization was a key
consideration to prevent overfitting of the CNN, especially in a small dataset application,
so 50 % dropouts were used in the decoder section of the network, as has been previously
shown to maximize regularization.32 Transpose convolutions were used instead of
upsampling followed by convolution, based on preliminary experiments to improve
performance. Final output masks were produced with a 1⨯1 convolution kernel and a
sigmoid function. All images were used to compute the mean and standard deviation (SD)
of intensities for data centering and normalization. Improvements in the network accuracy
were investigated by performing experiments on the training dataset (Sec. 6.2.2) for the
learning rate and epoch hyper-parameters. Learning rates ranged between 10-3 and 10-5
with epochs tested from 50 to 200. Training and validation DSCs of approximately 85 %
resulted in the selection of a 10-4 learning rate with 100 epochs.
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Figure 6.1 A schematic of our CNN in the U-Net architecture with arrows denoting the
different operations. The numbers above the rectangles correspond to the output filters in
the convolution (i.e., multi-channel feature map) and the numbers along the side
correspond to the XY image size in pixels.

6.2.2

Datasets

Images and manual segmentations used for training, validation, and testing of the proposed
CNN were acquired from phantoms and five different clinical interventional procedures,
including prostate and interstitial gynecologic brachytherapy, liver ablation, and kidney
ablation and biopsy, with the assumption that only a single tool was present in each 2D
image. A single trained observer generated gold standard manual segmentations by
selecting the tool tip and a second point on the tool shaft. An assumption of a 2.1 mm tool
diameter with a conical tip was used to create linear, needle-shaped masks (Figure 6.2)
along the user-defined axes. In the gynecologic brachytherapy images, the needle tip was
not always visible within the image field-of-view and therefore the deepest visible point
along the needle path was selected as the tip in these cases and the conical tip assumption
was removed from mask generation. This dataset, totaling 1242 images and segmentations,
was split into a 74 % training set and a 26 % unseen testing dataset (Table 6.1). Since
multiple tools were occasionally visualized per patient, all images for an individual were
assigned to either the training or testing dataset to avoid potential redundancies in the
anatomical background. This ensured that the testing dataset contained solely unseen data
to improve the approximation of future clinical use and robustness. The training dataset
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was further split into 80 % training and 20 % validation datasets to train and optimize the
network weights.

Table 6.1 Training and testing dataset distributions of 2D US images containing needlelike tools from interventional applications, with the number of unique patients provided for
clinical applications and the number of independent tool insertion experiments for the
phantom.
Image
Background

Images in Training Set
(Number of Patients)

Images in Testing Set
(Number of Patients)

Phantom
Prostate
Gynecologic
Liver
Kidney

23 (7)
18 (4)
34 (4)
540 (18)
302 (9)

9 (3)
8 (1)
18 (2)
256 (8)
34 (3)

Overall

917

325

Figure 6.2 Input 2D US images illustrating background and tool appearances (top row),
tool masks generated from manual segmentation (middle row), and tool masks predicted
by the CNN algorithm prior to post-processing (bottom row) for each of the applications
tested, showing examples of various segmentation performance quality.
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Data augmentation was investigated to increase the number of images used for training and
further reduce overfitting to improve the generalization of the tool segmentation CNN.
Combined strategies used to augment our data included horizontal flips, horizontal and
vertical shifts up to 20 % of the image size, 20° maximum rotations, and a 20 % zoom
range. Augmentation was performed at the time of training in batches of 10, which doubled
the dataset for each epoch, but with different augmentations on subsequent epochs.
Training and testing of the CNN were performed using a Python implementation of Keras
on Windows 10 (Microsoft, WA, USA). This was run on a personal computer with two
Xeon E5645 central processing units (CPUs) at 2.40 GHz (Intel Corporation, CA, USA),
24.0 GB of memory, and a GeForce GTX TITAN (NVIDIA Corporation, CA, USA)
graphics processing unit (GPU). This hardware allowed for training to be performed in
approximately 3.5 hours.
To ensure the generalizability of the algorithm, images from clinical applications with
varying tool properties and appearances were used, with examples shown in Figure 6.2.
Phantom procedures were performed in a tissue-mimicking agar mixture and microwave
ablation applicators with 2.1 mm outer diameters were inserted (depth range: 55.5–81.1
mm) with oblique insertion angles relative to the probe (range: 17.4–65.9°). Phantom
images had a pixel size of 0.2⨯0.2 mm2 and were acquired with a Philips iU22 US system
using a C5-1 curvilinear probe (Philips Healthcare, the Netherlands). Prostate
brachytherapy procedures used 2 mm diameter plastic needles, whereas gynecologic
brachytherapy procedures used 1.65 mm diameter stainless steel needles. Both prostate and
gynecologic brachytherapy images were acquired using a BK ProFocus 2202 US system
with an 8848 endocavity probe (BK Medical, MA, USA). Pixel sizes for the brachytherapy
images ranged between 0.126⨯0.126 mm2 and 0.212⨯0.212 mm2. Both brachytherapy
procedures had needles inserted nearly parallel to the linear US imaging face, often
resulting in reverberation artifacts. Other artifacts also impacted the appearance of these
needles, as more anterior needles often appeared partially obstructed due to shadowing in
prostate images and air artifacts occasionally created discontinuities in gynecologic
images. Ablation and biopsy images with pixel sizes between 0.151⨯0.151 mm2 and
0.428⨯0.386 mm2 were acquired with a Philips iU22 US system using a C5-1 curvilinear
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probe (Philips Healthcare, the Netherlands). For ablation procedures and kidney biopsy,
1.3 mm and 2.1 mm outer diameter applicators were inserted with widely varying depths
and angles (depth range: 30.4–99.0 mm; insertion angle range: 23.3–77.2°) resulting from
the free-hand nature of applicator insertion. These angles relative to the curvilinear US
probe can create discontinuities in the intensity of the applicator with anatomical features
creating a large amount of image clutter and making applicator visualization difficult.

6.2.3

Post-processing and evaluation

Smaller disconnected regions were sometimes present in the predicted segmentations.
Since we assumed that only a single tool was present in our images, we employed two postprocessing methods to filter the predicted masks and fit a single trajectory corresponding
to the needle-like tool. Both methods were implemented offline in MATLAB R2019a
(MathWorks, MA, USA) using a Windows 10 (Microsoft, WA, USA) personal computer
with an i7-5820K CPU at 3.3 GHz (Intel Corporation, CA, USA) following the prediction
using the CNN. Neither approach was optimized for speed or for use with a GPU.
Processing times reported included only the time for filtering and fit, excluding the time to
read or write the predictions and results, as it was assumed that this would be incorporated
into the pipeline when implemented as a routine part of the algorithm.
The simpler approach to tool fitting was implemented using a largest island post-processing
technique to save only the largest connected region of predicted pixels, as has been
previously studied.29 A linear least-squares fit on this map was then used to predict the
tool’s tip and trajectory. In an attempt to more robustly establish the tool axis in the
presence of disconnected outlier regions, a RANSAC model-fitting approach10 was also
evaluated. The RANSAC method used a linear model with a 14-pixel diameter, as nominal
tool widths were between 5 and 14 pixels, depending on the application. The RANSAC fit
was initially performed twice with a 90º rotation of the predicted mask between the two
fits and the direction that maximized the number of inliers was then selected. To produce
a more consistent result and reduce the likelihood of a poor fit resulting from the random
nature of the RANSAC fit, the fit was run two more times in the chosen direction. From
the three fits in the selected direction, the fit with the largest number of inliers was chosen.
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Any pixels that were classified as part of the tool prediction but were not considered inliers
were removed from the mask to generate the filtered mask.
Evaluation of the predicted tool segmentations was performed using a combination of
traditional metrics for pixel map comparisons and tool segmentation-specific error metrics.
Since the number of pixels within the predicted tool region-of-interest (ROI) was expected
to be small relative to the total number of pixels within the image, only pixel map
comparison metrics that excluded true negative predictions were considered. These criteria
included the DSC, recall (i.e., sensitivity), and precision classification statistics. Pixel map
comparisons were performed prior to post-processing and following both filtering
approaches. Tool segmentation-specific errors included the tip and trajectory errors of the
predicted segmentations. Tip errors were computed by determining the Euclidean distance
between the manual gold standard tip location and the automated segmentation tip location
determined by linear fits for both post-processing approaches. Since two points were used
to create the gold standard manual segmentations, vectors for the manual segmentations
(𝑣⃑𝑚𝑎𝑛 ) and the computed vector from the algorithm (𝑣⃑𝐶𝑁𝑁 ) were used to assess trajectory
errors by:
∆𝑇 = cos−1 (

6.2.4

𝑣⃑𝐶𝑁𝑁 ∙ 𝑣⃑𝑚𝑎𝑛
) [°].
‖𝑣⃑𝐶𝑁𝑁 ‖ ∙ ‖𝑣⃑𝑚𝑎𝑛 ‖

(6.1)

User variation

While a single trained user, now denoted U1, generated the gold standard masks used for
training and testing, two additional trained users also generated manual segmentations to
obtain an insight into the potential variability in the gold standard masks. All users
generated two masks per tool on over 200 images with a minimum of 24 hours between
segmentations to allow for quantification of the intra-rater repeatability of the masks. Users
also generated segmentations on a dataset of 211 images to compare the inter-rater
segmentation performance. The intra-rater repeatability was assessed by calculating a tip
localization error analogously to a fiducial localization error33 and the SD of the
corresponding trajectories, as well as the DSC, recall, and precision. Agreement metrics
for the inter-rater comparison were tip localization error, the SD of corresponding
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trajectories, and a three-user DSC,34 as well as a Fleiss’ kappa,35 which determines the
agreement between users while correcting for chance.

6.2.5

Statistical analysis

Statistical calculations were performed in GraphPad Prism 7.00 (GraphPad Software, Inc.,
CA, USA). The normality of distributions was evaluated using the Shapiro-Wilk test and
led to the use of nonparametric statistical tests when the normality assumption was
violated. The corresponding nonparametric alternative tests are presented in parentheses
for the remainder of the section. For nonparametric distributions, descriptive statistics were
reported using medians with interquartile ranges. The significance level for statistical
analysis was chosen such that the probability of making a type I error was less than 5 % (p
< 0.05). The tip and trajectory errors of tools with short visible lengths were compared to
the tip and trajectory errors of tools with longer visible lengths using t-tests (Mann-Whitney
tests). Intra-rater metrics were compared using a one-way analysis of variance (KruskalWallis) test with multiple comparisons performed using a Tukey (Dunn’s) test. The threeuser DSC and Fleiss’ kappa were implemented in MATLAB R2019a (MathWorks, MA,
USA).

6.3
6.3.1

Results
Unfiltered predictions

The CNN algorithm generated predicted segmentations in approximately 50 ms per image.
Examples of the predicted masks generated by the algorithm for each application prior to
post-processing are shown in Figure 6.2, including the corresponding background images
and manual masks used as the gold standard. The small island in the predicted mask of the
gynecologic brachytherapy example is a result of a reverberation artifact in the image and
was eliminated by both post-processing methods. The algorithm identified tools in 96.9 %
of the images in the unseen testing set with three of the ten failures in the kidney images
and the remaining seven in the liver images. The pixel map comparison error metrics prior
to post-processing for each application are summarized in Table 6.2. It should be noted that
due to the large number of liver images available, the overall values reported throughout
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this section are strongly influenced by the liver results. The kidney segmentations
demonstrated much lower DSC and recall medians relative to the other anatomical
backgrounds, reflecting the difficulties in distinguishing needles in kidney US images.29

Table 6.2 Resulting medians [first quartile (Q1), third quartile (Q3)] for DSC, recall, and
precision metrics on an unseen testing dataset prior to post-processing.

6.3.2

Image
Background

DSC (%)

Recall (%)

Precision (%)

Phantom (n = 9)
Prostate (n = 8)
Gynecologic (n = 18)
Liver (n = 249)
Kidney (n = 31)

85.6 [82.1, 89.9]
76.2 [71.0, 84.0]
88.7 [85.8, 92.0]
71.8 [58.0, 86.2]
58.0 [44.7, 70.1]

94.3 [91.0, 99.0]
79.3 [62.8, 88.8]
91.0 [85.7, 95.2]
72.1 [53.1, 88.5]
49.2 [38.6, 59.0]

78.0 [73.0, 84.1]
76.3 [71.1, 82.1]
88.6 [80.8, 91.6]
83.2 [69.4, 89.5]
83.1 [67.2, 98.9]

Overall (n = 315)

71.9 [58.0, 86.3]

72.3 [52.4, 89.3]

83.2 [70.9, 89.8]

Post-processed predictions

The largest island filtering and linear fit were performed with a 2 ms processing time per
tool. The median tip, trajectory, and pixel map metrics resulting from this approach are
summarized in Table 6.3. Similarly, the error and pixel map metrics using the RANSAC
method of fitting and filtering are summarized in Table 6.4 and performed with a
processing time of 23 ms per tool. Overall, the RANSAC method produced lower tip and
trajectory errors than the largest island approach with median [first quartile (Q1), third
quartile (Q3)] tip errors of 3.5 [1.3, 13.5] mm and 4.4 [1.5, 17.8] mm, respectively, and
median [Q1, Q3] trajectory errors of 0.8 [0.3, 1.7]° and 1.4 [0.4, 2.5]°, respectively. The
RANSAC method also had a slightly higher DSC than the largest island method, as well
as improved the precision to a median [Q1, Q3] of 87.5 [76.2, 95.1] % from 84.1 [73.6,
90.4] % obtained with the largest island. Both methods improved the DSC and precision
relative to the unfiltered predicted masks. The largest island method yielded a higher recall
value with a median [Q1, Q3] of 72.3 [51.5, 89.3] % compared to RANSAC with a median
[Q1, Q3] of 67.4 [48.8, 77.6] %, which is also lower than the unfiltered mask recall.
Examples of cases from Figure 6.2, showing the performance of the fitting and filtering
approaches are shown in Figure 6.3. The gynecologic case demonstrates the feasibility of
both approaches to remove the smaller second island generated by the reverberation
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artifact. The liver example shows similar performance between the two techniques but with
the largest island and linear fit approach producing a more accurate tip position than
RANSAC. In the kidney case, the predicted tool appeared fragmented leading to a poor
result using the largest island and a much more accurate result using RANSAC. Kidney
predictions demonstrated much higher tip errors than the other anatomical backgrounds.
Particularly using the largest island approach, removing the kidney from the overall
calculations improves the tip error from 4.4 [1.5, 17.8] mm to 3.5 [1.3, 16.6] mm and also
improves the overall tip error from 3.5 [1.3, 13.5] mm to 3.1 [1.2, 12.7] mm with RANSAC
post-processing. Excluding the kidney results also leads to slight improvements in the
overall trajectory error, DSC, and recall with both post-processing methods.

Table 6.3 After largest island filtering and linear fit, resulting medians [Q1, Q3] for tip and
trajectory errors and DSC, recall, and precision metrics on an unseen testing dataset.
Image
Background

Tip
Error (mm)

Phantom
2.0 [0.6, 3.6]
(n = 9)
Prostate
1.4 [0.9, 8.2]
(n = 8)
Gynecologic
0.3 [0.2, 0.4]
(n = 18)
Liver
5.0 [1.7, 18.1]
(n = 249)
Kidney
10.9 [4.4, 33.4]
(n = 31)
Overall
(n = 315)

4.4 [1.5, 17.8]

Trajectory
Error (°)

DSC (%)

Recall (%)

Precision (%)

0.8 [0.2, 1.9]

85.6 [82.1, 89.9]

94.3 [91.0, 99.0]

78.0 [73.0, 84.1]

0.7 [0.2, 1.3]

76.3 [72.6, 84.8]

79.3 [62.7, 88.8]

81.6 [75.5, 93.4]

0.3 [0.2, 0.6]

89.8 [86.7, 92.9]

89.9 [85.7, 95.2]

89.9 [85.7, 91.7]

1.4 [0.5, 2.4]

71.8 [58.9, 86.4]

72.1 [52.7, 88.5]

83.9 [72.1, 89.8]

3.2 [1.6, 6.0]

58.4 [46.2, 70.5]

44.8 [30.0, 59.0]

87.5 [73.9, 100.0]

1.4 [0.4, 2.5]

72.2 [59.1, 86.6]

72.3 [51.5, 89.2]

84.1 [73.6, 90.4]
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Table 6.4 After RANSAC fitting and filtering, resulting medians [Q1, Q3] for tip and
trajectory errors and DSC, recall, and precision metrics on an unseen testing dataset.
Image
Background

Tip
Error (mm)

Phantom
1.0 [0.6, 3.1]
(n = 9)
Prostate
1.5 [0.9, 8.3]
(n = 8)
Gynecologic
0.3 [0.2, 0.4]
(n = 18)
Liver
3.8 [1.6, 14.3]
(n = 249)
Kidney
10.1 [3.5, 33.8]
(n = 31)
Overall
(n = 315)

3.5 [1.3, 13.5]

Trajectory
Error (°)

DSC (%)

Recall (%)

Precision (%)

0.5 [0.2, 1.9]

87.3 [83.5, 90.3]

94.2 [89.5, 98.7]

80.8 [78.9, 84.5]

0.4 [0.3, 0.7]

78.9 [73.8, 84.7]

73.2 [62.4, 81.9]

87.9 [84.8, 95.8]

0.4 [0.2, 0.7]

88.7 [84.6, 93.5]

85.2 [80.9, 91.1]

93.2 [89.6, 97.0]

0.8 [0.3, 1.6]

72.4 [57.0, 81.4]

67.6 [50.2, 75.5]

87.0 [74.0, 95.0]

2.9 [1.3, 7.5]

55.8 [36.6, 67.9]

42.2 [33.2, 56.6]

86.1 [65.7, 98.9]

0.8 [0.3, 1.7]

73.3 [56.2, 82.3]

67.4 [48.8, 77.6]

87.5 [76.2, 95.1]

Figure 6.3 Cropped predicted masks of example cases from in Figure 6.2 (top row) and
the result after filtering with the largest island approach (middle row) and RANSAC
approach (bottom row) with the corresponding fits shown in red. Both methods performed
similarly for the gynecologic and liver examples, but the RANSAC approach performed
much better than the largest island in the scenario provided by the kidney image.
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The visible length of the tool within the image appeared to influence the variability of the
tip errors, as shown in Figure 6.4(a), and there also appeared to be a trend, illustrated in
Figure 6.4(b), when examining the trajectory errors. This encompassed cases where the
tool was captured in an US image when the tool and imaging plane were not coplanar.
Based on the trajectory errors, an empirical threshold was established where tools with <
35 mm visible within the image demonstrated larger predicted trajectory errors compared
to those tools with ≥ 35 mm visible. Since only liver and kidney images contained tools
with short visible lengths (i.e., < 35 mm), only those applications were included in this
analysis. The tip and trajectory errors after RANSAC post-processing for tools on either
side of this threshold are shown in Table 6.5. As these errors did not pass a normality test,
Mann-Whitney tests were used to evaluate the statistical significance between the two
groups of tools. While the tests failed to show a significant difference in the tip errors, the
liver and kidney tools both showed significant differences between the trajectory errors for
the longer and shorter tools; however, there were only a small number of tools meeting the
criteria for short visible length (7 in kidney images and 26 in liver images) in this study.
Additionally, tip error variability increased for long tools when observing liver and kidney
images combined, but this trend was only demonstrated for liver images when investigated
independently, as the third quartile for kidney (Table 6.5) decreased for long tools.

Figure 6.4 Influence of the visible length of the tools in the liver and kidney US images
on (a) tip error and (b) trajectory error after RANSAC fitting and filtering. There was a
statistically significant difference in the trajectory error between tools with visible lengths
longer and shorter than 35 mm, but no significant difference was observed in the tip error.
The trajectory difference was only observed in kidney and liver applications as all other
applications had all visible lengths longer than 35 mm.
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Table 6.5 Median [Q1, Q3] tip and trajectory errors using RANSAC fitting for kidney and
liver tools with < 35 mm visible (short) within the 2D image compared those ≥ 35 mm
(long) with significance from Mann-Whitney tests shown.
Number of
Tools
Image
Background

Short

Long

Liver

26

223

Kidney

7

24

Overall

33

247

6.3.3

Tip Error (mm)

Short

Long

Trajectory Error (°)

p-value

4.6
3.7
[1.4, 9.2] [1.6, 17.5]
10.7
10.0
[2.6, 71.1] [3.7, 31.6]
4.9
4.4
[1.8, 10.4] [1.7, 18.5]

0.4505
0.5320

0.8021

Short

Long

1.4
[0.8, 3.0]
12.6
[2.9, 27.5]

0.8
[0.3, 1.5]
2.0
[0.6, 4.1]

2.1
[1.0, 6.8]

0.8
[0.3, 1.7]

p-value
0.0007
0.0223

< 0.0001

User variation

A subset of images was used to assess intra-rater repeatability (Table 6.6) for the three
trained users that produced manual segmentations. Though the actual differences in user
performance were small with all median pixel map metrics differing by < 4 %, a KruskalWallis test found significant intra-rater performance differences (p < 0.01) for the DSC and
recall metrics. Using Dunn’s tests, significant differences (p < 0.05) were found between
the intra-rater pixel map performance metrics of U1 and U2 and between U2 and U3, but
not U1 and U3. This indicated that U2 was significantly more repeatable and sensitive than
the other users. U1 and U2 had equivalent tip localization errors of 3.4 mm and median
trajectory SDs of 0.3º, whereas U3 had slightly poorer consistency with a tip localization
error of 4.3 mm and median trajectory SD of 0.5º.

Table 6.6 Intra-rater repeatability for three trained users producing manual segmentations.
Tip localization error and median [Q1, Q3] trajectory SD, DSC, recall, and precision
metrics were determined on a repeated image subset (N) with more than 24 hours between
segmentations.
User [N]

Tip
Localization
Error (mm)

Trajectory SD
(°)

DSC (%)

Recall (%)

Precision (%)

U1 [215]
U2 [251]
U3 [275]

3.4
3.4
4.3

0.3 [0.2, 0.7]
0.3 [0.1, 0.6]
0.5 [0.2, 0.9]

89.7 [84.0, 93.5]
91.9 [83.8, 95.7]
89.5 [82.1, 94.0]

88.9 [82.9, 93.0]
92.2 [85.8, 95.8]
88.5 [82.3, 93.4]

91.3 [86.2, 95.1]
92.7 [84.7, 96.3]
91.3 [85.7, 95.2]
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An identical set of 211 images was used to assess the inter-rater reproducibility (Table 6.7)
with the multi-user DSC and Fleiss’ kappa both showing very strong agreement between
users. The tip localization error, trajectory SD, and DSC had values for the inter-rater
agreement on the same order as the intra-rater repeatability.

Table 6.7 Inter-rater reproducibility of the manual segmentations produced by three trained
users. Tip localization error and the median [Q1, Q3] values of trajectory SD, DSC, and
Fleiss’ kappa metrics are reported for a repeated image subset of 211 images.

6.4

Tip
Localization
Error (mm)

Trajectory SD
(°)

DSC (%)

Fleiss’ Kappa (%)

2.8

0.6 [0.3, 1.1]

90.6 [86.5, 93.8]

87.3 [82.6, 91.7]

Discussion

In this study, we designed and evaluated a CNN-based method for segmenting needle-like
tools in 2D US images in near real-time (approximately 50 ms per tool), demonstrated on
unseen data from phantoms and five different interventional applications from four
anatomical sites. The widespread use of 2D US makes the algorithm clinically relevant for
a large variety of minimally invasive percutaneous interventions that require accurate
placement of tools to achieve desired diagnostic and therapeutic results. The near real-time
segmentation of the algorithm provides the potential for live localization and better
visualization of tools during insertion for interventional procedures. This could enable
clinicians to immediately evaluate the tool position and trajectory and adjust accordingly,
compensating for misalignments without disrupting the clinical workflow or adding
additional segmentation time to the procedure. Future work will involve integrating this
segmentation into the live video stream from the US machine to provide intraoperative
guidance, which could potentially improve the accuracy of tool placement and clinician
confidence in the treatment (e.g., ablation) and sampling (e.g., biopsy) of lesions. One key
advantage of our approach over existing general tool segmentation algorithms developed
for US is the availability of both phantom and patient images from five different clinical
applications and different US machines for development. These images were acquired from
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different facilities with different operators and had a variety of characteristics, including
variable image and pixel sizes, acquisition with different US systems and probe geometries,
and different tool types and diameters. Images from the five clinical interventions, as well
as phantom images, were used for evaluation, whereas most current techniques have only
been tested in phantom or ex vivo environments, occasionally with one clinical application
included. The broad testing environment that our study leveraged for assessment of our
proposed general algorithm provides evidence that our technique may work across many
interventional applications.
Overall pixel map comparisons showed good overlap and agreement between the manual
and predicted segmentations, as described by the DSC (71.9 [58.0, 86.3] %), true positive
rate (recall) of 72.3 [52.4, 89.3] %, and a positive predictive value (precision) of 83.2 [70.9,
89.8] % prior to post-processing. Following post-processing, there was a minor
improvement in the overall DSC, as well as a higher precision. These pixel map
comparisons showed DSC > 85 % and recall rates with both post-processing methods > 85
% for phantom and gynecologic images. Using the RANSAC approach, all applications
had a precision > 80 % and had higher precision for every image background compared to
the largest island approach; however, filtering with the RANSAC approach had the
opposite effect on recall, which decreased for every background. Since the largest island
approach doesn’t modify the predicted pixels and only keeps the largest connected region,
these changes in the pixel map metrics indicate that the CNN had a higher chance to overpredict pixel regions relative to the manual mask resulting from lower false-negatives and
higher false-positives. Since the RANSAC method only keeps inlier pixels based on the
maximum nominal tool diameters, spurious regions, such as the bump on the left side of
the gynecologic example shown in Figure 6.3, are removed. As a result, over-predictions
or predictions wider than this threshold diameter become slimmer, reducing the number of
false positive pixels or increasing the false negative pixels, respectively. Aside from the
kidney, a higher DSC also resulted when using a RANSAC approach and produced
predictions more representative of the tool’s true shape.
The predicted regions were sufficient to estimate the tool’s tip and trajectory using both
post-processing methods. Overall, the RANSAC approach produced a more accurate tip

172

and trajectory identification for the tools than the largest island method but performed
slower than the largest island approach. While neither approach has been optimized for
speed, the chosen method for post-processing could change depending on the application
and choice to prioritize speed or accuracy. Although currently slower, there is the potential
to implement parallelization of the RANSAC method to improve processing time as the
approach executes the fitting step multiple times. Limitations of both approaches are the
assumptions that tools are linear and that there is only one tool present in the images;
however, the type of fit selected could be modified in the future to include other variations
and step-wise predictions with subsequent image filtering could provide a method for
multi-tool segmentation, but both will need to be investigated further.
Tool segmentation was not consistent across all images investigated and varied widely by
anatomical location. Gynecologic images demonstrated the most accurate tool
segmentation-specific metrics when compared to manual masks (median tip: 0.3 mm and
median trajectory: 0.4°). This was likely due to the distinct needle appearance attributable
to being nearly parallel to the linear US imaging face. However, the tip error in these
images may not be a reflection of the true accuracy as they did not always contain the
needle tip within the image field-of-view. In some cases, the tip point was selected to be at
the edge of the image, which may be easier for the algorithm to detect as it removes the
insertion direction component of error. Further investigation into the tip error for this
application is necessary, but likely would be similar to that observed in the prostate
brachytherapy images. The prostate images also demonstrated low tip and trajectory errors
and the overall performance of the algorithm on brachytherapy images demonstrates
robustness to large artifacts, such as the reverberation and shadowing observed in these
images. Following RANSAC post-processing, phantom, prostate, and gynecologic images
all produced median tip errors ≤ 1.5 mm and tools in these images, as well as the liver
images, demonstrated median trajectory errors < 1º. The trajectory errors associated with
kidney and liver ablation tools were shown to improve significantly for tools with more
than 35 mm visible in the image field-of-view, but the spread of the tool tip error was also
observed to increase proportionally with the tool length. Figure 6.4(a) shows that some
liver predictions had very large tip errors, which is also reflected in the high variability in
tip error reported in Table 6.3 and Table 6.4. These large errors were typically associated
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with deeply inserted tools and, due to the free-hand nature of the procedure, are likely the
result of partially visualized tools not entirely in-plane with the US image. In the reported
analysis, we did not implement a success/failure threshold; however, in a clinical setting,
physicians would be able to keep in mind the insertion depths of tools to interpret the
reasonability of the provided segmentation and, in most cases, these large errors likely
appear only for a few frames in a video sequence. Therefore, future work will involve
investigating a method for segmenting very short visible tool lengths and improving deep
tool tip identifications, which may be integrated into the algorithm to improve
performance. Despite the variability in performance across anatomical location, the
performance on the liver images had a relatively high impact on the overall metrics reported
in this study. The negative impact of the poorer performance on kidney predictions also
influenced the overall values reported, but this would cause reported values to be more
conservative compared to the true performance in other anatomical locations and the
relatively larger number of liver images minimizes this influence.
Although the overall median tip error was slightly higher than those reported for other deep
learning-based US tool segmentation methods,27,28 the accuracy achieved is likely
sufficient for most clinical applications. As the other methods were developed only in ex
vivo models28 or specifically for liver27 and kidney29 procedures, they may not reflect the
complexity of clinical scenarios, limiting the generalizability of the approaches and
diversity of the datasets. We demonstrated a median trajectory error for the liver tools of
0.8°, showing an improvement over the mean error of 2° reported by Arif et al.27 Since the
tool angle of incidence in liver images is steeper relative to the US probe than in other
applications, visibility of the tool is reduced36 and tip identification is more challenging,
leading to the observed median tip error of 3.8 mm.
Our algorithm demonstrated much poorer performance in kidney images than the other
applications in this study; however, the DSC of 58.0 % prior to post-processing is similar
to the value of 56.65 % reported by Lee et al.29 Additionally, our median trajectory error
of 2.9º for the kidney ablation tools may offer a substantial improvement over the trajectory
error of 13.3º reported by Lee et al.29, though a direct comparison is not possible given the
use of RMS error in that study. Assuming a similar pixel size, our tip error appears larger
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than the distance error from the Lee et al.29 study; however, their value does not represent
the tip error, which is often much higher since the largest segmentation challenge is
typically the early truncation of the tool path in the insertion direction. The high errors
reported by both studies on the localization of tools in kidney images shows the US
visibility challenges associated with steep tool insertion angles and increased number of
anatomical interfaces with similar echogenicity, emphasizing the need for further research
in this area.
Our precision (83.2 [70.9, 89.8] %) was much higher than that observed by Mwikirize et
al.30 prior to pre-processing, with a similar recall rate; however, Mwikirize et al.
emphasized the importance of pre-processing US images to reduce high-intensity artifacts
in the image, providing a vast improvement in the recall and precision rates of their
algorithm. While pre-processing was avoided in our study to more closely reflect the
intraoperative clinical realities, this may be an area of future investigation to further
improve the accuracy of our results.
The three users in our study produced high pixel map scores on repeated segmentations of
the same tools, all having DSCs > 89 % and recall and precision rates > 88 %, indicating
high intra-rater repeatability in these metrics with U2 demonstrating the highest rate of
repeatability and sensitivity. Although the median trajectory SDs were all ≤ 0.5º, variability
in tip localizations were high with median differences ranging from 3.4 mm to 4.3 mm,
demonstrating the difficulty of the task. This variability is also comparable with the tip
errors produced by our method, suggesting that a large proportion of our reported algorithm
errors are due to manual variability in tip localization. Thus, an alternative to manual
segmentation is required to improve ground truth segmentations for further improvement
in performance. The inter-rater comparison was consistent with intra-rater metrics and
showed that using a single user for earlier comparisons was likely sufficient for assessing
our method. The users also showed strong agreement with minimal effects of chance,
demonstrated with the median Fleiss’ kappa of 89.3 %.
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6.5

Conclusions
We have presented a near real-time approach using deep learning techniques for

fast and accurate segmentation of general needle-like tools in a variety of clinical cancer
applications, demonstrating the potential to improve and ease tool localization in
intraoperative environments during minimally invasive percutaneous interventions.
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Chapter 7

7

Conclusions and directions for future work

Image-guided medical interventions that use 3D information intraoperatively may provide
improvements to the diagnosis and treatment of cancer, but these procedures rely heavily
on the accurate targeting, guidance, and verification of needle-like tools for planned
outcomes. This thesis focused on the application of 3D US imaging and image processing
methods during image-guided interventions in the prostate and liver to provide accessible,
fast, and accurate improvements to the clinical workflow. This chapter provides the
summary, conclusions, limitations, and future directions from the work in Chapters 2-6.

7.1

Summary and conclusions

In Chapter 2, an automatic 2D-3D registration method approaching the frame rate of a US
system was investigated to compensate for prostate motion during 3D TRUS-guided
biopsy procedures. Since patient motion can be continuous or intermittent throughout a 3D
TRUS-guided biopsy procedure, MR-derived targets can be misaligned during biopsy
sampling, which can result in increased needle targeting error and the chance of missing
cancer in suspicious regions identified in the MR image. Two registration modes were
investigated: motion compensation using a single user-initiated correction that could be
performed before biopsy and real-time continuous motion compensation that could be
performed automatically as a background process. A previously developed1 intensity-based
algorithm was further optimized on retrospective patient images by implementing the
algorithm on a GPU, downsampling the 2D and 3D TRUS images by a factor of four,
cropping the 2D TRUS images to 356  292 pixels, and optimizing the Powell search
space order with translations first to avoid local optima near the registration initialization
position. This optimization on patient images resulted in a mean ± SD TRE and
computation time of 1.6 ± 0.6 mm and 57 ± 20 ms, respectively. After implementation in
a 3D TRUS-guided system, a tissue-mimicking prostate phantom with embedded agar
spheres was used to evaluate the user-initiated and continuous registration approaches with
known displacements provided by a micrometre-driven stage. The user-initiated mode
performed registrations with computation times of 108 ± 38 ms, 60 ± 23 ms, and 89 ± 27
ms for in-plane, out-of-plane, and roll motions, respectively, and corresponding
registration errors of 0.4 ± 0.3 mm, 0.2 ± 0.4 mm, and 0.8 ± 0.5°. The continuous method
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performed registration significantly faster (p < 0.05) than the user-initiated method, with
observed computation times of 35 ± 8 ms, 43 ± 16 ms, and 27 ± 5 ms for in-plane, out-ofplane, and roll motions, respectively, and corresponding registration errors of 0.2 ± 0.3
mm, 0.7 ± 0.4 mm, and 0.8 ± 1.0°. The presented method encourages implementation of
real-time motion compensation algorithms in a prostate biopsy as registration errors are
around the previously determined 1.6 mm requirement for sampling clinically significant
prostate cancer with a 95 % confidence.2 Image registration approaching the frame rate of
an ultrasound system offers a key advantage to be smoothly integrated into the clinical
workflow and could be used further for a variety of image-guided interventions, like
prostate brachytherapy or liver ablation, to treat and diagnose patients by improving
targeting accuracy.
Chapter 3 focused on automating the 3D TRUS-guided biopsy workflow further with
additional application to 3D TRUS-guided brachytherapy by developing an algorithm
using a deep learning-based approach for automatic 3D TRUS prostate segmentation.
Using 3D TRUS images effectively typically requires the physician to manually segment
the prostate to define the margins and volume used for accurate registration, targeting, and
dose calculations. However, manual prostate segmentation is a time-consuming and
difficult limitation on clinical workflow, often occurring while the patient is under sedation
(biopsy) or anesthetic (brachytherapy).3 A supervised deep learning-based method was
developed to segment the prostate in 3D TRUS images from different facilities, procedures,
acquisition methods, and commercial ultrasound machine models to create a generalizable
algorithm for needle-based prostate cancer procedures that avoids the development of
procedure-specific approaches. The developed modified U-Net with 3D reconstruction
performed with a median [Q1, Q3] absolute DSC, recall, precision, VPD, MSD, and HD
of 94.1 [92.6, 94.9] %, 96.0 [93.1, 98.5] %, 93.2 [88.8, 95.4] %, 5.78 [2.49, 11.50] %, 0.89
[0.73, 1.09] mm, and 2.89 [2.37, 4.35] mm, respectively, when tested on a dataset of 20
unseen end-fire and 20 side-fire 3D TRUS images. When compared to three fully 3D
networks (i.e., V-Net, Dense V-Net, and High-resolution 3D-Net), our proposed method
performed with significant improvement across nearly all metrics investigated.
Computation time of <0.7 s per prostate was observed, which is a sufficiently short
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segmentation time for intraoperative implementation and enables a generalizable
intraoperative solution for needle-based prostate cancer procedures.
In Chapter 4, a new geometrically variable 3D US scanner, mechanically assisted system,
and 3D-printed therapy applicator guide was developed to provide methods for imaging
and guiding focal liver tumor ablations. Image guidance variabilities with 2D US imaging
during freehand therapy applicator targeting can limit the sufficiency of ablation volumes
and the overall potential of ablation procedures. However, US offers a safe, cheap,
accessible, and real-time advantage over other methods of image-guidance. Proposed
imaging solutions like CT and MRI can provide useful tools for applicator targeting, but
often require longer procedure times, which are more complex and costly, limiting their
widespread use. 3D US was proposed as an alternative image-guidance approach and a
three-motor scanner was designed to be used with any commercially available US probe to
generate accurate, consistent, and geometrically variable 3D US images. The designed
scanner was mounted on a counterbalanced stabilizing and mechanical tracking system for
determining the US probe position and orientation, which was assessed using optical
tracking to have a mean positioning error of 1.85 ± 1.33 mm when performing compound
joint manipulations. The utility of the motorized scanner enabled the development of an
image-guidance navigation workflow that moved the probe to any identified target within
an acquired 3D US image. The complete 3D US guidance system was used to perform
mock targeted interventional procedures on a phantom by selecting a target in a 3D US
image, navigating to the target, and performing needle insertion using a custom 3D-printed
needle applicator guide. Registered post-insertion 3D US images and CBCT images were
used to evaluate tip targeting errors when using the motors, tracking system, or mixed
navigation approaches. A combined approach for navigation that incorporated the
motorized movement and the in-plane tracking system corrections performed best with a
mean tip error of 3.77 ± 2.27 mm and 4.27 ± 2.47 mm based on 3D US and CBCT images,
respectively. 3D US image geometries used during the needle targeting experiments
involved a small-footprint tilt scan and a large field-of-view hybrid scan, which were
observed to have no significant differences in needle tip errors over a total of 48 targeted
needle insertions. 3D US images were qualitatively evaluated in a healthy volunteer and
compared to a commercially available matrix array US probe, which resulted in a clear
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reconstruction of clinically relevant anatomy. Overall, this system provides a utility that
enables enhanced applicator guidance, placement verification, and improved clinical
workflow during focal liver tumor ablation procedures, potentially reducing local cancer
recurrence rates and the feasibility of 3D US stereotactic interventional procedures.
Chapter 5 described the development of a semi-automatic 3D US needle-like therapy
applicator segmentation algorithm that used a single user input to augment the addition of
3D US, like the system described in Chapter 4, to focal liver tumor ablation workflows.
The algorithm was initialized by creating a spherical search space of line segments around
a manually chosen seed point that was selected by a user on the needle applicator visualized
in a 3D US image. The most probable trajectory was chosen by maximizing the count and
intensity of threshold voxels along a line segment and was filtered using the Otsu method
to determine the tip location. Homogeneous tissue-mimicking phantom images containing
needle applicators with manual segmentations were used to optimize the parameters of the
algorithm to median [Q1, Q3] trajectory, axis, and tip errors of 2.1 [1.1, 3.6]°, 1.3 [0.8, 2.1]
mm, and 1.3 [0.7, 2.5] mm, respectively, with a mean ± SD segmentation computation time
of 0.246 ± 0.007 s. The segmentation method was tested with a four-user study using 16 in
vivo, retrospective 3D US patient images, which resulted in overall median [Q1, Q3]
trajectory, axis, and tip errors of 4.5 [2.4, 5.2]°, 1.9 [1.7, 2.1] mm, and 5.1 [2.2, 5.9] mm.
This 3D US semi-automatic tool segmentation offers the ability to quickly assess and adjust
needle applicator placements intraoperatively, potentially improving 3D US liver ablation
clinical workflow and adoption.
A general needle and applicator tool segmentation algorithm was developed in Chapter 6
for 2D US images from multiple image-guided interventions and anatomical regions. Many
interventional procedures, like focal liver ablation, leverage the temporal resolution of 2D
US to provide real-time feedback to aid in the accurate placement of interventional tools.
Identifying tools in 2D US images during intraoperative insertion is necessary for correctly
achieving planned targets for optimal diagnosis or treatment of cancer, but it is often timeconsuming with accurate position information difficult to distinguish. A deep learningbased method, similar to Chapter 3, was used to predict tools in 2D US images in
approximately 50 ms for multiple anatomical sites, despite the widely varying appearances
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across interventional applications. A modified U-Net architecture was trained with realtime

data

augmentation

on

917

images

and

manual

segmentations

from

prostate/gynecologic brachytherapy, liver ablation, and kidney biopsy/ablation procedures,
as well as phantom experiments. Post-processing to identify the tool’s tip and trajectory
was performed using two different approaches, comparing the largest island with a linear
fit to RANSAC fitting. Comparing predictions from 315 unseen test images to manual
segmentations, RANSAC post-processing resulted in improved performance with an
overall median [Q1, Q3] tip error, trajectory error, and DSC of 3.5 [1.3, 13.5] mm, 0.8 [0.3,
1.7]°, and 73.3 [56.2, 82.3] %, respectively. The predictions with the lowest median tip and
trajectory errors were observed in gynecologic images (median tip: 0.3 mm and median
trajectory: 0.4°) with the highest errors in kidney images (median tip: 10.1 mm and median
trajectory: 2.9°). Although variability was observed across different anatomical
applications, the proposed approach could accurately segment tools in 2D US images from
multiple anatomical locations and a variety of clinical interventional procedures in near
real-time. This avoids the need for application-specific methods and provides the potential
to improve image guidance during a broad range of diagnostic and therapeutic cancer
interventions.

7.2

Limitations

The significant limitations of this thesis are discussed in this section and provide a
summary of the discussions presented in Chapters 2-6.

7.2.1

General limitations

All studies investigating patient data in this thesis were retrospective in nature, which was
more practical for developing new methods since relevant images were previously
acquired. However, prospective imaging studies including larger unseen patient test data
for additional evaluation would provide stronger evidence for the clinical utility of the
image processing methods developed. This could include additional evaluations such as
the practicality of integration into clinical workflow, physician approval through a Likert
scale assessment, and randomized control trials to prove the benefit over conventional,
manual techniques. The registration and deep learning methods described in this thesis also
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rely on the need for a GPU to perform at the reported computation speeds, which is not
traditionally available on systems currently used clinically and could limit translation.
However, GPUs are easily incorporated into new systems, such as the liver system
described in Chapter 4, and offer the potential for additional software acceleration to
processes that could benefit from real-time functionality, such as US colour flow imaging.4
Obtaining ground-truth for accuracy assessment is often very complex and difficult, relying
on gold standard techniques, such as manual annotations, to perform as a substitute. These
gold-standard

manual

annotations

include

fiducials

for

registration,

prostate

segmentations, and needle applicator tip and shaft locations. All studies investigating
patient data did not include external validation from other measurement sources due to the
retrospective nature of the studies, which could provide an improved method of accuracy
quantification. However, external system evaluation was performed during phantom
experiments to address this need, such as a micrometre-driven translation stage, optical
tracking, and CBCT images.

7.2.2

Study specific limitations

In Chapter 2, the optimization of the real-time 2D-3D TRUS registration algorithm was
performed on a retrospective patient dataset and tested on phantom images in an ideal
imaging scenario. Optimization on the patient images enabled an approach to refine the
algorithm on expected clinical images, but manually identified fiducials and the TRE
metric were used as a surrogate measure of ground truth displacement and were performed
by a single user. Despite the variability introduced due to manual selection of
corresponding fiducials, an improved method of evaluation would require the knowledge
of a patient’s true displacement without the uncertainty associated with imaging error,
which is an extremely challenging endeavour. This motivated the use of a micrometredriven phantom as an alternative, feasible, and accurate approach to provide ground truth
information for evaluation. However, this approach limits extrapolation to expected
clinical use where images might have less contrasting structures and more image artifacts.
Three independent motions were testing with the phantom to get an impression of the
algorithm’s performance, but complex motion combining multiple degrees-of-freedom
was not investigated. In addition, obtaining variability in phantom motion speed was
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difficult using a hand-driven micrometre stage, but motion speed could influence the
performance of a continuous registration approach since inter-frame displacements would
be larger than investigated, potentially increasing registration computation time. Although
this was not tested, it is assumed the performance would have an upper bound at the level
of the user-initiated results since that experiment mimicked large displacements across a
single US image frame. Finally, the phantom fabricated was a rigid body and was shown
to be easily compensated using a rigid registration algorithm, but the real-time continuous
method still needs to be verified in prospective patient studies where additional motion due
to prostate deformation may occur.
In Chapter 3, an automatic prostate segmentation method was trained, validated, and tested
on a clinically diverse dataset of 3D TRUS images. Although excellent performance was
demonstrated with the proposed algorithm, a parameter that may influence computation
time and accuracy is the step angle for radial slice generation and 2D predictions. Varying
the step angle away from 15° would likely alter computation time since predictions would
be performed on different amounts of image information, but the variability in accuracy is
unknown. When training the 3D CNNs for performance comparison, hyperparameters
were optimized on the V-Net and were used for the other two networks. Although these
hyperparameters were found to perform the best during preliminary experiments on the
Dense V-Net and High-resolution 3D-Net, a rigorous optimization was not performed and
has the potential to increase performance. Another limitation of this study was the use of
only one observer for providing gold standard manual segmentations. Although inter- and
intra-observer variability was not assessed for the dataset used, variability in end-fire 3D
TRUS images5 and side-fire 3D TRUS images6 were previously assessed by our group.
Previously reported user variabilities were comparable to the reported DSC of the proposed
segmentation method in this chapter, showing that the algorithm was performing at the
level of variability observed in the gold standard segmentations. Due to the demonstrated
variability between different observers when segmenting 3D TRUS images, segmentations
from other observers should be investigated and incorporated into the testing dataset to
further demonstrate the robustness of the proposed method.
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In Chapter 4, a novel mechanically assisted 3D US system with geometrically variable
image geometries was evaluated using optical tracking, phantom images, and CBCT
images. One caveat of the navigation errors reported in the study was the ideal nature of
the needle insertion experiments, which did not contain expected clinical issues such as
liver motion. The imaging phantom was also limited in deformation characteristics relative
to a patient, which could cause issues like needle deflection during needle insertion.
Healthy volunteer images were also acquired under a breath-hold technique to evaluate
clinical imaging feasibility. Although the images were reconstructed to visualize clinically
relevant anatomy for liver ablation procedures, patients who are unable to hold their breath
for 12 s would incorporate motion artifacts during 3D US acquisition. Image acquisition
can be performed faster with this system by acquiring fewer images, but alterations to
image reconstruction quality were not assessed. Images of healthy volunteers were only
shown for one volunteer, so a wider range of body sizes should be investigated in the future.
In Chapter 5, a semi-automatic 3D US needle applicator segmentation algorithm was
developed and optimized on phantom images before evaluation on a dataset of patient 3D
US images containing needle-like therapy applicators in the liver. This relatively small
dataset of patient images limited potential development of the segmentation algorithm as
images of phantoms with minimal US echogenecity were relied on for optimizing the
approach. Although the dataset was small, this was the largest clinical liver dataset of 3D
US images evaluated to-date for needle applicator segmentation. A fixed adjustment to the
Otsu threshold was implemented for accurate applicator tip localization, but it is possible
that the adjustment is influenced by the needle applicator’s SBR in the 3D US images and
investigation into a dynamic adjustment was limited. The choice to use an Otsu threshold
was also a potential limitation in this study as the assumption of a bimodal intensity
distribution that was split between foreground (i.e., applicator) and background was not
always maintain when evaluating the clinical images. Image features that were observed to
limit the performance of the algorithm were large gaps along the needle applicator shaft
and the presence of arteries and veins causing similar acoustic reflection intensities.
Needle-like therapy applicators were also assumed to be linear, but this was a sufficient
assumption for the clinical images investigated. However, this assumption limits
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application to a broader range of procedures that include thinner diameter interventional
tools that have a higher probability for deflection and bending.
In Chapter 6, a deep learning-based approach compared two post-processing techniques
for segmenting needle-like tools in 2D US images. This method was trained, validated, and
tested on unseen data from five different interventional applications from four anatomical
sites and phantom experiments. The advantage of this study compared to previously
reported methods was the variability in image data used for development; however, the
number of patients and images accessible for this study were not balanced across all
anatomical sites investigated. Overall values of accuracy were reported, but these results
were heavily skewed by the performance using liver images. Tip errors reported for
gynecologic images may not be a reflection of the true accuracy for this anatomical region
as they did not always contain the needle tip within the image field-of-view. Since the
identification of the tip location is typically the most difficult aspect of needle-like tool
segmentation, the complete understanding of performance on gynecologic images could be
limited. Despite this limitation, performance is expected to be similar to the prostate
brachytherapy images since tool trajectories are parallel to the US probe face, which
demonstrated low tip and trajectory errors with robustness to large artifacts, such as
reverberation and shadowing. The post-processing approaches tested with this method also
assumed a single tool was present and that it was linear, which might limit the performance
of the algorithm if multiple tools are visible, as in brachytherapy procedures, or if tools
deflect within the body. However, the type of fit used in this work could be modified in the
future to include other variations and step-wise predictions with subsequent image filtering,
which could provide a method for multi-tool segmentation. Lastly, investigation on user
variability when producing manual segmentations revealed large median differences for
tip identification relative to the reported metrics on the test dataset. This limits a complete
understanding of the segmentation performance as errors reported incorporated a nonnegligible amount of human error and did not isolate the accuracy solely due to the
algorithm, stressing the difficulty of the segmentation problem.
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7.3
7.3.1

Future directions
2D-3D prostate motion compensation clinical translation

A 2D-3D TRUS registration method was implemented on a guidance system in Chapter 2
for evaluating the clinical feasibility of a continuous registration approach during prostate
biopsy. To expand beyond the phantom experiments and provide additional evidence for
clinical feasibility, a proof-of-concept prospective clinical study has been investigated with
the implemented method in Chapter 2.7 Although the patient sample size was small (i.e.,
three patients), the registration approach was observed to have a median [Q1, Q3]
registration error of 3.4 [1.5, 8.2] mm and a mean ± SD computation time of 27 ± 8 ms
when evaluating 21 2D-3D image pairs acquired during the conventional biopsy
procedure.7 Larger registration errors were observed during sampling of tissue samples on
the lateral edges of the prostate, so a new method of navigation that emphasized US probe
rotation was developed during continuous 2D-3D TRUS registration. This new approach
resulted in a median [Q1, Q3] registration error of 2.0 [1.3, 2.5] mm and a mean ± SD
computation time of 22 ± 3 ms when evaluated on 18 image pairs, providing evidence that
clinical implementation of the registration algorithm with a workflow adjustment could
improve prostate biopsy targeting. These results support the investigation into a larger
clinical trial with prospective patient imaging and may require the need for external
imaging after needle insertion to directly verify needle targeting accuracy.

7.3.2

Multi-institutional 3D TRUS prostate segmentation

Chapter 3 described the development and evaluation of an automatic prostate segmentation
method on 3D TRUS image acquired using end-fire and side-fire probes. Another common
geometry for 3D TRUS image acquisition can be achieved using biplane probes during 3D
TRUS-guided prostate brachytherapy, which have transverse elements that can be used to
axially-reconstruct 3D images using tracked steppers.8 A dataset including these images
with manual 3D segmentations could easily be evaluated and would enable the proposed
approach to have a wider potential impact and further prove the results of the method being
image reconstruction geometry independent. Even if significant differences were to be
observed when evaluated on this new acquisition geometry, including additional images in
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the training set of the deep learning approach may be the only required alteration, which is
an easily performed task.
Providing further evidence for prospective clinical utility and impact of the automated
segmentation approach could be performed through the use of a multi-user and multiinstitutional study. This could either provide evidence that the method is not biased to the
single user used for training the approach or stress the need to incorporate alternatives for
different users. The clinical impact could also be investigated across multiple users through
the evaluation of segmentation accuracy and variability on radiation dose planning. Also,
an editing time metric could be investigated to provide supporting evidence for benefits to
clinical workflow and patient throughput.9

7.3.3

CT-US fusion-guided liver ablation

Figure 7.1 Proposed workflow for a CT-3D US-guided focal liver ablation.
3D US has the potential to improve applicator targeting accuracy during focal liver tumor
ablation therapies with the opportunity to draw many parallels to MR-TRUS fusion-guided
prostate biopsy. Conventional liver ablation procedures are typically only performed on
lesions with diameters less than 50 mm due to the accuracy required for placing and
repositioning multiple applicators with overlapping ablation volumes,10 but an accurate
image-guidance pipeline and system could provide the tools necessary to expand the
number of patients eligible for ablation procedures. As shown in Figure 7.1, many modules
can be incorporated into the system to plan, guide, and verify an applicator(s) placement at

191

the location of a tumor(s). Planning in the preoperative setting based on an initial CT image
could allow for the segmentation of the tumor and provide targets for an applicator
planning application to determine the optimal configuration, especially for multi-applicator
treatments.11 A CT to 3D US deformable image registration12 could bring these CT-derived
segmentations and targets into the intraoperative setting on the day of the procedure.
Image-guidance could be performed using a motion compensation 2D-3D US registration
algorithm, like an adaptation from the method described in Chapter 2, to adjust coordinate
systems and allow for motorized target navigation, as described in Chapter 4. Using the
method described in Chapter 6, 2D applicator segmentation could be performed on the live
image sequence to help aid with applicator insertion. Lastly, verification of applicator
guidance could be performed with subsequent and repeated 3D US images. These images
could be used with the 3D applicator segmentation method developed in Chapter 5, or a
fully automated deep-learning approach, for generating applicator locations and planned
ablation volumes for therapeutic margin assessment before initiating the therapy session.
Technology that enables a stereotactic interventional approach could exploit the low
complication rates and recovery times of focal liver ablation procedures, while increasing
patient eligibility, decreasing local cancer recurrence rates, and increasing overall patient
survival.
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Accuracy of a 3D Ultrasound System for Interventional Liver Cancer Therapies,” Imaging
Network Ontario (ImNO) [3rd Place], Virtual Meeting, March 26-27, 2020
2. Papernick, S, Gillies DJ, Barker K, Gardi L, Fenster A, “Validating Three-Dimensional
Ultrasound Measurements of the Synovium for Diagnosis of Rheumatoid Arthritis,” Imaging
Network Ontario (ImNO), DoubleTree by Hilton, London, ON, March 28-29, 2019
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Retreat, King’s College, London, ON, June 1, 2018
9. Gillies DJ, Awad J, Rodgers JR, Edirisinghe C, Kakani N, Fenster A, “Making It Easier to
See: Applicator Segmentation for Interventional Liver Therapies in Three-dimensional
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14. Gillies DJ, Zhao R, Gardi L, Fenster A, “Motion Compensation During Prostate Biopsies
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